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A. General introduction 
 
In medical diagnostics, visualizing molecular processes with cellular resolution is required for 
early diagnosis and therapeutic approaches. Thereby, considerable efforts have been devoted 
toward developing various imaging modalities. Each available imaging modality has its own 
strengths and weaknesses in terms of sensitivity, spatial resolution, target-to-background 
contrast or potential in clinical applications. After the first visualization of the human body 
via magnetic resonance imaging (MRI) in 1977 [1], [2] , MRI has become the most 
widespread clinical diagnostic imaging technique in cancer therapy. MRI offers several 
significant advantages over other modalities such as high spatial resolution, noninvasiveness, 
absence of ionizing radiation, and capability to elicit both anatomic and physiologic 
information simultaneously [3].  
However, MRI is emerging an advantageous technique; overriding challenge with MRI is its 
relatively low sensitively (insufficient contrast) for label detection. In order to better 
distinguish targeted tissue from surrounding tissue, contrast of the images needs to be 
enhanced. The contrast of MRI could be affected either by intrinsic (T1, T2 T2
*
, proton-
density, flow, chemical environment, diffusion and perfusion) or extrinsic (pulse sequence, 
acquisition parameters (TE and TR, flip angel, etc.), strength of applied field and contrast 
agents) parameters. One common approach to overcome the lack of MRI sensitivity is 
applying the contrast agents to provide additional contrast. A tremendous effort has been 
spent on designing contrast agents which exhibits high relaxivity, low toxicity, specificity, 
and suitable long intravascular duration and excretion time.  
Macrocyclic ligands are widely utilized as the metal chelators owing to high thermodynamic 
and kinetic stability [4]. Among the studied macrocyclic chelator, porphyrin has attracted 
much attention in cancer diagnosis and treatment due to its feature preferential uptake by 
tumor cells (including sarcomas, carcinomas, and atheromatous plaque) [5] while the reasons 
for this selectivity remain  obscure till now. After the first report about high efficiency of 
water soluble Mn(II)-mesoporphyrin  as a tumor targeting MRI contrast agent [6], numerous 
works have been devoted to study the potential of various water soluble Mn(II) and Fe(II) 
mesoporphyrins as MRI contrast agents. Nonetheless, low stability of Gd(III)-mesoporphyrins 
has prevented in development of these complexes. Metallated meso-tetra-pyridyle porphyrin 
is considered as an axial-ligand stretch due to the coordination of the metal with one nitrogen 
atom coming from the adjacent porphine molecules  which can improve its stability [7]. One 
way to improve water solubility, is by encapsulating in or covalently attaching the CA on the 
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surface of nanocarriers, leading to improving simultaneously stability, biocompatibility, and 
the release of paramagnetic ions. Over the last decades, numerous nanocarriers have been 
explored as platforms for paramagnetic-labeling and/or encapsulation, including polymers, 
proteins, dendrimers, micelles, and vesicles. Among the studied polymers, chitosan has been 
receiving much attention in drug delivery and molecular imaging owing to its characteristic 
properties, including biocompatibility, biodegradability, nontoxicity, and mucoadhesive 
properties [8], [9]. Hence, conjugation/or encapsulation of metallated- meso-tetra-pyridyle 
porphyrin with chitosan could be considered as a novel contrast agent.  
On the other hand, developing favorable multifunctional imaging probes becomes 
increasingly more demanding these days in order to obtain complementary physiological and 
anatomical information and improving the detection of tumor tissues. Nanoparticles offer an 
ideal platform for developing dual modality probes in molecular imaging techniques owing to 
their high surface to volume ratio and the possibility to perform surface modification, 
functionalization and bioconjugation. In this context, quantum dots (QDs) doped with 
paramagnetic metal ions have been extensively investigated as dual magneto optical cancer 
probes. Mn-doped QDs are some of the most investigated QDs in medical imaging. Although, 
research has been mostly focused on the potential of manganese-doped QDs  as a fluorescent 
bio-label [10], its efficiency as an MRI contrast agent is less well studied. Moreover, the 
majority of Mn-doped QDs as both a MRI contrast agent and a fluorescence label are 
core/shell structured nanoparticles.  While doping of metal ions on the surface of QDs could 
be a new approach to design the dual agents (i.e. fluorescence and MRI agents) which offers 
an opportunity to improve the relaxivity of QDs.  
Besides the experimental studies, the computational studies allow to gain detailed information 
about the structure of the paramagnetic substance, solvent, intramolecular interactions of the 
paramagnetic species in aqueous solution and dynamics of molecules in system [11]. 
Molecular dynamic simulation (MDs) is one of the most utilized numerical techniques to 
approximate macroscopic properties of the system. MDs is widely used to understand the 
dynamic and thermodynamic properties of materials and living matter by observing the 
position of certain number of atoms/particles over given period. Thus, modeling the contrast 
agents surrounded with water molecules via molecular dynamic simulation permits us to 
obtain reliable insight through interaction between a paramagnetic ion and solvation water, 
while the long-term goal is understanding the relaxation mechanism. 
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B. Objective of thesis 
 
The main aim of my work is developing two new paramagnetic complexes as magnetic 
resonance imaging longitudinal MRI contrast agents in the form of macromolecular and 
nanoparticular contrast agents.  
1. Developing Gd-meso-tetra-pyridyle porphyrin conjugated with chitosan nanoparticles, 
which exhibit the high efficiency as MRI contrast agents with a great potential in 
biomedical applications owing to interesting chitosan properties such as 
biocompatibility, biodegradability, and mucoadhesive. 
2. Developing Mn-doped ZnS quantum dots with high Mn dopant concentrations, in 
which the majority of Mn lies close to or on the surface of ZnS to extend their 
application as MRI contrast agents. In order to obtain significant insight about 
Mn:ZnS interaction with surrounding water molecules, molecular dynamic simulation 
is carried out for better understanding the relaxation mechanisms of Mn-doped ZnS 
dispersed in water. Then the simulated results correlate with experimental r1 relaxivity 
as a function of Mn dopant concentration. 
 
C. Thesis outline 
 
The theory of relaxation mechanism is described in Chapter 2. It provides the necessary basics 
of MRI and relaxation mechanism of paramagnetic contrast agents. In Chapter 3, the literature 
related to the objective of thesis is reviewed.  Owing to the interdisciplinary character of this 
work, the literature review chapter is composed of four major parts. The first part provides an 
overview of metalloprphyrin complexes and their in-vitro and in-vivo efficiency as MRI 
contrast agents. The second part describes the potential of different developed 
macromolecular contrast agents. Afterwards, the third part of the literature review deals with 
the potential of quantum dots as MRI contrast agents. Finally, the numerical simulation 
background of nanoparticles in particular those used for evaluating/interpreting the dynamic 
of QDs in aqueous solution will be explained. Chapter 4 concerns methodological and 
characterization of both developed paramagnetic complexes. Meantime, molecular dynamic 
simulations procedure and the potential parameters are explained. Chapter 5 deals with the 
results and discussion of physicochemical characterization of two novel developed contrast 
agents and their efficiency as MRI contrast enhancers. The simulated results of Mn:ZnS QDs 
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in vacuum and in aqueous media (water) are then described in the last section of Chapter 5.  
Finally in the Chapter 6, the contributions of my thesis work is summarized by providing 
some helpful prospectives to future research directions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter II: Relaxation mechanism 
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A. Basic principle of MRI 
 
Magnetic Resonance Imaging (MRI) is based on the magnetic properties of water protons 
(hydrogen) and on the water protons interaction with both applied magnetic field and 
radiofrequency producing highly detailed images of the human body. The hydrogen atom has 
a net magnetic moment. Therefore, in the absence of an external magnetic field, protons are 
randomly orientated. The protons tend to align with or against the magnetic field and precess 
around it. The frequency of precession is described by Larmor’s equation  
Ω=γB         (1) 
where ω is the frequency precession and γ is the gyromagnetic ratio, which is a constant, and 
B is strength of applied field. During application of an external magnetic field (B0), the 
majority of protons align along the field direction into the low energy state, giving rise to a 
net magnetization in the direction of B0. The second weaker magnetic field, radiofrequency 
(RF) pulse, is applied in a perpendicular direction to the first field and oscillated at a Larmor 
frequency. This causes the magnetic moment (M) to tilt away from B0 and flip about an angle 
dependent on the pulse duration and amplitude as presented in Fig. 1. After the termination of 
the RF pulse, the magnetization will not precess perpetually around the B0-field but will return 
to its equilibrium position along the z-axis (direction of B0). 
 
 
Figure 1. Schematic represents a) precession of magnetic moment around B0, b) effect of RF 
radiation on net magnetic momentum which is tilted from its original orientation (z-axis) into 
transverse plane (x-y), and c) flip angle [12]. 
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During relaxation, the nuclei lose energy by emitting their own RF signal. This signal is 
referred to free-induction decay (FID) response signal, which could be observed thanks to the 
induced current in a detector coil. After a 90° RF pulse, the amplitude of the signal detected 
by the coil does not rapidly drop down to zero. The loss of transverse magnetization with time 
because of spin dephasing is referred to as Free Induction Decay (FID). The Larmor 
frequencies of distinctive nuclei and their respective contributions are obtained by Fourier 
transform of this signal. 
 
B. Relaxation time  
 
The return of magnetic moment to its equilibrium state is expressed as relaxation. T1 
relaxation (also known as spin-lattice or longitudinal relaxation) is the realignment of spins 
(M) with the external magnetic field B0 (z-axis). T2 relaxation (also known as T2 decay, 
transverse relaxation or spin-spin relaxation) is the decrease of the Mxy component. 
 
 
Figure 2.  a) Longitudinal and b) Transverse relaxation time of magnetic moment after 
termination of RF [13] 
 
B.1. Longitudinal relaxation time 
 
After the RF pulse, nuclei will dissipate their excess energy as heat and revert to their 
Boltzman equilibrium position. Realignment of the nuclei along z-axis (B0), through a process 
known as recovery, leads to a gradual increase in the longitudinal magnetization. The time 
taken for a nucleus to relax back to its equilibrium state is called longitudinal relaxation time. 
The process of equilibrium restoration is described as follows  
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)1).(0()( 1T
t
zz eMtM

       (2)     
where T1 is the time taken for the longitudinal magnetization to be restored. 
 
B.2. Transverse relaxation time 
 
After applying a RF pulse, all the individual spins magnetic moments precess coherently 
around the z-axis, creating a magnetization component in the xy-plane. The magnetic 
moments interact with each other causing a decrease in transverse magnetization. The 
transverse relaxation time corresponds to the time taken for disappearance of magnetization in 
the xy-plane. The transverse relaxation time is described by the following equation  
2).0()( T
t
xyxy eMtM

       (3) 
while T2 is the time taken that the transverse magntizations decay to 37% of its initial value. 
The relaxation time of water could be shortened by nearby paramagnetic or 
superparamagnetic particles due to their large electronic magnetic moments (dipoles) in the 
presence of external magnetic field. Gd (III) with seven and Mn (II) and Fe (II) with five 
unpaired electrons are the most widely used paramagnetic ions for increasing proton 
relaxation rate of water molecules.  
The efficiency of paramagnetic ions to affect the relaxation times of water protons is 
evaluated by relaxivity (r1 or r2) which are defined as the increase of relaxation rate (1/T1 or 
1/T2) produced by 1mmol per liter of paramagnetic substance (expressed mmol
-1
.s
-1
). The r1 
and r2 relaxivities are the main physicochemical parameters in development and design of 
contrast agents.  
Cr
TT
i
diaiobsi

)()(
11
  i=1,2                 (4) 
where 
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1
obsiT
 corresponds the relaxation rate of aqueous system (s
-1
) , 
)(
1
diaiT
relaxation rate of 
the solvent (s
-1
), C concentration of paramagnetic ion (mmol
-1
) and ri the relaxivity (mmol
-1
.s
-
1
). 
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C. Paramagnetic relaxation time 
 
A quantitative theoretical model has been developed to demonstrate the relaxivity of contrast 
agents [14]. The paramagnetic relaxation of water protons originates from the dipole-dipole 
interactions between proton nuclear spins of water molecules and the fluctuating local 
magnetic field, which is produced from unpaired electron spins of the paramagnetic ions [15]. 
The paramagnetic relaxation is explained by inner, second, and outer sphere contributions 
[16], as shown in Fig. 3. The inner sphere contribution arises from interaction of water 
molecule(s) in the first coordination sphere with paramagnetic ions which transmitted to bulk 
via chemical exchange [17]. Besides the inner sphere coordinated water, there are some water 
molecules that may be bonded to the ligand (hydrogen-bonded) or to the inner sphere water 
molecule(s). These water molecules also contribute to overall paramagnetic relaxation, 
identifying as second sphere contribution [17]. The bulk water molecules, which have 
diffused around the paramagnetic center, also experience the paramagnetic effect. This 
relaxation mechanism is defined as outer sphere contribution. Thereby, total paramagnetic 
relaxation rate can be expressed as follows 
2,1
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where IS, SS and OS stand from inner, second and outer sphere, respectively. 
 
 
Figure 3. Schematic representation of the inner, second and outer sphere contributions on 
relaxation time [18] 
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C.1. Inner Sphere Proton relaxivity 
 
The relaxivity of bulk water is based on exchange of coordinated water with paramagnetic 
ions, defined as  
 
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
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Where 
mT1
1
and 
mT2
1
are longitudinal and transverse relaxivities, m is the chemical shift 
difference between coordinated water and bulk water, m   is lifetime of coordinated water in 
first sphere, and q is the number of coordinated water moolecules. The relaxation of a 
coordinated water proton is governed by dipole-dipole coupling (dd) between the 
paramagnetic ion and hydrogen of water [19], scalar relaxation (sc) [19], and curie spin (cs) 
relaxations [20]. It is noteworthy that at high magnetic field of 1.5T and higher, only dipolar 
relaxation contributes to longitudinal relaxation rate while all three mechanisms can 
contribute to transverse relaxation rate. 
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Moreover, transverse relaxivity arises from inner sphere contribution is defined as follows 
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Where γ is the nuclear gyromagnetic ratio, g electron factor, μB Bohr magneton, rMH the 
electron spin-proton distance, τc correlation time, and ωI and ωH are the nuclear and electron 
Larmor frequencies, respectively. The correlation time (τc) is defined as  
ieRmci T
1111


                                               i=1,2   (14) 
while τR is the rotational correlation time and T1e and T2e are longitudinal and transverse 
electron spin relaxation time. 
 
C.1.1.  Dipolar interaction 
 
The interaction between two magnetic moments causes the field fluctuation. The alignment of 
spin to magnetic field influence the local dipolar field of neighboring spin (as shown in Fig. 
4). This interaction is known as dipole-dipole or dipolar coupling. The interaction could be 
heteronuclear or homonuclear, between different nuclei or the same sort, respectively. The 
dipolar interaction plays a main role in the relaxation mechanism, especially for the higher 
spin system.    
 
Figure 4. Orientation-dependent dipolar field experienced by a neighboring spin 
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C.1.2.  Scalar interaction 
 
The scalar interaction occurs when the nucleus-electron distance is about the nucleus radius. 
Thereby, the nuclei bound directly to the paramagnetic specie undergoing the scalar 
interaction. The scalar interaction is mainly influenced by electron spin relaxation and by 
water exchange rates and remains unaffected by orientation of the molecule. The correlation 
time of scalar interaction is given by  
MieSCi T 
111
    i=1,2                                                       (15) 
For the CAs composed of paramagnetic ions with S>1/2, electron spin relaxations are 
interpreted in terms of Zero Field Splitting (ZFS) interaction. The electronic relaxation is field 
dependent. For Gd(III) complex the rates are interpreted as follows 
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Where τv is correlation time for modulation of ZFS interaction, Δ amplitude of transient ZFS 
and τS0 electron spin relaxation time at zero field. 
 
C.1.3.  Curie relaxation 
 
In paramagnetic system, due to the Boltzman distribution there is a difference in the 
populations of electron spin energy levels, which induce a magnetic moment. This 
perturbation can influence the relaxation mechanism which is known as curie relaxation.  
Referring equations 6 to 18, numerous parameters have an impact on protons relaxivity from 
inner sphere contributions.  
1. Rotational coordination time ( R ): reorientation of vector between paramagnetic ion 
and the water molecule proton.  
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2. Electronic relaxation time ( ee TT 21 , ): the process of returning to equilibrium state of 
magnetization associated to electrons during transitions between electronic levels of 
paramagnetic center. 
3. Number of coordinated water molecules (q) 
4. Distance between proton and paramagnetic ions (rMH) have sixth-power dependence 
and influence significantly the dipolar relaxation rate.   
5. Residence time of coordinated water )( M : exchange between water molecules 
surrounding the complex and water coordinated to the metal ion. The residency time 
should be long enough to increase the probability of relaxation to occur meanwhile 
short enough to exchange the relaxed water molecule with the bulk water [21]. 
 
C.2. Second sphere relaxivity 
 
The second sphere relaxation pathway in principle depends on the same parameters as the 
inner sphere term. The contribution is enhanced by slowing down rotational correlation time, 
increasing the number of hydrogen-bonded waters and their residency lifetime. The 
distinguishing contribution of the second sphere from the outer sphere term is very difficult. 
The effect of second sphere term on relaxivity has been reported for [Gd-DOTP]
5-
 (q=0) with 
human serum albumin (HAS). The relaxivity enhancement of [Gd-DOTP]
5-
 in the presence of 
(HAS) has been attributed to the presence of exchangeable protons on proteins close to the 
interaction site of the complex and from hydrogen-bonded water molecules in the second 
sphere shell. 
 
C.3. Outer sphere relaxivity 
 
Outer sphere theory demonstrates the relaxation induced by diffusion of water molecules 
within the magnetic field gradient around the paramagnetic hydrated ion [22]. This 
mechanism may contribute to the relaxivity of paramagnetic complexes at the imaging fields, 
arising from modulation of dipolar interaction of the paramagnetic ions with water molecules 
which are diffusing next to the surface of the complex. The component relaxivity arising from 
the outer sphere has been estimated by a expression derived by Freed [23].   
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Where a is the distance of closest approach, D diffusion constant, and τD translational 
correlation time equal to a
2
/D, constant C
OS
 (5.8x10
-10
 m
6
mol
-1
s
-2) and J(ω) is the non-
Lorentzian spectral density. At the imaging field, the outer sphere relaxivity depends on 
distance of closest approach, which attributes to the molecular dimension and charge 
distribution of complex, and on the relative diffusion coefficient of solute and solvent.  
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Over decades, much effort has been focused on developing the MRI contrast agents with high 
efficiency. However, until now only some of these agents are clinically approved. The Gd-
based contrast agents available for clinical use, presented in Fig. 5 and summarized in Table 
1, are nine coordinated complexes, binding with eight ligand sites and one water molecule, 
with molecular weight less than 1000 Da. Among the listed CAs, [Gd(DTPA)(H2O)], first 
approved contrast agent [24], [Gd(DOTA)(H2O)], [Gd(BOPTA)(H2O)] and MS-325 are ionic 
CAs while the rest are neutral CAs.  
 
Figure 5. Schematic of commercial Gd-based clinical approved MRI contrast agents [25] 
 
The first generation of currently available clinical contrast agents is non-specific extracellular 
MRI CAs. They distribute into the intravascular and interstitial space. This allows us to 
evaluate the physiological parameters, including renal function and status or existence of 
blood brain barriers [26].  Non-specificity of conventional CAs causes their poor performance 
for early diagnosis and imaging of specific organs. However, CAs with preferential uptake to 
 
 
22 
 
a particular tissue would improve the diagnostic accuracy. This type of CAs has been named 
as targeted CAs or second generation CAs.  
Table 1. Available commercial Gd-based MRI contrast agents  
Chemical name Generic name Brand 
name 
Charge Company Relaxivity 
(mM
-1
s
-1
) 
(Gd(DTPA)(H20)]
 
Gadopentetate 
dimeglumine 
Magnevist 2- Schering(Germany) 
+
r1=4.9, r2=6.3 
[Gd(DOTA)(H20)]
 
Gadoterate 
meglumine 
Dotarem 1- Guerbet (France) r1=3.4, r2=4.8, 
B0=1.0T 
[Gd(DTPA-BMA)(H20)] Gadodiamide Omniscan 0 Amersham *r1=5.4 
[Gd(HP-D03A)(H20)] Gadoteridol ProHance 0 Bracco (Italy) *r1=5.4 
[Gd(D03A-butrol)(H20)] Gadobutrol Gadovist 0 Schering(Germany) r1=3.6, B0=1.0 
T 
(Gd(DTPA-
BMEA)(H20)] 
Gadoversetamide OptiMARK 0 Mallinckrodt (U. S.)  
♦
[Gd(BOPTA)(H2O)] Gadobenate 
Dimeglumine 
MultiHance 2- Bracco spa (Italy) 
+
r1 = 9.7, r2 = 
12.5 
♦
Gd-EOB-DTPA Gadoxetic acid Primovist 2- Schering (Germany) *r1 = 6.9, r2 = 
8.7 
MS-325 Gadofosveset 
trisodium 
Vasovist 3- EPIX/Schering, 
Malinckrodt 
r1=27.7, 
r2=72.6, 1.5T 
+ In heparinized human plasma, at 39°C 
* In citrated human plasma, at 37°C 
♦ 
Second generation of CAs 
 
Gd[BOPTA] and Gd-EOB-DTPA are classified as second generation contrast agents. Second 
generation CAs exhibit responsive behavior to physiochemical environments such as pH of 
solution, temperature, redox potential, metal ion concentration (Zn, Ca, Cu), and enzyme 
activity. These agents have shown the selectively uptake by a particular kind of cell. For 
instant, [Gd (BOPTA)]
2-
 has shown great efficiency in the imaging of liver and myocardium 
[27]. Moreover, it has been used in applications of perfusion cardiac MRI for the diagnosis of 
coronary artery disease, cardiac tumors, inflammations and different types of 
cardiomyopathies [27]. [Gd(EOB-DTPA)]
2- 
is applied  for detection of liver metastases [28]. 
Nowadays, much research has been focused on designing targeted CA. 
 
A. Tumor-Targeting contrast agents  
 
In actively growing tumor cells with volume greater than 2 mm
3
, delivery of nutrients and 
oxygen become limited. In order to supply oxygen and nutrients to tumor cells, new blood 
vessels form around tumor cells with enlarge gap junction of 100 nm to 2μm [29]. These new 
vessels are irregular and poorly organized which shows leaky fenestrations. This leads the 
extravasations of small macromolecules and nanoparticles smaller than 100 nm, which are out 
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of vasculature, into tumor cells [30]. Moreover, tumor cells show higher compound retention 
time compared with healthy tissues because of their inefficient lymphatic drainage [31], [32]. 
These two features provide an enhanced permeability and retention (EPR) effect in tumor 
cells that is playing an important role for passive targeting and accumulation of contrast 
agents in tumor interstitium [29]. The accumulation of targeting agents in tumor cells 
passively or actively is schematically presented in Fig. 6.  
 
 
Figure 6. Schematic of targeted CAs in tumor cells passively and actively [33] 
 
Furthermore, one method to increase the accumulation of CAs in tumor tissues is surface 
conjugation of CAs with appropriate ligands to targeting either cell surface or receptor 
targeting. These CAs have the ability to recognize cellular membrane of specific molecular 
sites. Thus, by administration of targeting CAs, the concentration of CAs in targeted tissue is 
much greater than in non-targeted tissue, which enhances the selective tissue’s relaxation and 
may increase contrast between specific tissue and its surrounding. Whilst some complexes 
such as porphyrins have shown the intrinsic uptake by tumor cells [34], [35]. 
 
A.1. Macrocyclic chelator 
 
Among the available commercial CAs, non-macrocyclic chelators such as DTPA shows a 
releasing Gd(III) which causes nephrogenic systemic fibrosis disease [4]. Thus, complexes 
with high stability to chelate the paramagnetic ions are desirable. The advantages of using 
macrocyclic complexes as chelators is their high thermodynamic, kinetic stability, and ability 
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to tune their coordination environment [4]. In Fig. 7, the most common macrocyclic chelators 
used as imaging agents are presented. 
 
Figure 7. Developed macrocyclic chelators for biomedical application [4] 
 
On the other hand, the developed macrocyclic ligands have been modified to target specific 
tissue or cellular receptors in order to enhance the contrast of MR imaging. For instance, 
conjugation of macrocycle Gd-Dota to polyarginie oligomers and stilbene derivatives could 
help Gd-Dota become a targeting MRI CA [36]. Meade and his colleagues succeeded in 
attaching progesterone derivatives to Gd-DO3A which could be applied as breast cancer 
prognostic marker, presented in Fig. 8a [37].  In other research, Gd-DO3A have been 
functionalized with an alkyl group as MRI targeting contrast agents, shown in Fig. 8b [38].  
Gd(III) cyclen macrocycle has also been modified for using as bone imaging and therapy by 
addition of phosphate group in the macrocycle [39]. 
 
Figure 8. Structure of Macrocycle chelator as targeting MRI CAs 
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As described before, macrocyclic complexes have been chemically modified to be used as 
targeting agents. Furthermore, porphyrin is a macrocyclic chelator which has a natural 
tendency to penetrate into tumor cells. 
 
A.1.1.  General reviews of Porphyrins 
 
Porphyrin stems from the Greek word porphura due to its intense purple color. The utility of 
naturally occurring porphyrin compounds is aa strong incentive for widespread attention in 
porphyrin chemistry. Porphyrin plays an important role in the metabolism of living 
organisms. For instance in mammalian blood, hemoglobin is iron substituted porphyrin 
derivatives. Cytochrome is hemeproteins, which transfer electron to cell respiration. 
Adenosylcobalamin or vitamin B12 is another naturally occurring porphyrin, which is made of 
cobalt/corrin complex. Corrin is similar to the porphyrin ring while it contains one less 
methine bridge causing loss of planarity and aromaticity within the macrocycle. While this 
complex in the body helps in methylation of DNA and producing hemoglobin. Chlorophyll, 
which is responsible for transfer of photonic energy to the reaction center in plants and plays 
an important role in photosynthesis, is the other example of a naturally occurring porphyrin 
derivative. 
The simple structural feature of porphyrin (porphine) consists of four pyrrolic units connected 
through one-carbon methine bridges. The bridging of pyrrole units results in a large and 
planar macrocyclic structure with unsaturated atomic center. The porphyrin compounds 
follow Huckel’s rule [40], which estimates the aromatic properties of planar rings. Due to this 
rule, the number of π electrons in a cyclic ring equals to (4n+2) while n is zero or a positive 
integer. In porphyrin, n equals to 4 thereby there are 18 π conjugated electrons. It is 
noteworthy that there are 22 π electrons in porphyrin while just 18 π electrons are delocalized 
[40]. High stability and astonishing photophysical properties of porphyrin complexes arise 
from this strong conjugation. The porphyrin can be substituted in different positions. Positions 
5,10,15,20 are four meso-substituted positions while 2, 3, 7,8,12,13,17,18 are the eight β-
substituted positions, as shown in Fig. 9. The rest are the eight possible α-substituted 
positions. β- and meso positions can be substituted by functional groups. Among the various 
porphyrin derivatives, meso-substituted porphyrins have received great attention in many 
fields including solar cell, biomedical, chemical sensor and photodynamic therapy. 
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Figure 9. Schematic of porphine and peripheral position of atoms in porphine structure 
 
As presented in Fig. 9, two pyrrolenine nitrogen atoms in porphyrin rings are capable of 
accepting protons while two NH groups are capable of losing protons. The losing proton 
results in the formation of dianion species which makes it suitable to insert metal ions in the 
core of porphyrin. Free base porphyrin can bind with almost all metals and some semi-metals 
to form metalloporphyrin complexes. Referring to the position of metal ions in 
metalloporphyrin, they can be categorized as in plane, out-of-plane or in bimetallic 
complexes. 
 
A.1.2.  Synthesis of meso-substituted porphyrin complex 
 
The arrangement of diverse substituents in specific patterns is the main theme in the synthesis 
of porphyrins [41].  Control over this arrangement enables us to design and tailor different 
types of porphyrins for specific applications [41]. Meso-tetraphenylporphyrin has been 
successfully synthesized for the first time by Rothemund in 1936 [42]. Rothmund has 
reported the formation of meso-substituted porphyrin in one step using pyrrole and 
benzaldehyde under acidic conditions in a sealed flask  at 150°C for 24h [43] (Fig. 10). The 
low yield, irreproducible  and harsh experimental conditions are the limitation of this set up 
[44], [45]. 
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Figure 10. The Rothemund synthesis of meso-substituted porphyrin 
 
In Rothemund synthesis, the character of substituent on the phenyl ring affects the yields of 
tetraphenylporphyrin [46]. The reaction and yields of tetrraphenylporphyrin can be 
accelerated by electron-accepter substituents  while electron donor substituents can retard the 
reaction and reduce the yields [47]. This retardation is attributed to preferable polymerization 
of pyrrole to obtain polypyrrole. 
In 1967, Alder, Longo and coworkers reexamined and modified the Rhotemund method [48]. 
They reacted benzaldehyde and pyrrole by condensation in refluxing propionic acid in 
glassware open to the atmosphere [48] (Fig. 11) under 141°C for 30 minutes. Performing the 
reaction on the large scale is the advantage of Alder’s method. Moreover, this method is much 
milder than Rothemund’s synthesis conditions and it is compatible with a variety of aldehydes 
with yields of 20%. 
 
Figure 11. The Aldler-Longo method for preparing meso-substituted porphyrin 
 
However, while the Alder method works better than Rothemund method, it has a limitation 
such as failing reaction with benzaldehydes, no crystallization of porphyrin , purification 
problem, and low and often irreproducible yields [49]. 
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The Alder method was optimized by Lindsey and coworkers in 1987[50], [51]. In this 
method, a new strategy for the synthesis of meso-substituted porphyrin has been used. The 
reaction has been performed using acid-catalyzed pyrrole-aldehyde condensation in the 
presence of CHCl3 for one hour at room temperature. The first step has been monitored to 
obtain maximum porphyrinogen which can be oxidized rapidly to porphyrin with addition of 
3 equivalents of quinon oxidant in the 2
nd 
step [52], as shown in Fig. 12. The reaction was 
carried out under gentle conditions to achieve equilibrium during condensation and to avoid 
any side reaction. The oxidation of porphyrinogen in the Lindsey method has been carried out 
by adding p-chloranil, 2,3-dichlor-5,6dicyano-1,4-benzoquinone (DDQ) which require one 
hour for a complete reaction. This method also has its own limitation such as expensive cost, 
destroying some porphyrinogen during adding DDQ, requiring large volume of solvent 
(pyrrole and aldehyde), and difficult purification of porphyrin [53]. 
 
Figure 12. Two steps synthesis of porphyrin at room temperature 
 
In the MacDonald method, different meso-substituted trans-porphyrins can be prepared by 
condensation of a 5-disubstituted dipyrromethane with aldehyde as shown in Fig. 13 [54] . 
The drawback of this method can be referred to modest yields of porphyrin (10-30%), and 
condensation in dilute solutions (10 mM). Sometimes the dipyrromethane-aldehyde 
condensation is not desirable to produce trans-A2B2-porphyrin because of obtaining the 
mixture of porphyrins which are difficult to separate [47]. 
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Figure 13. The MacDonald type 2+2 condensation method 
 
A.1.3.  Electronic absorption Spectrum of porphyrin  
 
For the first time in 1960, the absorption spectrum of porphyrin was successfully explained in 
terms of four orbital models. Due to four orbital models of Martin Gouterman [55], absorption 
bands in porphyrin complex originate from transition between two highest occupied 
molecular orbital (HOMO and HOMO-1 , π orbitals) and two lowest unoccupied molecular 
orbital’s (LUMO and LUMO+1, π* orbitals) as presented in Fig. 15. For metalloporphyrin 
with 4-fold symmetry, the LUMOs are degenerate (labeled as egx and egy) whereas HOMOs 
are nearly degenerate (labeled as a1u and a2u). Excited states comes from the transition 
between a1u,2u→egx,gy (x-polarization) and those between  a1u,2u→egy,gx (y-polarization). These 
polarized excited states are mixed and split into two states in energy, lower energy (labeled as 
Qx and Qy) and higher energy (labeled as Bx and By) states. Lower energy (with less oscillator 
strength) and higher energy (with greater oscillator strength) give rise to a Q band and Soret 
band, respectively. In the case of free base porphyrin, 2- fold symmetry results in 
nondegeneracy of LUMOs and splitting of Qx and Qy as well as Bx and By transition.  
Transition between HOMOs and LUMOs in free base porphyrin produces four excited states. 
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Figure 14. The Gouterman’s four orbital models for D2h symmetry free-base porphyrin (top) 
and for D4h symmetry metalloporphyrin [56] 
 
As explained, the electronic absorption spectrum of porphyrin contains two distinct regions. 
The first region, which involves the transition from ground state to the second excited state, is 
called the Soret band. The Soret band of porphyrin is in the range of 380-500 nm depending 
on the type of porphyrin- whether meso- or β-substituted.  The second region, in the range of 
500-700 nm, is called Q band, which involves the weak transition from ground state to the 
first excited state. Protonation of two inner nitrogen atoms during metallation of porphyrin 
causes strong changes to the visible absorption spectrum. This change is attributed to more 
symmetry in protonated (metallated porphyrin) than the free base one that simplifies the Q 
band pattern. 
Based on relative intensities of four Q bands, four basic spectra have been identified in UV-
visible spectra of porphyrin, presented in Fig. 14. If the relative intensities of Q bands are in 
the order of IV>III>II>I, the spectrum is called etio type. This type of spectrum can be 
observed in β-substitued porphyrin while six or more positions are substituted with groups 
such as alkyl without any π-electrons. Rhodo type of spectrum could be observed while β-
positions of porphyrin have been substituted with groups such as carbonyl or vinyl groups 
which has π-electrons. This causes a change in the relative intensity of Q bands (III>IV>II>I) 
and shifting the spectrum to the longer wavelength (redshift). Substituting of two electron-
withdrawing groups on opposite pyrrole rings causes a change in maxima absorption 
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intensities follow the order III>II>IV>I, has been called oxo-rhodo-type spectrum. And the 
fourth spectra observed when substitution of meso positions causes to obtain maxima 
intensities in order of IV>II>III>I, which is called phyllo-type spectrum [57]. 
As described above, metallation of porphyrin changes the absorption spectrum by reducing 
four Q bands to two Q bands, designated by α and β, and Soret band around 400 nm. Whereas 
the intensity of metalloporphyrin’s α and β bands depends on the coordination of metal with 
the ligand. While metal forms a stable square-planar complex with the porphyrin ring, the 
intensity of α band is higher than β band. 
 
 
Figure 15. Typical UV-visible spectra of a) free-base and b) metallated porphyrin 
 
Porphyrins have been widely studied due to their characteristic optical properties. The UV-
visible spectrum of porphyrin contains two main regions. One intense absorption peak around 
400 nm that is named Soret band following low intense peaks, Q band, in the region of 450 
nm-700 nm. The intensity and position of peaks depends on the solvent, concentration as well 
as nature of porphyrin side chains and their positions.  
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Figure 16. UV-visible absorption spectrum of porphyrin with its typical Soret and Q bands 
 
A.2. Application of porphyrin in cancer therapy and imaging 
A.2.1.  Photodynamic Therapy 
 
Porphyrins have been extensively utilized as photosensitizers [58]. Exciting with UV-visible 
light, photosensitizers induce photochemical reactions using irradiating energy. Singlet 
oxygen is produced during photochemical process. Combination of photosensetizers with 
oxygen induce the lethal cytotoxic agents which results in cell death and tissue destruction 
[59]. These agents can be applied in photodynamic therapy (PDT).  For the first time, Raab in 
1900 reported the chemical sensitization of tissue by light [60]. In 1903, Tappeiner and 
Jesionek [61] have successfully treated skin cancer by applying topically eosin and light [62]. 
Later, Raab and Tappeiner discovered that certain dyes could destroy the cell in the presence 
of light [63]. Afterward, certain attention has been focused on using PDT for malignant 
lesions in human. With administration of photosensitizers to cancer cells, either intravenous 
or intraperitoneal injection, the cancer cells could be irradiated with light.  During returning 
the photosensitizer to its ground state, the singlet oxygen could be produced from transferring 
released energy to triplet molecule. This singlet oxygen is the trigger for tumor destruction in 
PDT, as presented in Fig. 17. The lifetime (1-320 ns) and diffusion distance (10-55 nm) of 
singlet oxygen in cells are very short. Thus, the damage of PDT is highly depending on the 
sub cellular localization of photosensitizers.  
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Figure 17. Schematically presents the photodynamic therapy using photosensitizers [64] 
 
The ideal photosensitizers should be retained by diseased tissue in order to minimize the 
damage of healthy tissues during photochemical reaction. In order to obtain the satisfactory 
results, photosensitizers should localize in target tissue. This could improve the efficacy of 
cell destruction to obtain effective PDT. The majority of successful and effective 
photosensitizers are based upon tetrapyrrole chromophore such as porphyrin, chlorine, and 
bacteriochlorin complexes. Most photosensitizers in PDT are based upon porphyrin or 
porphyrin-related derivatives due to their preferential localization in tumor tissues and their 
characteristic optical properties. 
 
A.2.2.  Fluorescence Imaging 
 
Referring to characteristic optical properties of porphyrins, they can also be used as imaging 
agents. Porphyrins emit light at high wavelength (red or near-infrared wavelengths) during 
their irradiation. The emission at high wavelength could be useful in cellular imaging studies.  
Due to preferential localization of porphyrinic complexes into tumor tissues and their 
characteristic fluorescence features, it is possible to visualize the tumor cells using porphyrin 
complexes as fluorescence agents. The history of fluorescence imaging of tumor tissues goes 
back to 1924. First fluorescence emission (red/brown) from tumor cells was observed by 
Policard [65], [66]. Lforth et al. have reported the localized fluorescence emission of different 
porphyrin and metalloporphyrin complexes from tumor tissues [67], but not from healthy 
tissue [58].  
Fluorescence imaging and PDT modalities are based on the same principles while the 
outcome is different. Fluorescence imaging has shown no/low cytotoxicity which is attributed 
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to using low fluence rate to generate light activation. Whereas in PDT, the aim is using the 
cytotoxic effect of photosensitizers, high fluence rate have been applied to generate singlet 
oxygen to destroy the tumor cells. Thereby, the porphyrinic complexes could be applied as 
imaging and therapeutic agents at the same time. 
 
A.2.3.  Magnetic Resonance Imaging 
 
In 1984, for the first time the efficiency of water soluble metalloporphyrin as MRI contrast 
agents has been suggested by Chen et al. [68]. They have studied the potential of three water 
soluble metalloporphyrins such as Mn(III), Fe(III), Cu(II) tetra-(4-sulfanatophenyl) porphyrin 
(TSPP) to shorten the relaxation time of nearby water protons [68]. Among these three 
metalloporphyrins, Mn (TSPP4) and Cu(TSPP4) have exhibited respectively the highest 
(r1=10.36 mM
-1
.s
-1
, 20 MHz) and the lowest ( r1=0.139 mM
-1
.s
-1
, 20 MHz) relaxivity.  In 
order to examine the effect of another ligand upon relaxivity of water protons, Fe(TSPP4) has 
been added to the solution of 0.2 M pyridine in water [68]. The reduction of r1 from 3.9 mM
-
1
.s
-1 
to 0.2 mM
-1
.s
-1 
was observed which was attributed to a decrease in the high spin form of 
Fe(III) complex in the presence of pyridine [68].  Subsequently, Furmanski and Longley in 
1988 have investigated the in-vitro and in-vivo efficiency of Gd(III) and Mn(III) meso-tetra n-
methyl-4-pyridyl porphyrin (TMPyP) as MRI CA at 10.7 MHz [69]. Gd(TMPyP) has 
exhibited the low r1 of 5.19 mM
-1
s
-1
 which is less than the r1of free Gd(III) (14.67 mM
-1
s
-
1
)which was ascribed as chelating of Gd(III) with porphyrin causing the loss of available 
proton coordination site [69].   In another research, Lyon and co workers have investigated 
relaxivity of Gd(III), Mn(III), and Fe(III)-tetraphenylporphine sulfonate, Gd(TPPS), 
Mn(TPPS), Fe (TPPS),  where the porphyrin is substituted by sulfonato group in aromatic 
ring [70]. The relatively high r1 of Gd(TPPS) (22.8 mM
-1
.s
-1
) was obtained while this 
compound was found to dissociate rapidly in solution which was an obstacle for further 
studies [70]. Gd-hematoporphyrin (Gd-H) and Gd-boronated porphyrin,1, 6, 11, 16-tetra (3-o-
carboranyl- methoxy) phenyl-porphyrin (Gd-TCP)) are two other Gd-mesoporphyrins which 
have been studied as MRI contrast agents [71]. Gd-TCP in aqueous solution has possessed the 
higher r1 of 31.4 mM
-1
s
-1
 at 7T and 23°C [71], additionally; it has exhibited the significant 
uptake in tumor tissues compared with Gd-H [72]. One significant obstacle for going further 
with water soluble Gd-meso-porphyrin derivatives as MRI contrast agents is the low stability 
of the complexes because of the large size of Gd(III). After observing the low stability of 
Gd-mesoporphyrin, a new class of Gd-porphyrin with high stability has been 
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synthesized. Bis-triethylen glycol gadolinium texaphyrin diacetate (Motexafin gadolinium), 
extended porphyrin, and exhibited a high relaxivity (16.9 mM
-1
.s
-1
 at 50 MHz) and high 
stability [73]. Furthermore, the potential of gadolinium complex conjugated with porphyrin 
has been also investigated as a MRI contrast agent.  One of the developed complexes is 
Gdophrin-2, Gd (III) mesoporphyrin-IX-13,17-bis [2-oxo-4,7,10,10-tetra 
(carboxylatomethyl)-1,4,7,10-tetraazadecyl]-Diamide. It shows high r1 of 8.3 mM⁻¹.s⁻¹ at 
0.47T [74]. This compound was recognized as a positive enhancing myocardium- and 
necrosis- targeted MRI contrast agent [75]. In 2011, Guo-Ping  Yan et al. synthesized 
porphyrin containing polyaspartamide gadolinium complex by the incorporation of water 
soluble 5-(4'-aminophenyl)-10,15,20-tris (4'-sulfonatophenyl) porphyrin, trisodium salt 
(APTSPP) as the tumor targeting groups and DTPA into poly-α,β-[N-(2-hydroxyethyl)-L-
aspartamidel] (PHEA) [76]. They observed that r1 of the new complex was around 14 mM
-1
s
-1
 
however the relaxivity of the commercial Gd-DTPA CAs is 3.68 mM
-1
s
-1 
[76].  
 
Table 2. List of studied metalloporphyrins and their relaxivities 
Metalloporphyrin  R1(mM
-1
s
-1
) Condition Ref. 
Gd-porphyrin derivatives 
Gd(TMPyP) 5.19 10.7 MHz, 37°C in 
37% dimethyl sulfoxide/water 
[69] 
Gd(TSPP) 22.8 0.25 T, 37°C [68] 
Gd-H 16.3 7T and 23°C [71] 
Gd-TCP 31.4 
Gd-MP 9 1T [77] 
Gd-DTPA-APTSPP- PHE 14  [76] 
Gd-Motexafin 16.9 50 MHz, 25°C [73] 
Gdophrin-2 8.3 0.47T, 39°C [74] 
Mn-porphyrin derivatives 
Mn(II)(TCP) 16 1T [78] 
Mn-uroporphyrin 4.8 300 MHz, in plasma [79] 
Mn(TPPAS) 20 20 MHz [80] 
Mn(TPPS)
3+ 
10.3 
Mn(TPP) 13 20 MHz [77] 
Mn-TE-2PyP ~9  [81] 
Mn-Tn-Hex-2-PyP ~13 
Mn(TSPP4) 10.36 37°C,20 MHz, in water [68] 
Mn(TSPP4) 7.6 37°C,20 MHz, in pyridine 
Mn(TMPyP) 11.53 10.7 MHz, 37°C in water [69] 
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After observing the low stability of Gd-mesoporphyrins, an increasing interest has been 
devoted to study the potential of Mn-porphyrins as MRI contrast agents. The manganese(III)- 
tetraphenyl-porphyrin-sulfonate have been studied by some researchers due to its in-vitro high 
stability and simultaneously preferential localization in  mitochondria [70]. Although, the 
relatively high toxicity of TPPS4 (LD50=0.5 mmol/kg) is reduced after metallation with 
Mn(III), Mn(TPPS4) is reported as a toxic complex [82], [83].  Besides Mn(TPPS4), the 
relaxivity of less sulfonated compounds such as Mn(TPPS3) and Mn(TPPS2) were also 
screened by Fiel et al. [84]. Among them, Mn(TPPS3) showed the best tissue contrast with 
r1~10.3 mM
-1
s
-1
 at 20 MHz [84]. Moreover, Mn-mesotetraphenylporphyrin, Mn (TPP), has 
shown high r1 of 13 mM
-1
s
-1
 at 20 MHz in aqueous solution [77]. In another research, the 
potential of two Mn-mesoporphyrins substituted with different polyhydroxylamides, Mn(III) 
5,10,15,20-tetrakis{[4-carboxylic acid-(2,3-dihydroxyisopropyl)amide phenyl) porphyrin 
(Mn(TPPIS)) and  Mn(III) 5,10,15,20-tetrakis(4-carboxylic acid-( 1,3-
dihydroxyisopropyl)amide phenyl) (Mn(TPPAS)), as MRI contrast enhancement has been 
studied [80]. It has been observed that Mn(TPPAS) has the higher relaxivity (almost two 
times) than r1 of Mn(TPPS) (10.3 mM
-1
s
-1
) which has been attributed to two water molecules 
in the inner sphere instead of one for Mn(TPPS) porphyrin [80]. Although, Mn(TPPAS) has 
shown  great signal enhancement at heart, liver, lungs and gastrointestinal tract, this 
compound exhibited significant  toxicity [80]. The more basic porphyrin derivatives, 
protoporphyrin IX (Mn(PPIX)) has shown the lower relaxivity compared with those of 
Mn(TPPS) which was attributed to its aggregation in dilute phase [85].  The relaxivity of Mn-
boronated protoporphyrin has been also reported of 4.43 mM
-1
s
-1
 at 10.7 MHz [86]. The 
relaxivity of two Mn-mesoporphyrins such as: Mn(III) meso-tetrakis(N-ethylpyridinium-2-
yl)porphyrin (MnTE-2-PyP(5+)) and Mn(III) mesotetrakis(N-hexylpyridinium-2-yl)porphyrin 
(MnTnHex-2-PyP(5+)) have revealed the high efficiency r1 of almost two and three-fold 
respectively higher than r1 of Gd-DTPA, of these two complexes as MRI CA [81]. 
 
A.2.4.  In-vivo MRI studies of metalloporphyrin  
 
In-vivo MRI studies of Mn (TPPS3)2 has been performed by Cheng et al. [87], presented in 
Fig. 18. After tail vein injection of Mn (TPPS3)2 at rat (25 μmol.kg), strong T1 contrast (bright 
signal) enhancement in cardiovascular systems has been observed [87]. After 10 min of 
Mn(TPPS3)2 injection, the reduction of T1 of blood from 1700 ms to 200 ms has been 
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reported, moreover, T1 effect still could be observed after 24 h [87]. Meantime, the Mn 
(TPPS3)2 shows the long retention of  1h in rats without any significant T1 changes which 
results in increasing the temporal   imaging window [87]. 
 
 
Figure 18. T1 weighted images of healthy rats after postinjection of Mn (TPPS3)2 from spin 
echo sequences at 3T compared with those of after postinjection of conventional CAs Gd-
DTPA as reference [87] 
 
The biodistribution of Mn(TSPP4), Mn-TCP, and Mn(TSPP3)2 in rats have been studied by 
Cheng et al., Fig. 19 [78]. Significant signal enhancement has been observed after 0.05 
mmolMn/kg administration of Mn-porphyrins, specially in kidney and bladder, within 10 min 
of postinjection [78]. After 1h, the majority of signal enhancement in kidney has been 
relocalated into bladder and fully disappeared after 24h. Among those three Mn-porphyrins 
studied, Mn-TCP was the one which was rapidly cleared via renal filtration [78]. The signal 
intensity of kidney remains high after 60 min of postinjection of Mn(TPPS). While, 
Mn(TSPP3)2 showed significant T1 enhancement in the liver whereas after 3 days no bladder 
enhancement was observed. Due to strong T1 enhancement after postinjection of Mn(TSPP3)2 
in blood vessel and heart, it has been suggested that this compound could be applied as blood 
pool CAs [78]. 
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Figure 19. T1 weighted spin echo of rat after pre and postinjection of Mn-porphyrins such as 
Mn-TCP, Mn(TPPS) and MnP2 (Mn(TPPS3)2) in comparison with Gd-DTPA as a reference 
at 3T. yellow circle: left kidney, blue circle: bladder [78] 
 
The signal enhancement of Gd-TCP, Gd-H porphyrins in different tissues including kidney, 
liver, spleen and tumor tissues of mice and their biodistributions in melanoma xenograft have 
been studied and compared with those one of GdCl3 and Gd-DTPA [88]. The signal intensity 
in tumor tissues after postinjection of Gd-porphyrins were higher than those using a 
commercial one which confirms the specific accumulation of Gd-porphyrins in tumor tissues 
[88], as shown in Fig. 20. 
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Figure 20. MRI signal intensity after postinjection of different Gd(III) compounds and their 
distribution in melanoma xenografts in nude mice after 24h [88] 
 
Over recent decades, conjugation/encapsulation of CA with/within macromolecules is 
becoming an approach to improve the efficiency of CAs. In the next section, the developed 
macromolecular CA and their relaxivities will be reviewed. 
 
B. Macromolecular Contrast agents  
 
Conventional CAs mostly exhibit rapid extravasate from vasculature and distribute in 
extracellular space nondiscriminatively because of their low molecular weight as shown in 
Fig. 21, providing a short time window for imaging. For instance, the Gd-DTPA-BMA CA 
administered in rat has exhibited the distribution of 4.6±1.7 and elimination half-life of 
18±2.8 min [89].  Thus, it is required to develop CAs with long blood pool retention as well 
as providing a wider time window for cardiovascular and oncological MRIs [89]. 
Recently, macromolecular CAs have been developed in order to prolong blood pool retention 
times. Macromolecular CAs (MCAs) could be defined as CAs with high molecular weight 
(>1 kDa) and long half-life in blood circulation (>10 min).  Meantime, chelating of 
paramagnetic ions with macromolecules can affect the relaxivity of CAs due to retarding the 
rotational motion of the complex and increase τR. Thereby, high relaxivity and prolonged 
pharmacokinetics could help to minimize administration of MMCAs, reducing the risk of 
nephrogenic systemic fibrosis [90], [91].  The other advantages of MMCAs over CAs with 
low molecular weight is their ability to be adapted as a targeted CAs, drug carrier and their 
flexibility for labeling due to their inherent multivalency [92].  
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Figure 21. Schematic presents diffusing of A) low molecular weight and B) macromolecular 
CAs from tumor vessels into the interstitial space [93] 
 
For instance, conjugation of Gd-DTPA with poly-L-lysine with the molecular weight of 3.3-
102 kDa enhance the r1 up to 2.5 times higher than Gd-DTPA (at 2.4T and 37°C) in aqueous 
solution [94]. In another work, Gd-DTPA conjugated onto rigid poly(propylene imine) (PPI) 
dendrimers has shown r1 and r2 of 19.7 mM
-1
s
-1
 and 27.8 mM
-1
s
-1
 (1.5T and 20°C), 
respectively, which is almost 5 times higher than those of Gd-DTPA [95]. Conjugation of Gd-
DTPA onto flexible polyethylene glycol (PEG) has shown  a slight enhancement of relaxivity 
[96]. The Gd-DTPA-PEG with molecular weight in the range of 10-83 kDa possesses r1 of 6 
mM
-1
s
-1
 at 20 MHz and 37°C. This negligible enhancement has been attributed to the 
flexibility of linear copolymer PEG that could not significantly retard rotational motion of the 
complex.  
However, sometimes conjugation of CAs with polymer could  not significantly enhance the 
relaxivity of CAs due to reduce the number of coordinated water and slower the water 
exchange rate. For instance, conjugation of dendrimer-Gd-DOTA with PEG has shown r1 of 
13.7 mM
-1
s
-1
 due to decrease hydration number and slower water exchange rate [97]. 
However, water soluble Gd-DOTA dendrimer with molecular weight of 61.8 kDa possesses 
an r1 of 18.8 mM
-1
s
-1
 at 25MHz [97].  It has been observed that by PEGylation of non-
polyaminocarboxylate Gd chelate the number of coordinated water decreases from 2 to 1. 
Thereby, the PEGylation causes either negligible increase of r1 or reduction of r1. 
Additionally, it has been observed that by PEGylation of dendrimer-Gd-DOTA the blood 
elimination half-lives increased up to 1219 min and seven-day liver uptake dropped to 8% of 
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the administered dosage, compared with dendrimer-Gd-DOTA with blood half-lives of 
maximum 115 min and seven-day liver retention of over 40% [97]. In the following section, 
we will focus on a literature review of different developed macromolecular contrast agents. 
 
B.1. Macromolecular Contrast agents classification 
 
Different varieties of Macromolecular Contrast agents (MMCAs) have been synthesized 
during the past decades. MMCAs have been classified as block, and nano-polymeric MMCAs 
[98].  The block MMCAs are made of paramagnetic chelates that are located in the polymer 
backbones such as DTPA di-ester or DTPA-bisamide copolymers. Thus, insertion of 
paramagnetic chelates in the backbone of polymers restricted the CAs rotation which 
enhances relaxivity.  
Over two recent decades, nanotechnology has created new opportunities in the medical area, 
including drug delivery, cancer therapy, and molecular imaging. Using nanoparticles in the 
range of 10nm-500 nm has shown a significant impact on drug delivery. In this context, 
polymer nanoparticles have shown particular promise as unique biomedicine vehicles. The 
large surface to volume ratio of polymeric nanoparticles offers the high capacity to absorb 
large amount of drug or imaging agents [99], [100]. 
 
B.1.1.  Block macromolecular contrast agents  
 
Series of copolymers of diethylenetriaminepentaacetic acid (DTPA) and poly(ethylene glycol) 
(PEG) diamines have been used as chelater of Gd, resulting in molecular weight in the range 
of 10.8 to 83.4 kDa [101]. While, the highest r1 (10.1 mM
-1
s
-1
, 20 MHz and 40°C) was 
observed for Gd complex with molecular weight of 13.6 kDa [101]. Referring to high 
molecular weight of complex, the r1 was not as high as expected. The flexibility of PEG 
could prevent the enhancement of the complex relaxivity.  
In another work, Gd-DTPA coupled with L-tartaric acid, with two different degrees of 
polymerization of n=12 (Gd4(H2O)) and n=19 (Gd10(H2O)) as presented in Fig. 22, have 
exhibited r1 of 4.7 and 4.4 mM
-1
s
-1
, respectively, at 400 MHz and 310 K [102]. However, the 
per molecule r1 of Gd4(H2O) and Gd10(H2O) were reported as high as 51 and 80 mM
-1
s
-1
, 
respectively, which provides a substantial 16- and 25-times higher r1 compared with that of 
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Gd-DTPA-BA [102].  The low relaxivity values per Gd ions has been referred to the internal 
flexibility of the complex and slow water exchange rate of Gd-DTPA  [103]. 
 
Figure 22. Structure of coupling L-tartaric acid to Gd-DTPA with two degree of 
polymerization of n=12 (Gd4(H2O)) and n=19 (Gd10(H2O)) 
 
In the other studies, the relaxivity of two linear polymerizations of DTPA with 1,6-
hexanediamine (HMD) and trans-1,4-cyclohexanediamine (CHD) have been investigated by 
Duarte and colleagues [104]. They observed that r1 of Gd-DTPA-CHD was slightly higher 
than Gd-DTPA-HMD, as presented in Fig. 23, which were two times higher than Gd-DTPA. 
From the relaxometry studies, rigidity of cyclic diamide linking has been referred as an 
obstacle to enhance the relaxivity of the complexes. Compared with the MMCAs, their 
relaxivities were not high. Moreover, the short length of linking groups could prevent the 
hydrophobic interaction between polymer chains [104]. Referring to evaluated rotational 
correlation time, presented in Fig. 23, it has been deduced that substantial residual flexibility 
and long residence time of water molecules in the inner sphere could block the increase of r1 
[104]. 
 
Parameters Gd-DTPA-HMD Gd-DTPA-CHD 
Mw 4900 6400 
r1(mM-1s-1) 7.8* 8.1* 
τR (ps)
+ 580 997 
τM (µs)
+ 1.33 1.45 
τV (ps)
+ 21 32 
τSO (ps)
+ 120 140 
        * at 9MHz and 298K 
                +    rGd-O=0.31 nm, D=3.5x10
-9 m2s-1, and q=1 
            τR: rotational correlation time 
                  τV: correlation time modulating electric relaxation 
             τM: residence time of inner sphere water molecule 
            τSO: electronic relaxation time 
                        
Figure 23. Structure a)DTPA-HMD and b)DTPA-CHD linear polymers and evaluated the 
relaxometry properties of two Gd complexes [104] 
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Gd-DTPA-cytine copolymer (GDCP), and Gd-DTPA-cytine diethyl estercopolyemrs 
(GDCEP) with different molecular weights have been synthesized by Zong and coworkers, 
summarized in Fig. 24 [105]. GDCP exhibited  more prolonged and contrast enhancement in 
blood pool and liver which was ascribed as higher molecular weight of GDCP, compared with 
those of GDCEP [105]. 
 
 
 
 
Mw (kDa) 
GDCEP GDCP 
73 48 34 62 46 22 
Gd content (wt.%) 16.9 17.7 16.9 16.7 17.1 16.4 
Relaxivity (mM-1s-1)* 4.5 4.8 4.6 6.9 5.8 5.4 
* at 3T and room temperature 
 
Figure 24. Structure and physicochemical parameters of GDCP and GDCEP [105] 
 
Furthermore, relaxivity of GDCP conjugated with different molecular weight of PEG has 
been studied [106]. It was observed that PEG chain length did not significantly alter r1 of 
GDCP. PEG2000-GDCP exhibited the highest r1 of 8.73 mM
-1
s
-1
 at 3T [106]. The grafting of 
GDCP with PEG did not enhance the r1, which was attributed to high density of PEG chains 
[106]. 
 
B.1.2.  Nano-polymeric macromolecular contrast agents  
 
Different varieties of polymer carriers, either natural or synthetic, have been used as a 
platform for synthesis of various types of tumor imaging CAs or tumor therapy nanoparticles. 
Depending on the preparation route, the CAs or drug could either be entrapped in or 
covalently conjugated to the surface of the polymer platform, presented in Fig. 25. The 
synthetic polymer nanocarrires include polyethylene glycol (PEG), polyglutamic acid (PGA), 
poly-D,L-lactide-co-glycolide (PLGA), polylactic acid (PLA) and N-(2-hydroxypropyl)-
methacrylamide copolymer (HPMA) [107]. The drawback of the majority of synthetic 
polymers is their non-biocompatibility, non-biodegradability and expensive cost in 
fabrication. The natural polymers which have been extensively used include chitosan, dextran, 
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albumin, heparin, and Sodium alginate [107]. Among the abundant natural polymeric 
nanocarriers, much attention has been focused on chitosan and its derivatives [108], [109]. 
 
 
Figure 25. The classification of developed polymeric nanocarries A) dendrimer, B) liposomes, 
C) polymer-CAs conjugated, D) polymeric nanosphere, E) polymer core-shell nanoparticles 
[110] 
 
B.1.2.1. Chitosan 
 
Chitosan is one of the most promising polymers for pharmaceutical and biomedical area 
[108], [109]. Chitosan is a natural liner polysaccharide, composed of β-(1-4)-linked-2-amino-
2-deoxy-β-D-glucopyranose and 2-acetamido-2-deoxy-β-D-glycopyranose, derived through 
partial deacetylation of chitin[111]. Chitosan nanoparticles (CNs) have been intensively 
investigated for drug delivery administration due to their unique properties such as 
biocompatibility, biodegradability, nontoxicity, antibacterial, and mucoadhesive properties 
[8], [9]. As mentioned before, chitosan can be obtained by modulation of the deacetylation 
degree of chitin. Therefore, chitosan with different molecular weight and deacetylation degree 
can be obtained while both of these parameters have an effect on their physicochemical and 
biomedical applications.  By introducing hydrophobic moieties in to the chitosan backbone, it 
is possible to obtain an amphiphilic compound [112], which is useful to form the 
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nanoparticles. Thereby, the hydrophilic core of chitosan nanoparticles can efficiently 
encapsulate the drug. 
 
 
Figure 26. Fabrication of chitosan from chitin by modulation of deacetylation degree  
 
The size, polydispersity, charge, as well as capacity for drug encapsulation of chitosan 
nanoparticles depend on the preparation method and chitosan structure such as molecular 
weight and deacetylation degrees. Thereby, due to the important role of physicochemical 
properties of the nanoparticle on its biomedical applications, in the next section the method 
used for synthesis of chitosan nanoparticles will be briefly described. 
 
B.1.2.2. Protocol of chitosan nanoparticles preparation 
 
For the first time, Ohya and colleagues demonstrated the intravenous delivery of an anticancer 
drug via chitosan nanoparticles which were synthesized via emulsification and cross-linking 
[113]. Thenceforward, much attention has focused on preparation of chitosan nnaoparticles.  
The methods employed to prepare CNs were emulsion-droplet coalescence, emulsion solvent 
diffusion, reverse micellar route, ionic gelation, and desolvation [114], as summarized in 
Table 3. 
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Table 3. Methods employed for fabrication of chitosan nanoparticles (CNs) [114] 
Method Matrix  Ref. 
Emulsification and cross-lining Chitosan, glutaraldehyde [113] 
Emulsion droplet coalescence Chitosan [115], [116] 
Reverse micellisation Chitosan, glutaraldehyde [117]–[119] 
Emulsion solvent diffusion Chitosan [120] 
Ionic gelation Chitosan, glutaralde [109], [121] 
Modified ionic gelation  Chitosan, acrylic acid, methacrylic acid, 
polyethylene glycol, polyether 
[122], [123] 
Desolvation Chitosan [124]–[126] 
 
The ion gelation method is one of the most commonly used methods to fabricate chitosan 
nanoparticles due to its mild preparation conditions, hydrophilic environment, no organic 
solvents, and no high shear forces [114]. Referring to high protonation degree of amine 
groups of chitosan, the chitosan could form hydrogels in the presence of polyanion. Thereby, 
chitosan nanoparticles can be produced from inter and intra-molecular cross-linkage of bulk 
chitosan by ionic molecules. Calvo and coworkers have developed a very mild ionic gelation 
method to fabricate chitosan nanoparticles [109]. They have used polyanion tripolyphosphate 
(TPP) as ionic molecules to interact with positively charged amino groups of chitosan in 
acidic media. After adding TPP in the chitosan solution under mild stirring, the chitosan 
nnaoparticles are immediately formed. After 10 min of stirring, the reaction has fully 
completed and the suspension centrifugated to separate the nanoparticles from unreacted 
chitosan and TPP. In order to obtain small and monodispersed chitosan nanoparticles, there 
are some parameters such as stirring pattern, centrifugation condition, temperature, 
concentration of chitosan and cross-linker, and volume of resuspension, should be optimized 
[127]. Additionally, other factors also play an important role in the size of CNs [109], [121], 
[127]. For example, it has been reported that the size of CNs increase with chitosan 
concentration [123], and contrarily the cross-linker concentrations [128]. The recent work has 
shown that maintaining the reaction temperature below 4°C has significantly effect on 
average particle size of CNs [121]. This has been attributed to the reduction of CNs collision 
polarity due to the formation of hydration layer around nanoparticles via reducing 
temperature. This results in increasing hydrogen bonds between water molecules and chitosan 
polar groups, leading to the formation of hydration layer around the CNs [121]. 
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B.1.2.3. Biodegradability, biocompatibility, biodistribution and toxicity of chitosan 
composites 
 
As mentioned before, the unique features of chitosan which attracted much attention is its 
biocompatibility, biodegradability and biodistribution. Herein, these three key features of 
chitosan will be briefly discussed and reviewed. 
The molecular weight of polymer for renal clearance should be in the range of 30 kDa – 40 
kDa, while polymer with higher molecular weight should tolerate degradation either 
chemically or enzymatically [129]. Chemical degradation is attributed to acid catalyzed 
degradation. While enzymatical degradation depends on the structure of the polymer, for 
instance chitosan could be degraded via enzyme able to hydrolyze the linkages of 
glucosamine–glucosamine, glucosamine–Nacetyl-glucosamine and N-acetyl-glucosamine–N-
acetylglucosamine [129]. Furthermore, for chitosan degradation, redox reactions and free-
radical degradation could occur while they are unlikely to affect in-vivo degradation of 
chitosan [130]. Chitosan is known as a biodegradable polymer, predominantly via lysome and 
some colon bacterial enzymes [131]. The rate and extent of  in-vivo chitosan biodegradability 
increase with decrease of chitosan deacetylation degree [132]. In General, chitosan in 
appropriate conditions and given enough time would sufficiently degrade. The degradation, 
distribution and elimination mechanism of chitosan are dependent on molecular weight of 
chitosan [133]. The two possible degradation sites for chitosan are referred to liver and kidney 
[129]. Oral administration of chitosan has revealed certain degradation in gastrointestinal tract 
[129]. 
Due to clinical tests of chitosan biocompatibility in normal conditions, no inflammatory or 
allergic reactions have been observed following implantation, injection, topical application or 
ingestion in human body [133]. Its in-vitro biocompatibility has been already proven in 
myocardial endothelial and epithelial cells [134], hepatocytes [135], and keratinocytes [136]. 
Furthermore, in-vivo biocompatibility of chitosan for humans and mammals has also been 
proven [133]. 
Biodistribution of chitosan in body also depends on molecular weight, deacetylation degree, 
and the size of chitosan platform. For chitosan nanoparticles, the biodistribution and kinetics 
could be tuned via the size and charge of nanoparticles and not by chitosan chemical structure 
[129]. The chitosan with high molecular weight would be excreted without any absorption. 
Intraperitoneal administration of FITC-labeled chitosan has been studied [137]. It has been 
observed that the labeled chitosan predominately localized in kidney and they were absorbed 
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in peritoneal cavity [137]. Moreover, biodistribution of FITC-labeled chitosans with two 
different molecular weights of 3.8 kDa and 230 kDa have been studied [138].  it was observed 
that no uptake has been observed for higher molecular weight [138].   
Furthermore, chitosan in known as one of the non-toxic, biologically compatible polymers 
[139]. No determinal toxicity of chitosan in mice has been reported by Rao and his coworkers 
[140]. As well, Richardson et al. have also reported the non toxicity of chitosan with different 
concentration and deacetylation degree [141]. LD50 of paclitaxel chitosan micelles in mice 
has been reported of 72.2 mg/kg, additionally; no anaphylaxis has been observed in guinea 
pigs [142]. In oral administration of 100 mg/kg chitosan  (80 kDa and 80% DD) to mice, no 
toxicity has been observed [143]. 
 
B.1.2.4. Chitosan based MRI contrast agents 
 
Referring to the high biocompatibility and biodegradability of chitosan compound, they have 
been extensively investigated for biomedical applications such as drug delivery, gene 
delivery, tissue engineering, antimicrobial and antiviral activity. Moreover, chitosan has an 
ability to prolong residence time in gastrointestinal tract via mucoadhesion. These properties 
as well as its cellular permeability property are the major factors for using chitosan in 
biomedcine. Since conjugation of contrast agents to chitosan composites could also extend 
CAs applications, in the following section the efficiency of chitosan-based CA for in-vitro 
and in-vivo application  will be reviewed. 
 
B.1.2.5. In-vitro MRI studies of chitosan-based contrast agent  
 
The potential of chitosan-based CA as MRI contrast enhancement has been studied by some 
researchers. For instance, ultra-small Mn1-xZn xFe2O4 series (0 <= x <= 1) coated with 
chitosan have shown high r2 that increased from 69.4 mM
-1
s
-1 
to 118.2 mM
-1
s
-1
 with Mn 
content concentrations varied between x=0 to x=1 [144]. Chitosan-substitution 
with  diethylenetriaminepentaacetic acid (DTPA)  has been used as a Gd chelator to enhance 
the stability of complex on liposome surface [145]. The complex has exhibited high r1 of 
almost 6 mM
-1
s
-1 
at 3T which is attributed to the high number of Gd ions anchored on the 
liposome surface which improved water and Gd(III) interactions [145]. In another study,  the 
efficiency of Gd-DTPA-CS as MRI CAs has been studied via Huang and his colleagues [146]. 
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They have reported that r1 of Gd-DTPA-CS (11.65 mM
-1
s
-1
 at 32 °C and 0.5 )  is almost 3 
times higher than r1 of Gd-DTPA [146]. The increase of r1 relaxivity has been ascribed to 
increase the number of inner sphere coordinated water molecules, the decrease of rotational 
correlation rate by attachment to chitosan, and the increase of water exchange rate [146]. 
Furthermore, the conjugated Gd- 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid 1-
(2,5-dioxo-1-pyrrolidinyl)ester (DOTA-NHS) to the surface of a water-soluble 
glycol chitosan (GC) has possessed high r1 of 9.1 mM
-1
s
-1
 at 1.41 T  [147], [148]. On the 
other hand, the conjugation of Gd ions to the surface of CNs through diethylenetriamine 
pentaacetic acid (DTPA), using N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide 
hydrochloride (EDC) and N-hydroxysuccinimide (NHS),  showed r1 of 7.509 mM
-1
s
-1
 at 3T 
[149]. Furthermore, conjugation of Gd-based CNs to another macromolecular polymer has 
shown great potential as MRI CAs. For instance, poly-γ-glutamic acid (PGA)-folic acid 
conjugated to chitosan–Gd complex has shown a high efficiency (T1 of 244 ms at 1.5 T) 
[150]. The potential of chitosan functionalized with β- and γ-cyclodextrins (CDs) conjugated 
to DTPA-Gd has been reported  as high as r1 of 8.9  mM
-1
s
-1 
at 20 MHz and 298K[151]. The 
significant enhancement of relaxivity has been reported for Lectin-DTPA–Gd conjugated with 
CNs with r1 of 1.47x10
5
 mM
-1
s
-1
 at 1.5T and 20°C [152]. In this complex, chitosan as well as 
protein complexes carrying paramagnetic chelates which reduced molecular mobility, leading 
to prolonged rotational correlation time that causes enhancement of proton relaxivity [153], 
[154]. The incorporated / conjugation of Mn-based CAs to chitosan have also been studied. 
For instance, Mn-DTPA-CNs in aqueous solution has showen high r1 relaxivity of 7.21 mM
-
1
s
-1
at 0.5T and 32°C compared with those of Mn-DTPA [155]. The efficiency of iron oxide-
coated with chitosan has been also reported. Efficiency of ferrite coated with chitosan have 
been evaluated via NMR spectroscopy while chitosan based nanoparticles possess r1 of 
0.00291 ppm
-1
s
-1
 and r2 of 0.0691 ppm
-1
s
-1
 [156]. Further studies on conjugation of iron oxide 
on chitosan has been performed by Tsai et al. [157]. r1 and r2 relaxivities of iron oxide 
conjugated with chitosan have been evaluated of 22 mM
-1
s
-1
  and 202 mM
-1
s
-1
, respectively, 
via MRI 3T scanner [157]. The only published research regarding to efficiency of 
metalloporphyrin conjugated with CNs has been reported that  water-soluble tetra(carboxyl 
phenyl)Mn(II)-porphyrin-CNs possessed a r1of 6.11 mM
-1
s
-1
[158]. 
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B.1.2.6. In-vivo MRI studies of chitosan based contrast agents 
 
The developed GC-NH2-GdDOTA (0.03 mmol/kg Gd) have been intravenously administered 
in nude mice with T6-17 flank tumors, shown in Fig. 27 [147]. Less than 4 hours after 
injection, great contrast enhancement was observed with the maximum after 2h postinjection 
while no contrast or very little was observed after 24h of postinjection [147]. No discernible 
enhancement within tumor in T1-weighted images revealed any tumor specificity of GC-
NH2-GdDOTA [147]. The signal changes have been evaluated to study the relative signal 
intensity enhancement pre- and post-contrast T1-W MR images. After 2h of postinjection of 
GC-NH2-Gd-DOTA, signal intensity enhanced as high as 2.4 times [147]. Thereby, 
conjugation of Gd-DOTA to chitosan enhanced the signal and contrast of  T1-weighted 
images. 
 
 
Figure 27. In-vivo MR images of mice with T6-17 flank tumors [147] 
 
In another research, the efficiency of Gd-DTPA conjugated with chitosan as contrast 
enhancement in liver and kidney of rat has been studied [146]. It was observed that after short 
time of post intravenous injection of Gd-DTPA, contrast enhancement could be observed in 
rats’ liver meanwhile after 30 min the signal intensity of liver decreased, conversely to the 
signal intensity of kidney [146]. This indicates the poor blood circulation and fast clearance of 
Gd-DTPA from kidney. Additionally, liver parenchyma blood vessels were not clearly 
observed after administration of Gd-DTPA [146]. 
  
 
 
51 
 
 
Figure 28. T1-weighted of rat liver postinteravenous injection of Gd-DTPA-CS (0.08 
mmol/kg Gd) and Gd-DTPA (tail vein) into rat after A) 0 min, B) 5 min, C) 15 min, D) 30 
min and E) 90 min [146] 
 
As presented in Fig. 28, after short time of administration of Gd-DTPA-CS, signal intensity 
enhanced and the blood vessel of liver was visible [146]. It was observed that after 90 min 
still no contrast enhancement has revealed in kidney due to no excretion from liver into 
kidney in this period, Fig. 29 [146]. Thereby, conjugation of Gd-DTPA with chitosan 
enhances the blood circulation of CAs and increases the contrast and signal intensity in liver 
[146]. 
 
Figure 29. T1-weighted of rat kidney postinteravenous injection of Gd-DTPA-CS (0.08 
mmol/kg Gd) and Gd-DTPA (tail vein) into rat after A)0 min, B) 5 min, C) 15 min, D) 30 min 
and E) 90 min [146] 
 
C. Quantum Dots  
 
Over the last two decades, experimental and theoretical research on quantum dots (QDs) has 
increased significantly in order to explore their characteristic properties. In 1982, Efros and 
Ekrimov were first to report the synthesize of QDs [159]. It was found that the band gap 
energy of QDs is size-dependent while bulk semiconductors band gap energy depends on their 
composition [160]–[162] as presented in Fig. 30. Thereby, controlling the size of QDs has an 
important impact on their fluorescence emission wavelength.  
 
 
52 
 
Quantum dots (QDs) are semiconductor nanoparticle clusters, which exhibit quantum 
confinement effects. They are composed of atoms from groups II-VI, or IV-VI of periodic 
Table with the size in the range of 2-20 nm. Their composition and small size, consisting of 
100 to 100000 atoms per nanoparticles [163], give them extraordinary optical and electrical 
properties.  
These compounds are highly florescent due to their excitation states/ band gaps. The quantum 
confinement of QDs enables them to emit light at different wavelength, which depends on the 
diameter of their core. The small gap of larger particles causes the emission of red light, while 
small particles emit blue light due to their large band gaps. Moreover, small particles act as a 
single molecule while all constituent atoms are excited and emitted light together. Hence, the 
intensity of resultant signals increase. Compared to organic florophores, small QDs particles 
exhibit high florescence efficiency as well as lack of photobleaching due to their long 
florescence lifetime (10-40 ns). 
 
 
Figure 30. a) Different sized CdSe colloids irradiated with UV-visible light and emit different 
color light b)Emission wavelength of QDs at different particle size[164]  
 
C.1. Importance of QDs 
 
QDs possess characteristic properties, including high quantum yields, broad absorption band, 
high  molar extinction, large effective Stoke shifts, narrow and symmetric emission bands, 
and high resistance to photobleaching and chemical degradation [165], [166]. Meantime, their 
electrical and optical properties can be tuned up by changing their size [167]–[169] and their 
compositions [170], [171]. By modifying the surface of QDs, they can also be applied as 
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active targeting, diagnostic or therapeutic agents [172]–[174]. They have attracted a great deal 
of interest in optical imaging and other imaging modalities such as PET and MRI. Controlling 
the shape and size with the desired geometries are the main challenge for the synthesis of 
QDs. 
 
C.1.1.  Synthesis of QDs 
 
Several methods have been developed to synthesize QDs. Electron beam lithography, 
reactive-ion and wet chemical etching [175] are common methods to prepare QDs with 
diameter of about 30 nm while focused ion and laser beams have been utilized to fabricate 
zero-dimension dots [176]. The main drawbacks of the wet chemical and reactive-ion etching 
are the impurities incorporation into the QDs and structural imperfections [175]. 
Focused ion beam (FIB) technique makes possible to fabricate the QDs with extremely high 
lateral precision [175]. The surface of semiconductor substrate could be sputtered by highly 
focused beams from a molten metal source (e.g., Ga, Au/Si, Au/Si/Be, or Pd/As/B). Thus,  the 
ion beam has play a major role on the shape, size and inter-particle distance of the synthesized 
QDs with a minimum beam diameter of 8–20 nm which allows obtaining the QDs with 
dimension of less than 100 nm [177].  
Electron beam lithography followed by etching or lift-off processes is another method for 
fabrication of QDs [175]. The advantage of this approach is its high flexibility to design the 
nanostructure systems with any shape, precise separation and periodicity [175]. The III-V and 
II-VI QDs with diameter less than 30 nm have been successfully fabricated with this method 
[175]. 
Wet-chemical methods mainly pursue the conventional precipitation one while the solution or 
mixture of solution is carefully controlled during the synthesis. During the precipitation 
process, both nucleation and growth of nanoparticles is controlled. Wet chemical methods 
enable us to control the size, composition and shape of QDs [175]. Some parameters such as 
temperature, stabilizers or micelle formation, concentrations of precursors, ratios of anionic to 
cationic species and solvent have a strong effect on fabrication of QDs with wet chemical 
method [175]. 
Sol-gel technique is one of the most used method to synthesize small nanoparticles. In 
general, a metal precursor (e.g. alkoxides, acetates or nitrates) in an acidic or basic medium is 
prepared (sol) [175]. Hydrolysis, condensation (sol formation) and growth (gel formation) are 
the main three steps in sol-gel process [175]. CdS [178], ZnO [179]–[182], PbS [183] QDs 
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have been prepared via sol-gel method. Although, these methods have some advantages such 
as simplicity, low cost and suitable for scale-up, broad size distribution and a high 
concentration of defects are two main disadvantages of this method [183].  
Microemulsion processes, categorized as normal microemulsion, i.e., oil-in-water, or as 
reverse microemulsion, i.e., water-in-oil, are popular methods for synthesizing QDs. In the 
reverse micelle process, two immiscible liquids (polar water and nonpolar alkane) are mixed 
and stirred to form emulsion [175]. Using surfactants such as Aerosol OT (AOT), cetyl 
trimethyl-ammonium bromide (CTAB), sodium dodecyl sulphate (SDS) or triton-X would 
lead to disperse nanometer water droplets in n-alkane solution [175]. The II-VI core and 
core/shell QDs, such as CdS [184], CdS:Mn/ZnS [184]–[187], ZnS/CdSe [188], CdSe/ZnSe 
[189], ZnSe [190] and IV-VI QDs have been successfully synthesized with reverse 
microemulsion technique[191]. Same as the other methods of fabrication, sol-gel technique 
shows some advantages such as  the control of the QDs size with a narrow distribution, and its 
dispersion and disadvantages include low yield and incorporation of impurities and defects 
[175]. 
In 1993, Bawendi and colleagues for the first time explained the procedure of pyrolysis route 
for the production of QDs (~300°C) [192]. Precursors, such as alkyl [14], acetate [191], 
carbonate [191] and oxides [164,191] were mixed with phosphene or bis(trimethyl-silyl) 
precursors. In this method, trioctyl-phosphine oxide (TOPO, a coordinating solvent) dry at 
200–350 ºC under vacuum (1 Torr ) in a three-neck round flask. A mixture of precursor and 
tri-n-octyl-phosphine (TOP) selenide were simultaneously injected under vigorous stirring at 
~300 ºC, which results in formations of homogeneous nucleation of QDs. The stabilizing of 
QDs dispersion is relating to TOPO solvent [175]. The majority of II-VI [193]–[197], IV-VI 
[198] and III-V QDs [199] have been synthesized via this technique. The size and shape of 
prepared QDs depends on some parameters including reaction time, temperature, precursors, 
solvents, type of coordinating agents and its purity degree [175]. Although, the relatively slow 
growth of the particles, the size series of QDs can be obtained from the same precursor bath 
[175]. Some of the disadvantages of this method are the high cost of fabrication, the toxicity 
of the organometallic precursors, and generally low dispersivity in water [175]. 
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C.1.2.  Ligand exchange approaches towards biologically 
compatible probes 
 
Unfortunately, QDs are soluble only in nonpolar organic solvents, such as chloroform and 
hexane [200]. Various approaches have been developed to solublizing QDs. One of the most 
common method to water-solubilization of QDs is substitution of hydrophobic surface groups 
with hydrophilic one which is commonly achieved by replacing of the TOPO with 
bifunctional ligands which should possess the surface-anchoring group such as thiol [201], 
[202] and a hydrophilic end group such as carboxyl or hydroxyl [200]. Mercaptoacetic 
(MAA), mercaptopropionic (MPA) acids, and thiol-containing zwitterionic molecules, such as 
cysteine are the common ligands for functionalization of QD surface [200]. Regardless of the 
simplicity of thiol exchange procedure, the main challenge of using thiol as ligand is their 
tendency to quench fluorescence of QDs as well as its instability [203].  
Liu et al. have accomplished to improve the stability of QDs (~11.4 nm) by using di-thiol 
ligands dihydrolipoic acid (DHLA) conjugated to poly(ethylene glycol) (PEG) [204]. 
However, they found that the fluorescence efficiency of obtained QDs decreased. Afterward, 
Sukhanova and co-workers have achieved to solubilize CdSe/ZnS core/shell nanocrystals in 
water with DL-Cysteine and improved its  stability with poly(allylamine) [205]. Furthermore, 
Jiang et al. have enhanced the stability of ZnS-capped CdSe encapsulated with 
mercaptoundecanoic acid shell by covalently cross-linking neighboring molecules with lysine 
[206]. While, they have observed that the hydrodynamic radius of QDs colloids have 
dramatically increased from 8.7 to 20.3 nm due to shell cross-linking conjugation [206].  
Using multifunctional and multidentate polymer ligands for coating CdTe QDs (with coating 
thickness in the range of 5.6 and 9.7 nm) leads to  enhance its colloidal stability and 
photobleaching problem [207]. It has been found that grafting of balanced composition of 
thiol and amine coordination group into polymer chains could improve QDs colloids stability 
and overcome photobleaching as well as enhancing fluorescence quantum yields [207]. 
In another work, Gerion and colleagues have successfully embedded CdSe/ZnS core/shell 
QDs in siloxane shell and functionalized with either thiol or amine group [208]. In this 
procedure, silica/siloxane shell with thickness between 1-5 nm leads solublizing particles in 
polar solvent. Afterward, siloxane shell has been coated with bifunctional methoxy 
compounds, which shows highly stability against flocculation and great solubility in aqueous 
buffer. The only drawback of this approach is precipitation and gel formation of QDs colloids 
at neutral pH due to residual silanol groups on the QD surface[208]. 
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Another alternative approach to transfer TOPO capped QDs from organic to aqueous solution 
is encapsulating of QDs with amphiphilic molecules, including polymers or phospholipids 
[209], [210]. Several QDs such as CoPt3, CdSe/ZnS, and Fe2O3 have been successfully water-
soloublized via this method [210]. Although the water-solublized of QDs via this method is 
stable with maintained optical efficiency, the hydrodynamic radius of nanoparticles 
dramatically increases because of  deposition of several organic layers [211].  
Ligand exchange method often yields compact probes which exhibit low stability and 
fluorescence efficiency, whereas polymer-encapsulation approach causes to have high stable 
and bright QDs with the large particle size [200]. With water solubilization of QDs, the 
number of QDs have already used in biomedical research. While up to now, no method can 
satisfy all the design criteria imposed by researcher [200].  
 
C.2. QDs application in bioimaging 
 
Over decades, a significant amount of research is focused at using QDs in biological imaging 
[212]–[219]. Previously, most of optical bioimaging was based on traditional organic dyes 
[220]. Instability of organic dye is a major obstacle in bioimaging. Furthermore, conventional 
dye molecules have a narrow absorption and excitation band which makes difficult the 
simultaneous excitation of multiple dyes [221], [222]. Quantum dots offer several advantages 
over organic fluorophores which were commonly used for in-vitro labeling [223].  Comparing 
with organic dyes, QDs absorb light more efficiently, and an individual QD is 10–20 times 
brighter than organic fluorophores. Moreover, QDs are more photostable (about thousands of 
times), more resistant photobleaching (about more than 30 min of continuous high-energy 
illumination) than organic dyes. Overall, QDs generally exhibit broad excitation windows but 
narrow emission peaks and less toxicity than conventional organic dyes; QDs have replaced 
conventional organic dyes for in-vitro and in-vitro imaging and diagnostic of live cell [205], 
[224], [225]. Referring to properties of QDs, QDs have shown great potential in bioimaging 
applications. 
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C.2.1.  Application of Quantum dots as contrast enhancement of 
MR images 
 
Referring to aims of my project, the potential of reported metal-doped QDs as MRI contrast 
agents will be reviewed in this section. Among the paramagnetic ion doped quantum dots 
(QDs), Mn-doped QDs have attracted much attention as MRI CAs while the majority of them 
are core/shell QDs. The potential of 3-5 nm of Mn-doped CdTe/ZnS colloids  as MRI contrast 
agents has been studied by evaluating their relaxivities [226]. The r1 of Mn:CdTe/ZnS in 
aqueous solution at 3T increased from 5.4 mM
-1
s
-1
 to 10.68  mM
-1
s
-1
 with increase the Mn 
dopant concentration from 4.7% to 9.7%, respectively [226]. Furthermore, r1 of ultra small 
CdSe/Mn:ZnS QDs has been reported in the range of 11-18 mM
-1
s
-1
 at 7T and ambient 
temperature [227]. The high relaxivity of these complexes have been attributed to location of 
Mn ions on the shell of nanoparticles which causes slowing of the tumbling rotation and 
enhancing the interaction between Mn ions and water molecules [227]. It has been observed 
that r1 increased with the thickness of shell which was attributed to probability of higher Mn 
concentration localized in the shell [227]. Iron oxide-Mn:ZnS encapsulated with poly(lactic-
co-glycolic acid) has been also studied as MRI contrast agents at 3T [228]. The signal T*2 of 
MR images decreased with increasing PLGA concentration while the concentration of Mn 
and Fe were constant [228]. Meantime, the signal intensity (T*2) decreased more rapidly with 
increasing iron oxide concentration at lower TE [228]. The r*2 of nanoparticles have been 
evaluated as high as 523 mM
-1
s
-1
 [228]. In the other study, the hollow MnO particles has 
shown the highest r1  of 0.2 mM
-1
s
-1
 and r2 of 7.48 mM
-1
s
-1
 [229]. While after coating with 
iridium SiO2the relaxivity decrease to r1 of 0.17 mM
-1
s
-1
 and r2 of 1.67 mM
-1
s
-1
 [229]. By 
coating the MnO, the accessibility of water molecules diminished [229]. The MnO/SiO2 
grafted with PEG complex has showen high r1 of 13  mM
-1
s
-1
 at 0.81 MHz [230]. The high 
relaxivity of the compound was ascribed to high molecular weight of PEG for coating and its 
large size of 9.2 nm [230].  
The efficiency of QDs doped with other metal ions has been also studied. For instance, 20 nm 
of ZnO-doped Er, Yb, Gdx (x=1, 2, 3%) has shown great efficacy as MRI CAs with r1 varied 
between 23-168 mM
-1
s
-1
 for Gd(III) increased from 1% to 3% [231]. The high relaxivity of 
prepared nanoparticles has been attributed to the porous structure of nanoparticles which 
enhances the accessibility of water molecules to metal ions [231]. The potential of Gd doped 
ZnO as MRI contrast agents has been reported by Liu et al. [232].The strong T1 contrast 
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enhancement of Gd-doped ZnO colloids has been reported with r1 of 16 mM
-1
s
-1
 at 1.5T 
[232]. Furthermore, incorporation of Gd to CdS:Mn/ZnS  has been yielding enhancement of 
relaxivity (r1=20 mM
-1
s
-1
 and r2=151 mM
-1
S
-1 
at 4.7 T), attributing to contribution of Gd and 
Mn as well as grafting QDs with rigid macromolecules to avoid free rotation [233].  Doping 
Gd into InP/ZnS quantum dots extend its application as MRI contrast agents as well as 
florescence agents [234]. In-vitro MRI studies of novel nanoparticles have proven its high 
efficiency as MRI contrast agents with the high r1 of 12.2 mM
-1
s
-1
  at 35 MHz [234]. 
Moreover, ZnS:Tb,Gd and ZnS:Er,Yb,Gd nanoparticles have shown high relaxivity of 39.4 
mM
-1
s
-1
 and 57.8 mM
-1
s
-1
[235]. On the other hand, conjugation of Gd-complex on 
CulnS2/ZnS quantum dots have exhibited the r1 of 3.72 mM
-1
s
-1 
at 7.0T [236]. The in-vitro 
MRI studies of silica nanohybrids composed of CuInS2/ZnS and magnetite nanoparticles 
exhibited a high spin-spin relaxivity of 214 mM
-1
s
-1 
[237]. Europium doped gadolinium 
sulfide QDs synthesized via sonochemistry has been studied as photoluminescence and MRI 
contrast agents [238]. The nanoparticles in aqueous solution have shown r1 of 13.48 mM
-1
s
-1
 
at 4.7T [238]. Computer simulations have been carried out in our work to understand the 
assemblies of Mn-ZnS molecules dispersed in water in terms of their structure and 
microscopic interactions between water molecule and Mn molecules. 
 
D. Molecular dynamics simulation 
 
The two main familiar computer simulation techniques are molecular dynamic (MDs) and 
Monte Carlo (MC) simulation. The MDs show great advantages over MCs due to gathering 
dynamical information of systems as well as high accuracy. Molecular dynamic has emerged 
as one of the indispensable numerical techniques since 1957. Alder and Wainwright firstly 
introduced MD technique to investigate interaction of hard sphere [239]. Later on, liquid 
argon was simulated using a realistic potential by Rahman in 1964. In 1974, Rahman and 
Stillinger for the first time simulated the realistic system (liquid water) with molecular 
dynamic simulation [240]. Since then, MDs become a valuable tool in many disciplines such 
as physics, chemistry, materials science, etc. MDs can be categorized in two main families 
such as classical and quantum mechanics. In classical mechanics, the atom is considered as a 
ball, which is bonded together with elastic sticks and dynamics of the system is simulated by 
applying classical mechanics laws. The second category, quantum mechanics, the quantum 
nature of chemical bonds is taken into account. In this method, quantum equations are carried 
 
 
59 
 
out to determine the bonding in system whereas dynamics of ions is calculated using classic 
equations. MD is a numerical method for particle tracking by generating the trajectories of the 
system. For tracking of particles, appropriate interatomic potential and suitable initial and 
boundary conditions are required. Then, trajectory of N particles is obtained from integration 
of Newton’s equations of motion. The simple algorithm of MD is presented in Fig. 31. 
 
 
Figure 31. Algorithm of molecular dynamic simulation  
 
Figure 32 represents the MDs system contains N particles. At any instant, the particle 
coordinates’ are defined as r3N≡ {r1 (t), r2 (t), …, rN (t)} while rI is the coordinates of atom i. 
At time t=t0, the system is in its initial configuration. As the simulation runs, particles in 
system evolve through a sequence of timesteps (Δt), typical values ~10-15 s. The internal 
energy of system is defined as follows 
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After running simulation, the system reaches the desired condition. Then properties of system 
such as radial distribution, thermal condition, energy, etc of the system averages over time. 
One of the most important results extracted from MDs is radial distribution. Radial 
distribution is the probability of finding particles at a distance r from a reference particle. The 
RDF of the system is calculated as follows 
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While Nk is number of atoms at time k in a spherical shell dr, and ρ is average of density. 
From integration of RDF over dr, average coordination number of particle from reference 
particle can be evaluated. 
 
 
Figure 32. Schematic explicits simulation box and radial distribution evaluated 
 
D.1. Simulation Set-up and procedure 
 
Among all available softwares for MDs, DL_POLY and LAMMPS are the most popular ones.  
The five important gradients required for MDs can be listed as follows, initial condition, 
boundary condition, force evaluation, and integrator/ thermodynamic ensemble. The first step 
is initialization of atoms and choosing the suitable boundary conditions. Two main boundary 
conditions are isolated and periodic boundary conditions. Isolated is ideally suited for cluster 
while periodic boundary is used mostly for liquids and solids. Particles in isolated boundary 
condition interact among themselves and no interactions with outside. In periodic boundary, 
particles are kept track in a super cell while surrounded by infinite replicas. Thus, some 
particles might not interact with particles in same super cell, they interact with particles in an 
adjacent image of the super cell.  
Secondly, interaction should be identified by applying the appropriate force field. The 
interaction between atoms can be determined as inter and/or intratomic interactions. The 
interatomic potential is a critical parameter in MDs. It controls the simulation and accuracy of 
results obtained. The major challenge in MD is finding the appropriate potential for 
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describing the interaction between atoms of the system. The energy of the system can be 
considered as follows 
    ),...,,,(...),,(),,()( 321 NkjiNkjijii rrrrVrrrVrrVrVE               (23) 
While ri, rj, rk,…,rN are the particle positions and V1,V2,V3,…, VN are m-body potentials. The 
most used inter and intratomic potentials in DL_POLY are listed in Table 4.  
Thermodynamic ensemble is playing an important role for MDs. The ensemble is the group of 
atoms, which have same macroscopic state but in different microscopic states. The microstate 
of group of atoms can be defined in terms of thermodynamic quantities such as number of 
atoms N, pressure P, temperature T, volume V, etc. The common ensemble used in MDs are 
microcanonical ensemble (NVE), canonical ensemble (NVT), isobaric isothermal ensemble 
(NPT). In NVE, the system is isolated while total energy, number of atoms, and volume of 
ensemble are constant. This thermodynamic ensemble is commonly used to represent the 
possible atom states without controlling pressure or temperature of system. The canonical 
ensemble (NVT) is applied to control temperature of the system during simulation. The 
volume and number of atoms remain constant throughout the run. Finally, NPT allows us to 
control pressure and temperature of system.  
In the next step, we have to choose an appropriate algorithm for integration of Newton’s 
motion equations for positions and velocities at time t and after t+Δt (Δt is the timestep, in the 
range of 10
-15
s). Many numerical algorithms have been developed for integration of the 
Newton’s equation; Velvert being the most popular. Positions, velocities and accelerations of 
particles is approximated in Velvert algorithm scheme via Taylor series expansion 
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While r, Δt, v, 
.
r  are position, timestep, velocity and acceleration, respectively. 
.......
, rr  are the 
third and fourth time derivation of position. For Leapfrog velvert, velocity leaps over the 
positions and vice versa. Thereby, positions and velocities are not known at the same time. 
The velocities are explicitly calculated. However, positions, velocities and accelerations in 
velocity velvert algorithm are newly calculated at each time.  
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Table 4. List of most used potential developed in DL_POLY 
Intramolecular potential 
Core-shell   2
2
1
)( ijkrrU   
Tethering potential Harmonic 20 )(
2
1
)(  tii rrkrU  
Bond potential 
 
Harmonic 2
0 )(
2
1
)( rrkrU ij   
Morse   1))(exp(1)( 200  rrkErU ij  
12-6 
)()()(
612
ijij r
B
r
A
rU   
Lennard-Jones 








 612 )()(4)(
ijij rr
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6
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Cr
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
 
Coulomb 
)
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0 ij
ji
ij
ticsElectrosta
r
qqk
rkrU

  
Angle Potential Harmonic 2
0 )(
2
1
)(  ijkrU  
Dihedral Angle 
Potentiel 
Cosine  )cos(1)(   mAU  
Harmonic 2
0 )(
2
1
)(   ijkrU  
Intermolecular Potential 
Van der Wals Tabulated  
Buckingham 
6
)exp()(
ij
ij
r
Cr
ArU 

 
12-6 
)()()(
612
ijij r
B
r
A
rU   
Morse   1))(exp(1)( 200  rrkErU ij  
Metal EAM (embedded-
atom method)  
Tabulated potential 
Three body 
potential 
Harmonic 2
0 )(
2
1
)(  ijkrU  
Four body 
potential 
Harmonic 2
0 )(
2
1
)(   ijkrU  
External Filed Electric  qEF   
Magnetic  )(vxHqF   
 
The system should be relaxed from its initial condition to its natural equilibrium condition by 
choosing appropriate force field, and long enough time of simulation, and thermodynamic 
ensembles. After reaching the equilibrium condition of the system, the results obtained can be 
treated and visualized. 
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D.1.1.  Molecular dynamic simulation of ZnS and ZnS-doped 
nanoparticles 
 
ZnS is one of the most extensively investigated semiconductor materials. ZnS in nature can be 
found in two crystal structures such as zinc-blend (cubic) and/or wurzite (hexagonal) phases 
while solid-solid phase transition can occur under different conditions, including pressure 
[241], temperature [242], environment [243], and aggregation [244]. At standard temperature 
(~30°C) and pressure, ZnS structure remains sphalerite (cubic). In the sphalerite phase, both 
Zn and S atoms are coordinated tetrahedrally with three-layer repeat ABC. On the other hand 
in wurzite structure, which is more stable at high temperature (1020°C) due to high internal 
energy, ZnS dimers are close packed with a ABAB arrangement [245]. Physical, mechanical 
and opto-electrical properties of ZnS nanoparticles change with transformation of phase.  
Hence, study and/ or prediction of ZnS stability structure under different conditions have been 
investigated to shed light on dominant factors on phase transformation. In order to support the 
experimental results and obtain stepwise observations, classical MD simulations have been 
performed to investigate ZnS structure. 
In 1995, Wright and Jackson have developed shell potential to simulate ZnS nanoparticles 
[246]. The interatomic potentials used to describe ZnS atomic interactions were shell and 
Buckingham potentials. Firstly, they assumed S atoms have a neutral shell connecting to a 
core with atomic charges of -2 (M1). Secondly, both Zn and S atoms were assumed to have a 
core and a shell (M2). Thirdly, both S and Zn have core and shell and three-body potential 
was added to improve the results obtained (M3), summarized in Table 5.  
All three methods show good results, whilst the closest to experimental results has been 
obtained from M3. From M3 potential parameters, it is possible to reproduce ZnS 
polymorphs, sphalerite, and wurzite phases. Defect and activation energy of atomic migration 
of sphalerite ZnS structure have been calculated by Wright et al. [247]. It has been observed 
that the surface {110} of sphalerite has the lowest energy and type III surface such as {111} 
could be stabilized by introducing point defects [247]. Moreover, they have reported that Zn 
diffusion occurred because of the interstitial mechanism whilst S atoms diffuse because of 
vacancies in host lattice. Referring to higher defect formation energy of wurzite compared 
with sphalerite one, wurzite phase has shown much higher activation energy [247].  
  
 
 
64 
 
Table 5. Potential parameters developed by Wright and Jackson for model ZnS structure and 
comparing experimental and calculated structural results [246] 
Potential  (M1) (M2) (M3) (M1) (M2) (M3) (M1) (M2) (M3) 
Buckingham  A ρ C 
Zn-S 613.356 539.45 528.899 0.399 0.4099 0.4111 0 0 0 
S-S 1200 1200 1200 0.149  0.149 0.149 120 120 120 
  K       
Shell S-S 12.7 18.8 16.86       
Zn-Zn 0 3.52 2.181       
  K Θ  
Three-body  S-Zn-S      ---- ---- 0.713 ---- ---- 109.47 
Results (sphalerite) a(Å) V(Å
3
) C11 (MPa) C12 (MPa) C44 (MPa) 
Experimental 5.41 158.297 9.42 5.68 4.36 
Simulated (M3) 5.407 158.10 9.17 5.82 4.4 
 
Further investigation on aggregation, coursing and transformation in ZnS nanoparticles have 
been performed by Zhang and Banfield in 2004 [248]. For this purpose, 3 nm unrelaxed ZnS 
nanoparticles have been placed in the corner of tetrahedron and one in the center with the 
distance of 30.5 Å, presented in Fig. 33I. During the simulation, these nanoparticles have been 
randomly oriented with respect to the interatomic potential developed by Wright and Jackson 
[247]. The system after 1.1 ns did not reach the equilibrium state, Fig. 33II. After 10 ps, 
nanoparticles relaxed due to surfaces atom rearrangement. After relaxation of nanoparticles, 
the nanoparticles aggregation started to form because of translational and/or rotational 
movement of nanoparticles, up to 235 ps. Furthermore, atomic diffusion crystallization of 
nanoparticles upon each other causes coarsening of particles. The size of particles after 
coarsening becomes 5 nm in diameter with a close-packed periodic layer on the surface and 
wurzite structure in center, Fig. 33III. They have reported that during last 1 ps the majority of 
Zn or S atoms moved while the fast moving atoms were located on the surface of particle, Fig. 
33IV. They have observed that diffusion of atoms on the surface is much faster than in the 
bulk which affect the structural transformation, aggregation, and coarsening of particles [248]. 
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Figure 33.I. Snapshot of particle during simulation: a) 0 ps, b) 13.8 ps, c) 16.3 ps, d) 28.8 ps, 
e) 41.3 ps, f) 78.9 ps, g) 167 ps, h) 479.5 ps, i) 1100 ps, II. Potential energy of system during 
MDs time, III. Enlargened snapshot of particle at 479.5 ps, IV. Black balls are atoms with 
high mobility in the last 1 ps [248] 
 
Wrigth and Gale have developed the more complicated potential to model ZnxCdx-1S with 
sphalerite and wurzite structures [249]. The interatomic potentials used to model CdZnS 
structure in wurzite and sphalerite phases are listed in Table 6. They have reported that four-
body potential is a crucial potential to correct the phase stability of ZnS and it is impossible to 
stabilize sphalerite over wurzite phase in the absence of tortional potential [249]. Sphalerite is 
the most favorable crystal structure of ZnS in standard condition, while for CdZnS hexagonal 
is more stable. In solid solution of ZnxCd1-xS, transition from hexagonal to sphalerite has 
occurred at x=0.6. In 2009, Wright has described the potential parameters for ZnS 
nanoparticles doped with Cd, Mn and Fe ions in vacuum [250], as listed in Table 6. The 
atomistic simulation technique based on Born model has been carried out to describe the 
interaction between ions in system. From simulation, the impurities have a great tendency to 
replace at Zn sites rather than interstitially entering to system. They reported that the impurity 
could be located as isolated ion at low concentration causing slightly lower the defect energy 
especially when the dopant atoms are distant from each other. Above 30% concentration, the 
impurities are mostly located at adjacent sites. Moreover, concentration of Fe and Mn dopant 
atoms has no impact on surface energy of crystal structure. However, surface energy increases 
with Cd concentration especially at surfaces with high density of Zn sites such as (111) and 
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(110) surfaces. At surfaces with low ZnS site density, large Cd atoms have more space which 
is the reason to observe  less enchantment of surface energy [250]. 
 
Table 6. Interatomic potential values used for study incorporation of Cd, Mn, and Fe ions into 
ZnS sphalerite [249],[250] 
Potentials parameter values Atomic pairs 
Buckingham  Zn-S* Cd-S* Mn-S Fe-S S-S 
A (eV) 672.288 1240.9518 750.686175 782.4698 1200 
ρ (Å) 0.39089 0.371852 0.390889 0.385720 0.149 
C (eV/Å
6
) 0 0 0 0 0 
Cut-off 12 12 12 12 12 
Three-body  S-Zn-S* S-Cd-S* 
K (eV/rad
2
) 9.42834x10
6 
3.59468x10
7 
 Θ (°) 109.47 109.47 
ρ1/ ρ2 0.3 0.3 
Torsion  Zn-S-Zn-S* 
K (eV) 0.005 
m/n +1/+3 
rmin(Å) 2.5 
rmax(Å) 3 
Core-shell  S-S* 
K (eV/Å
2
) 13.302743 
 * Potential parameters used to model CdZnS bulk structure 
 
D.1.2.  Molecular dynamic simulation of ZnS and ZnS-doped 
nanoparticles in solution 
 
Classical molecular dynamic simulations are a common numerical method to investigate the 
system in aqueous solution over long time scales (over nanoseconds). However, this method 
is still at an early stage. Study of the interaction of nanoparticles with water molecules in 
many biological processes is received much attention due to the importance of understanding 
nucleation of nanoparticles from water solution. Semiconductor nanoparticles and their 
interaction with water molecules have already been studied via molecular dynamic 
simulation.  
For instance, stability of different sized ZnS nanoparticles (2, 2.5, 3, 4 and 5 nm) with 
sphalerite and wurzite initial structures surrounded with different number of water molecules 
have been studied numerically and experimentally [244]. The numerical simulation of ZnS 
has been performed by using the shell model plus Buckingham and three-body potentials at 
300 K using Nose-Hoover algorithm with time step of 0.5 fs. Different models such as shell, 
CVFF (consistent values from force field), and SPC/E (extended simple point charge model) 
have been used for water molecules MDs. Among these models, they have reported that the 
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shell model presented best compatibility with shell ZnS model. From MDs of model particles, 
loss of initial configurations in vacuum was observed while crystallinity increased following 
water binding, as presented in Fig. 34. The increase of crystallinity with lower water coverage 
was referring to the strong water interactions with surface of ZnS. From MDs results, they 
reported that binding polar water molecules to Zn or S ions in the surface would increase 
crystallinity and showing residual surface stress [244]. 
 
 
Figure 34. 3D snapshot of ZnS 3 nm MDs a) in vacuum, and b) with surface-bound water S 
atoms yellow, Zn red, O blue, H light blue [244] 
 
Formation of cluster ZnS in aqueous solution has been studied by Said et. al using molecular 
dynamic simulation [251]. They have investigated the influence of temperature and water 
concentration on formation of ZnS clusters. The Zn and S ions randomly placed in the box of 
water (ρ~0.977 g/cm3) at room temperature. The pre-equilibration was achieved after 40 ps 
while Zn and S ions are fixed and water molecules moved. Afterward, all atoms in the system 
are free to move during 20 ps to reach the equilibrium condition. The ZnS interatomic 
potential was the same as reported by Zhang [244]. The additional thermostat to control the 
temperature of system is applied with introducing the friction constant of 15 au/ps. For 
formation of ZnS cluster, temperature increased to 3000 K for 50 ps then decreased every 10 
K to reach 300 K [252]. The interaction between water and ZnS clusters was modeled using 
Buckingham and Lennard-jones potentials. At 300K, every Zn atom coordinated with 6 water 
molecules. On the other hand, S atoms do not form a stable complex by interacting with water 
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molecules. However, Zn-S pair in a distance of 4.6 Å forms a stable complex in solution. 
Forming cluster of ZnS has been observed while some atoms jump the barrier. After first 
cluster formation, growing cluster is easy. Due to results obtained from simulation, the most 
stable ZnS cluster forms at (ZnS)6-(ZnS)47 which forms a hollow cluster. 
 
 
Figure 35. a) ZnS3 and Zn2S3 first cluster formed, b) Zn6S8 cluster after 1.5 ns, c) cluster 
formation at 500 K, d) Zn9S11 bubble cluster after 6 ns. Yellow stick : S; blue stick : Zn; red 
sticks : O; and white sticks : H [251].  
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In this chapter, firstly synthesis and characterization of metallated porphyrin is presented. 
Secondly, conjugation of metallopoprhyin with chitosan nanoparticles via passive loading and 
chemical conjugation is described following with characterization. For the second thematic 
part of the thesis, synthesis and characterization of Mn:ZnS QDs will be explained in detail. 
Finally, the simulation procedures for modelling of MnZnS nanaoparticles in aqueous 
solution (water) will be indicated. 
 
A. Synthesis of Porphyrin 
A.1. Chemical materials 
 
Pyrrole (reagent grade, 98%), benzaldehyde (≥99.5%), dichloromethane, boron trifluoride 
diethyl etherate (≥46% BF3 basis), trifluoroacetic acid (99%), 4-chloroaniline (98%), 2,3-
dichloro-5,6-dicyano-1,4-benzoquinone (98%), manganese meso-tetrakis (4-sulfonatophenyl) 
porphyrin Mn(TSPP) (cat. No. 441813), silica gel, gadolinium acetylacetonate hydrate 
(99.9%), and 1,2,4-trichlorobenzene  analytical standard were purchased from Sigma-Aldrich. 
The Gd-Dota (Gd-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) was obtained 
from laboratory Andre Guerbet, France. 
 
A.2. Metallation of  meso-tetrakis(4-pyridyl)porphyrin with 
Gadolinium (Gd(TPyP)) 
 
Meso-tetrakis (4-pyridyl) (TPyPH2) free-base porphyrin was synthesized and purified 
following the Lindsey procedure [50]. The gadolinium meso-tetrakis(4-pyridyl) porphyrin 
were synthesized according to the method developed by Adler [253]. The solution of 
(TPyPH2) (0.26 g, 0.3 mmol) was heated with an excess of gadolinium acetylacetonate 
hydrate (0.34 g) in 190 mL of 1-,2-,4- trichlorobenzene under argon at 245°C. The reaction 
was followed and stopped after 80% disappearance of the visible Qv peak (513 nm) by 
checking the UV-visible spectra of the metal ion porphyrin. The product was filtered with 
alumina gel and then purified by column chromatography with alumina gel and eluted with 
the mixture of dichloromethane and methanol varied between 0 to 5%.  
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Figure 36. Schematic of Gd(TPyP) synthesis procedure  
 
A.3. Colloid preparation  
 
In order to prepare the colloids of metalloporphyrin complexes, different weighted amount of 
commercial Mn(TSPP), and Fe(TMPyP) were dissolved in 1mL of deionized water while 
synthesized Gd(TPyP) were dispersed in 1mL of ethanol because of its scarcely water 
solubility.  Referring to Table 7, concentrations of Fe(TMPyP) and Mn(TSPP) were in the 
range of 1mM to 10 mM and 0.1 mM to 1 mM, respectively. The Gd(TPyP) concentration 
varied between 0.1 mM up to 1mM. 
 
Table 7. Weighted amount and concentration of metalloporphyrins 
Product Mn(TSPP) Fe(TMPyP) Gd(TPyP) 
Weighted amount 
(mg) 
0.1 0.3 0.5 1 0.9 1.8 3.1 9.1 0.09 0.18 0.27 0.36 0.45 0.54 0.72 0.9 
Concentration (mL) 0.1 0.3 0.5 1 1 2 3 10 0.1 0.2 0.3 0.4 0.5 0.6 0.8 1 
 
Dilution of commercial Gd-Dota 500 mM solution was performed in dionised water and in 
the mixture of ethanol/water. It has been known that ionic contrast agents such as Gd-DTPA 
and Gd-Dota were crystallized when mixing with 100% ethanol [254]–[256]. Thus, in order to 
avoid crystallization, Gd-Dota was diluted with 94% ethanol and 6% water in glass vials, as 
described in [255]. After dilution, the glass vials were placed in an ultrasonic bath for 20 
minutes. The concentrations of diluted Gd-Dota in water and in the mixture were in the range 
of 0.6 -30 mM and 1-9 mM, respectively. 
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A.4. Characterization 
 A.4.1. UV-visible spectroscopy 
 
The metallation of TPyPH2 was studied using ultraviolet- visible spectroscopy (UVIKON XL 
spectrometer). The small quantity of TPyPH2 and Gd(TPyP) porphyrins were dispersed in 
ethanol. One milliliter (mL) of porphyrin colloid was put in the rectangular quartz cuvette 
with 1 cm pathlength. 
 
 A.4.2. Matrix assisted laser desorption/ionisation (MALDI)-TOF 
mass spectrometry 
 
Molecular mass of synthesized Gd(TPyP)  was investigated by Matrix-Assisted Laser 
Desorption/Ionisation time-of-flight mass spectrometry (MALDI TOF, Applied Biosystem 
Voyager-De Str). Dichloromethane was chosen as a matrix solvent. 
 
A.4.3.  Fourier transmission infrared spectroscopy  
 
Fourier transmission infrared spectroscopy (FT-IR, Bruker IFS 66 spectrometer) of TPyPH2, 
and Gd(TPyP) powder were carried out over the range of 4000-800 cm
-1
 using 10 scans. 
 
A.4.4.  NMR relaxometry 
 
r1 and r2 of prepared Gd(TPyP), Mn(TSPP) and Fe(TMPyP) colloids were evaluated via the 
Minispec NMR spectrometer (Bruker instruments, Mq20, Germany) at 20 MHz (B0=0.47 T). 
The temperature of system was fixed at 40°C. Data were acquired via minispec mplus 
software. The longitudinal relaxation times (T1) were measured using an inversion-recovery 
sequence. Ten inversion recovery times ranging from 10 ms to 5T1 of solution (10-1500 ms). 
T2 relaxation times have been determined by employing the Carr-Purcell Meiboom Gill 
sequence. The acquisition parameters were set as follows: pulse separation (τ)=1 ms, recycle 
delay=1.5 s, and number of echoes= 1000 with an echo time of 2ms. The tubes filled with 
metalloporphyrin colloids were preconditioned in a bath reservoir for 20 minutes in order to 
equilibrate the temperature at 40°C. The real temperature of the probe head sample (37°C) 
was measured by a calibrated thermometer. Data processing was performed with XWIN-
NMR Bruker. The T1 and T2 of metalloporphyrin and Gd-Dota in aqueous media were 
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determined by monoexponential fitting of NMR free induction decay (FID) signal intensity to 
equations 26 and 27, respectively   
))exp(21(
1
0
T
t
SS                                                                                (25) 
)exp(
*
2
0
T
t
SS 
                                                          (26) 
r1 and r2 relaxivities have been obtained from the linear least square regression of inverse of 
relaxation time versus the concentration of paramagnetic ions as bellow 
Cr
TT
i
diaiobsi

)()(
11
  i=1,2                 (27) 
Where )(obsiT and )(diaiT are respectively the relaxation times of aqueous solution (s
-1
) and 
relaxation times of the solvent (s
-1
), C is the concentration of paramagnetic ion (mmol
-1
) and ri 
is the paramagnetic relaxivity (mmol
-1
.s
-1
). 
 
A.4.5.  Magnetic Resonance Imaging 
 
Magnetic resonance imaging (MRI) of metalloporphyrins and Gd-DOTA colloids were 
acquired with MRI scanner (Philips ACHIEVA 3.0T TX) at 3T and 25°C.  The longitudinal 
and transverse relaxivities of prepared colloids were evaluated from obtained images. The T1 
weighted images were obtained from spin echo sequence by keeping the echo time TE of 8 
ms and varying repetition time TR (100-400 ms). For T2 weighted images, the spin echo 
sequence was used keeping the long repetition time TR=1500 ms and varying echo time TE 
(7ms - 40 ms).The other parameters were optimized such as: field of view (FOV)= 
154x154x5, slice thickness=5 mm, flip angle=90°, number of signal averages= 7, and 
voxel=1x1x5 mm
3
. The high resolution T1 and T2 weighted images were obtained from spin 
echo sequence (TR=400 ms and TE=8 ms) and (TR=1500 ms, TE=40 ms), respectively. After 
image acquisition, the magnitudes of signal intensities within region of interest (ROI) were 
inferred manually by ImageJ software. The MRI signal intensity was fitted on a voxel basis 
with a monoexponential function ))
1
exp(1.(0
T
TR
SS I  and )
2
exp(.0
T
TE
SS I  to evaluate 
T1 and T2 relaxation times, respectively. The slop of inverse T1 and T2 relaxation times 
versus concentration of paramagnetic ions was defined as r1 and r2 relaxivity, respectively. 
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B. Loading of Gd(TPyP) into Chitosan nanoparticles  
 
The insolubility of Gd(TPyP) in water is the major obstacle to introduce this product as a MRI 
contrast agent. It has been assumed that its solubility could be enhanced by encapsulating the 
complex in chitosan nanoparticles (CNs). Since physicochemical properties of CNs depend 
strongly on the condition of formation, we tried to optimize the procedure of CNs synthesis to 
obtain small nanoparticles with narrow distribution. The chitosan concentrations and 
processes such as stirring speed and stirring time, which could have an impact on size and 
polydispersity of final prepared nanoparticles, were optimized. Secondly, we investigated the 
feasibility of incorporation of Gd(TPyP) into chitosan nanoparticles via chemical conjugation 
and passive absorption methods. 
 
B.1. Chemical Materials  
 
Chitosan (from shrimp shells, medium molecular weight, deacetylation degree ≥85%), 
chitosan (high purity, low molecular weight (Mv=60-120 kDa), deacetylation degree≥ 93%), 
and sodium triphosphate pentabasic (TPP) (purity ≥98%) were purchased from Sigma-
Aldrich. All other reagents used were of analytical grade without further purification. 
 
B.2. Synthesis of Chitosan Nanoparticles (CNs) 
 
CNs were prepared by following the reported method by Fan et al. [257] with slight 
modifications. Different concentrations (0.5, 0.7, 1, and 1.7 mg/mL) of chitosan were 
dissolved in 70 mL of acid acetic (1%) under magnetic stirring overnight. The pH of solution 
was adjusted to 4.7 by adding dropwise 20% wt NaOH aqueous solution under magnetic 
stirring. 125 mg of TPP was dissolved in 100 mL of deionised water. Chitosan and TPP 
solutions were filtered through syringe filter (pore size 0.22 μm, Milipore). To prepare CNs, 3 
mL of the chitosan solution was heated for 10 minutes in the water bath at 60°C. The heated 
solution was mixed with 1 mL of TPP solution (4°C) under magnetic stirring in the cooled 
chamber (6°C).  The transparent solution became opalescent after mixing of TPP and chitosan 
(Fig. 37), followed by sonication (bioblock scientific, 32 Hz) for 3 min in a glass beaker. CNs 
suspension were centrifuged at 12,500 rpm at 4°C for 15 min and washed 3 times with 
distilled water. The nanoparticles were collected after freeze drying over night at 2°C. 
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Figure 37. Procedure of CNs preparation  
 
B.3. Preparation of Gd(TPyP) loaded chitosan nanoparticles 
 
Loading of Gd(TPyP) into CNs was done via chemical conjugation and passive absorption 
routes. In chemical conjugation, Gd(TPyP) was directly added to chitosan solution or to TPP 
solution. Thus, for active loading (chemical conjugation) of Gd(TPyP) into CNs, 1 mM of 
Gd(TPyP), dispersed in ethanol, was added into TPP or chitosan solution, as depicted in Fig. 
38. Then the procedure of CNs synthesis was followed. 
 
 
Figure 38. Chemical conjugation of Gd(TPyP)-CNs 
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The passive loading was performed by dry mixing of CNs with metalloporphyrin for 15 min. 
After 15 minutes mixing, the mixture was dissolved in distilled water under magnetic stirring 
for 15 min at 4°C, following sonication. In order to prepare different concentrations of 
Gd(TPyP)-CNs, four different quantities of Gd(TPyP) (2, 4, 8, 12 mg) were mixed with 4 mg 
of CNs. The centrifugation has been used to separate free Gd(TPyP) from Gd(TPyP)-CNs 
(Fig. 39).  
 
 
Figure 39. Passive loading of Gd(TPyP)-CNs 
 
B.4. Characterization of CNs and Gd(TPyP)-CNs 
B.4.1.  Dynamic light scattering 
 
The physicochemical properties of prepared CNs and Gd(TPyP)-CNs such as particle size and 
polydispersity have been studied by dynamic light scattering ZetaSizer-NanoZS (Malvern 
Instrument, UK) equipped with a standard 633 nm laser.  The size distribution of dispersed 
samples in 1mL of distilled water was calculated from autocorrelation function of light 
scattered from particles at 20°C. The homogeneity of solution was determined from 
polydispersity index (PdI) which varies between 0 to 1. A value below 0.3 indicates high 
homogeneity while those greater than 0.3 indicate heterogeneous dispersion. 
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B.4.2.  Microscopic imaging of CNs and Gd(TPyP)/CNs  
 
Surface morphology of CNs and Gd(TPyP)-CNs were examined using scanning electron 
microscopy (SEM) (cambridgeS260, UK).  A small drop of nanoparticles suspension was 
sprinkled on the golden surface and dried at the room temperature.  The quantitative analysis 
of Gd(TPyP)-CNs was examined by SEM coupled with energy dispersive X-ray spectroscopy 
(EDX). 
 
B.4.3.  UV-visible spectroscopy of Gd(TPyP)-CNs 
 
Due to the characteristic property of porphyrin complex, the ultraviolet-visible absorption 
spectroscopy has been used to study the porphyrin structure of Gd(TPyP)-CNs via different 
methods and to determine the Gd(TPyP) concentration in Gd(TPyP)-CNs. The UV-vis spectra 
were recorded by UV-visible spectroscopy (UVIKON XL spectrometer) in the range of 350-
700 nm at room temperature using quartz cuvettes (1cm optical path). 
 
B.4.4.  Fourier transmission infrared spectroscopy 
 
Fourier transmission infrared spectroscopy (FTIR) of bulk chitosan, CNs, Gd(TPyP), and 
Gd(TPyP)-CNs were carried out by FTIR spectroscopy over the range of 4000-800 cm
-1
. 
 
B.4.5.  Inductively coupled plasma mass spectrometry (ICP-MS) 
 
The concentration of Gd(TPyP) loaded into CNs has been confirmed via inductively coupled 
plasma mass spectroscopy ( Agilent 7700). The original solutions were all diluted 100x for 
the ICP measurements. The concentration from ICP-Ms has been compared with 
concentration measured from Soret band absorption. 
 
B.4.6.  Magnetic resonance imaging 
 
The magnetic resonance imaging (MRI) studies of Gd(TPyP)-CNs dispersed in water were 
performed at 3T and 25°C.  The longitudinal and transverse relaxivity of prepared colloids 
were evaluated from obtained T1 and T2 weighted images. The T1 weighted images were 
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obtained from spin echo sequence by keeping the echo time TE of 8 ms and varying repetition 
time TR (100-400 ms). The T2 weighted images were obtained from the spin echo sequence 
keeping the long repetition time TR=1500 ms and varying echo time TE (7ms - 40 ms).The 
other parameters were optimized such as: field of view (FOV)= 160x160x5, slice thickness=5 
mm, flip angle=90°, number of signal averages= 7, and voxel=2x2x5 mm
3
.  The presented 
high resolution T1 and T2 weighted images were obtained from spin echo sequence (TR=400 
ms and TE=8 ms) and (TR=1500 ms, TE=40 ms), respectively, with voxel=1x1x5 and field of 
view (FOV)= 160x160x5, slice thickness=5 mm, flip angle=90°, number of signal averages= 
7. After image acquisition, T1 and T2 relaxation times have been evaluated as described 
previously in section A.4.5. 
 
B.4.7.  Determination of entrapment efficiency, loading capacity 
and yield of Gd(TPyP)/CNs 
 
Gd(TPyP)-CNs was ultracentrifuged at 18000 rpm for 20 min at 4°C. The amount of free 
Gd(TPyP) in supernatant after ultracentrifugation was measured by UV-visible spectrometry 
(UVIKON XL spectrometer) at room temperature. The colorless solution was collected and 
the concentration of free Gd(TPyP) in solution was determined by UV-visible spectroscopy. 
Afterward, freeze-drying is employed to dry nanoparticles. The entrapment efficiency, 
loading capacity and yield percentage of Gd(TPyP)/CNs were calculated as follows: 
Entrapment efficiency (%) =
(𝐀−𝐁)
𝐀
 x100                                        (28) 
Loading capacity (%)=
(𝐀−𝐁)
𝐂
x100                                               (29) 
Yield (%)=(W1/W2 ) x100                                                   (30) 
while A, B and C correspond respectively to initial amount of Gd(TPyP), the amount of free 
Gd(TPyP) in the supernatant after centrifuge, and weight of CNs. W1 and W2 is the weight of 
dried Gd(TPyP)-CNs recovered after freeze-drying and the sum of initial amount of CNs and 
Gd(TPyP). 
C. Synthesis of ultra small Mn (II) doped ZnS nanoparticles  
C.1. Chemical material 
 
Zinc acetate dehydrate (99.9%, Sigma-Aldrich), manganese (II) acetate (99.9%, Sigma-
Aldrich), thiourea (99%, Alfa-Aesar), diethyleneglycol (Acros), tri-octylphosphine oxide 
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(99%, Acros) and mercaptoacetic acid, thioglycolic acid, (98%, Acros) are used as purchased 
with no further purification. 
 
C.2. Synthesis of Manganese Zinc Sulphide particles 
 
MnxZn1-xS nanoparticles were synthesized by the polyol method using the protocol described 
elsewhere [258] and adjusting the nominal zinc and manganese precursors concentration to 
vary x between 0.1 to 0.3. Light brown powders of MnxZn1-xS (0.1≤x≤0.3) were recovered by 
centrifugation at 23 000 tr.min
-1
. The different particle sizes of Mn0.3Zn0.7S were collected 
from different speeds of centrifugation. 
 
C.3. Particle Characterization of MnxZn1-xS (x=0.1, 0.2, and 0.3) 
C.3.1.  X-ray diffraction 
 
The x-ray diffraction of prepared powder was recorded using x-ray diffractometer 
(PANalytical X pert-pro diffractometer) with Cu Kα radiation ( = 1.54 Å). The crystal size 
of MnZnS powder were determined via MAUD software which is based on the Rietveld 
method combined with Fourier analysis. 
 
C.3.2.  Microscopy imaging 
 
The microstructure and crystallinity of prepared MnZnS were further studied by high-
resolution transmission electron microscopy (TEM) (HRTEM, JEOL-2100F). The particle 
size distribution was obtained from these micrographs by SAISAM software (Microvision 
Instruments). The chemical composition of powders was verified using EDX mounted on a 
JEOL-JSM 6100 scanning electron microscope (SEM). 
 
C.3.3.  Magnetic property 
 
The magnetic properties of the prepared samples were investigated via Super Quanducting 
Interference Devices (SQUID) magnetometer (Quantum Design MPMS-5S). The 
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magnetization measurements were performed at 310K and applied magnetic field varying 
between 0-50 kOe. 
 
C.4. Colloid Preparation 
 
Different quantities of Mn:ZnS nanoparticles were dispersed in cyclohexane (0.62 mg/mL) by 
sonication. 4 mL of the resulting solution was mixed with 4 mL of water. Afterward, 200µL 
of mercaptoacetic acid was added dropwise to the solution under sonication for 15 min. After 
aging for another 15 min, MnZnS nanoparticles were successfully transferred into water. The 
excess of mercaptoacetic acid was removed from the aqueous colloid by dialysis.
 
 
C.5. Colloid Characterization 
C.5.1.  Quantitative analysis of Mn(III)  
 
The quantitative analysis of Mn doped in ZnS was analyzed by x-ray fluorescence 
spectroscopy (MINIPAL4 XRF spectrometer) equipped with a rhodium X-ray tube operating 
at 30 kV and 87 μA current emissions. For this purpose, the fluorescence intensity of 15 μl of 
MnZnS suspension which was deposited on the cellulose membrane was compared with the 
fluorescence intensity of standard solution. 
 
C.5.2.  Fluorescence spectroscopy 
 
A fluorescence spectroscopy (model Fluorolog Horiba Jobin–Yvon) was used for 
photoluminescence (PL) measurements, which were carried out at room temperature using a 
Xenon arc lamp as an excitation source. The photoluminescence emission spectra of the 
colloids were recorded at λexc=405 nm. 
 
C.5.3.  Magnetic resonance imaging 
 
The relaxation time of prepared MnxZn1-xS colloids in water was studied by Philips 
ACHIEVA 3.0 T MRI scanner at 25°C. The T1 weighted images were acquired using spin-
echo pulse sequence maintenance the echo time (TE) at 8 ms and time repetition (TR) varied 
between 100 ms- 1000 ms.  The other acquisition parameters were optimized such as: field of 
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view (FOV)=154x154 mm
2
, slice thickness=5 mm, flip angle=90°, matrix size= 80x80, 
number of averages=7, and voxel=2x2x5 mm
3
. The acquisition parameters for Mn0.3Zn0.7S 
colloids in water with different particle size have been optimized as follows: field of view 
(FOV)=170x170 mm
2
, slice thickness=5 mm, flip angle=90°, matrix size= 96x96, number of 
averages=7, and voxel=2x2x5 mm
3
.  After image acquisition, the magnitudes of image signal 
intensities were inferred manually within regions of interest (ROIs) by ImageJ software and 
following the procedure described previously. 
 
D. Molecular dynamic simulation  
D.1. ZnS structure 
 
A few interatomic potentials have been developed for the molecular dynamic simulation of 
ZnS [259]–[261] . In this work, the empirical ZnS shell model which has been developed by 
Wright and Jackson [260] was employed to simulate ZnS crystal structure.  In the core-shell 
model of sphalerite ZnS, Zn and S atoms in molecule have been modeled by a massless shell 
(or very light) connected to a core, which contains all the atomic mass, via a harmonic spring. 
The sum of core and shell charges should be equal to the total charge of atoms. The spring 
potential is described as follows  
2
2
1
ijij Kru             (31) 
With the force constant of K and rij is the distance between atom i and j. The short range 
interaction between atom i and atom j was demonstrated via Buckingham potential  
     
6
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ij
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r
CR
Au 

            (32) 
Where rij is the distance between two atoms i and j, and Aij, ρij, Cij are three model parameters. 
For the nearest S-Zn-S atoms, three-body potential has been considered  
     
2)(
2
1
ijkijkij Ku             (33) 
Where θijk is the angle formed by atom Si and Znj (in center) and Sk, θ is the equilibrium value 
of the angle (109.4°), and k is the model parameter. These potential parameters are listed in 
Table 8.  
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The molecular dynamics simulation (MDs) has been conducted via DL_POLY_4 [262].  The 
initial configuration of ZnS atoms were constructed from atomic coordination of bulk 
sphalerite ZnS reported by Wyckoff [263].  The MD cell contains 5x5x5 unit cells that 
contain 500 ZnS molecules. The MD procedure was as follows: time step of 0.5 fs, pressure 
of 1.0 atm, applying periodic boundary condition, and using the canonical NPT and NVT with 
equilibration of 100 ps. We used the Nose-Hoover algorithm with thermostat and barostat 
relaxation times of 0.5 ps in both NPT and NVT ensembles to keep our simulations 
consistent. Afterward, the final data are collected from NVE ensemble simulation. After 
reaching the equilibrium, the bulk crystal cleaved to form nanosphere particles with desire 
diameter of 2.5 nm. 
 
Table 8. The potential parameters for simulation of ZnS 
Buckingham Parameters 
Atomic Pair A (eV) ρ(Å) C(eVÅ6) Cutoff(Å) 
Zn-S 513.356 0.3999 0.0 12.0 
S-S 1200.0 0.149 120.0 12.0 
Three body Parameters 
Atomic Pair K(eVrad
-2
) Θ0(deg) ρ(Å) Cutoff(Å) 
SS-Zn-SS 0.713 109.47 0.0 6.0 
Shell model Parameters 
Atomic Pair Mass Charge  K(eVÅ
-2
)  
S(core) 31.80 0.0 --  
S(shell) 0.20 -2.0 16.86  
Zn(core) 64.2 0.0 --  
Zn(shell) 0.8 2.0 2.181  
 
D.2. MnZnS crystal structure 
 
Wright has already reported the potential parameters for incorporation of impurities into ZnS 
crystal structure [264]. In our study, we used the potential parameters reported by Wright to 
model sphalerite MnZnS structure, listed in Table 9. The simulation procedure was the same 
as ZnS simulation. 
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Table 9 . The potential parameters for MnZnS solid structure simulation 
Buckingham Parameters 
Atomic Pair A (eV) ρ(Å) C(eVÅ6) Cutoff(Å) 
Mn-S 750.686175 0.390889 0.0 12.0 
S-S 1200.0 0.149 0.0 12.0 
Zn-S 528.8990 0.4110 0.0 12.0 
Three body Parameters 
Atomic Pair K(eVrad
-2
) Θ0(deg) ρ1/ρ2(Å) Cutoff(Å) 
SS-Zn-SS 9.4283e-6 109.47 0.3 6.0 
Shell model Parameters 
Atomic Pair Mass Charge K(eVÅ
-2
)  
S(Core) 30.0 1.357 --  
S(Shell) 2.0 -3.357 13.302743  
Mn 54.0 2.0 --  
Zn 65.0 2.0 --  
 
 
D.3. Molecular dynamic simulation of water molecule  
 
In order to study the interaction of MnZnS nanoparticles with water, two different water 
models, including TIP3P (transferable intermolecular potential 3P) [265], and SPC/E 
(extended simple point charge) [266] have been employed for MD simulation of water 
molecules. For simulation of liquid water, we simulated a box containing 2376 water 
molecules with initial density of ~1.0 g/cm
3
. The simulation was made under the NPT and 
NVT ensembles. Berendsen algorithm generates in both NVT and NPT ensembles with 
thermostat and barostat relaxation times set at 0.1 (ps). Equilibrium was reached in 50 ps, and 
simulation after the attainment of equilibrium was continued for 200 ps in steps of 0.1 fs. 
Final data were collected from NVE ensemble. The Newton equations of motion were 
integrated using the Verlet algorithm. 
 
 
D.4. Molecular dynamic simulation of ZnS nanoparticle surrounded 
with water molecules 
 
Interaction of 1877 water molecules with 228 ZnS molecules was studied. The box of water 
molecules with lattice constant of 39.034 Å was cut off and ZnS nanoparticles have been 
located in the center of vacancy space.  Buckingham potential [267] has been applied for 
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describing ZnS molecules interaction with water molecules for this modalling as listed in 
Table 10. 
 
Table 10. Buckingham potential [267] 
Atomic pair A(eV) r(Å) C(eVÅ
6
) 
S-O 41399.49  0.2039  0 
S-H 4268.15  0.3686  965.33 
Zn-O 14974.51  0.186011 0.0 
 
The simulation conditions were carried out using the NPT and NVT generating Berendsen 
algorithm with thermostat and barostat relaxation times of 0.5 (ps) in timesteps of 0.1 fs. Final 
data were collected from NVE ensemble. 
 
D.5. Interaction of MnZnS molecules with water molecules 
 
In order to achieve simulating MnZnS nanoparticles surrounded with water molecules, we 
need to describe the interaction between Mn atoms and water molecules. We used the 
Buckingham potential to describe Mn-O pair potential with potential parameters such as 
A=25974.51 (eV), ρ=0.188011 (Å), and C=20 (eVÅ6). Finally, the interaction of MnxZn1-xS 
nanoparticles (x=0.1, 0.2, 0.3) with water molecules has been simulated using MnZnS, Zn-O, 
S-H, S-O, Mn-O, and H2O potential parameters, following the same procedure applied for 
simulation of liquid water. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter V: Results and discussion 
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A. Metallated Porphyrin Complexes Results  
A.1. UV-visible Characterizing of (TPyPH2) and Gd(TPyP) 
 
The UV-vis spectra of TPyPH2 and metallated Gd(TPYP) are presented in Fig. 40, consistent 
with those reported one [268], [269].  The absorption spectrum of TPyPH2 in ethanol has an 
intense Soret band at 416 nm and four Q bands in the visible spectral region at 513, 542, 588 
and 642 nm. As presented in Fig. 40, the absorption spectrum slightly changes after 
metallation with Gd(III). Upon the metallation, the Soret band shifted from 419 nm to 422 nm 
while Q band underwent major changes and simplified. TPyPH2 has an intense peak at 554 
nm while in Gd(TPyP) this peak has almost disappeared and an intense peak has been 
observed at 515 nm. On going from freebase to metallated porphyrin, porphyrin deprotonates 
and the symmetry of the planar macrocyclic fragment increases leading to doubly degenerate 
molecular orbitals. This degeneration accounts for the reduction in the number of peaks in the 
Q band [270]. Referring to the UV-vis spectroscopy studies, TPyPH2 porphyrin is 
successfully metallated with Gd(III) ions. 
 
 
 
Figure 40. UV-visible absorption spectra of TPyPH2 and Gd(TPyP) dispersed in ethanol at 
ambient temperature 
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A.2. ATR-FT-IR spectroscopy of Gd(TPyP) and TPyPH2 
 
Compared with transmission IR techniques, attenuated total reflectance-Fourier transform 
infrared (ATR-FT-IR) spectroscopy is a useful technique for measuring the infrared spectrum 
of solids and liquids as well as probing adsorption on particle surfaces. ATR-FT-IR allows us 
to study the structure of thin films, powders, surface layers of bulk materials, polymers, and 
various chromophores and dyes. Herein, we studied the structure of developed Gd(TPyP) 
complex by ATR-FT-IR spectroscopy. 
Figure 41 illustrates the FT-IR spectrum acquired from Gd(TPyP) powder in comparison with 
the spectrum corresponding to TPyPH2. FT-IR peaks and their main assignments are listed in 
Table 11. The spectrum of Gd(TPyP) is quite similar to the one of TPyPH2 and both spectra 
exhibit the typical IR band of the porphyrin macrocycle. 
 
Table 11. FT-IR peaks of TPyPH2 and Gd(TPyP) 
Assignments Wavenumbers (cm-1) 
TPyPH2 Gd(TPyP) 
γ N—H 3309 ---- 
—OH stretching ---- 3255 
C═C stretch of  phenyl 1591 1594 
C═N stretch of pyrrole 1352 1334 
C—H bend of pyrrole 1068 1070 
C—H out of plane of pyrrole 785 790 
 
TPyPH2 spectrum contains C═C stretching of phenyl group at 1591 cm
-1
, C═N 
bandstretching of pyrrole at 1352 cm
-1
, and C—H vibration of pyrrole at 785 cm-1, which are 
in good agreement with those reported in [271]. By coordination of Gd(III) with 4 nitrogens 
of  the porphyrin ring, these typical peaks slightly shifted, including 1594 cm
-1
 (C═C 
stretching of phenyl), 1334 cm
-1
 (C═N bend) and 790 cm-1(C—H vibration of pyrrole). 
Moreover, (TPyPH2) has shown a peak at 3309 nm, corresponding to N—H, while this peak 
disappeared in the spectrum of Gd(TPyP). This is attributed to the coordination of metal ion 
with porphyrin nitrogen atoms. The wide band observed in the range of 3400-3000 cm
-1
 in IR 
spectrum of Gd(TPyP) is attributed to stretching vibration of hydroxyl group. On the other 
hand, peaks in the range of 1400-1500 cm
-1
 of Gd(TPyP) spectrum can be ascribed to IR of 
carboxylate (—COO-) overlapping with the C═C stretching of porphyrin [272]. Comparing 
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FT-IR spectrum of TPyPH2 with the Gd(TPyP) one, it could be deduced that Gd ions have 
coordinated with nitrogen atoms of the porphyrin ring and one acetate ligand. 
 
 
Figure 41. FTIR spectra of a) TPyPH2 and b) Gd(TPyP) 
 
A.3. Proton Nuclear Magnetic Resonance Relaxometry studies 
 
Metalloporphyrins have exhibited the ability to enhance relaxivity of water protons [70], 
[273] which is one of the most important parameters to enhance the contrast of MR images. In 
order to evaluate the efficiency of the synthesized Gd(III) porphyrin as a MRI contrast agent, 
longitudinal (T1) and transverse (T2) relaxation times of Gd(TPyP) colloids were  measured 
by 
1
H NMR relaxometry at 20 MHz (0.47T) and 37°C. Meantime, its efficiency has been 
compared with two water soluble metalloporphyrins such as Mn(III)-tetra-[4-sulfanatophenyl] 
porphyrin (Mn(TSPP)) and Fe(III)-meso-tetrakis[4-N-methylpyridiniumyl]porphyrins 
(Fe(TMpyP)) and commercial Gadoterate meglumine (Gd-Dota). 
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A.3.1.  T1 and T2 relaxation times of Fe(TMPyP) and Mn(TSPP) 
at 20 MHz 
 
Relaxation times of Mn(TSPP) and Fe(TMPyP) measured via 
1
H NMR relaxometry are listed 
in Table 12. From Table 12, T1 and T2 relaxation times of Mn(TSPP) and Fe(TMPyP) in 
water decrease with increasing concentration of paramagnetic ions. At the same paramagnetic 
concentration of 1mM, Fe(TMPyP) has shown longer T1 (~ two times) and T2 (~five times) 
than those one of Mn(TSPP). The relaxivity of Mn(TSPP) and Fe(TMPyP) are presented in 
Fig. 42 and Fig. 43, respectively.  
 
Table 12. Longitudinal and transverse relaxation time (T1 and T2) of Mn(TSPP) and 
Fe(TMPyP) dissolved in distilled water at 20 MHz and 37°C 
 
Relaxation time of Mn(TSPP) in water  Relaxation time of Fe(TMePyP) in water  
Concentration of Mn(III) (mM) T1 (ms) T2 (ms) Concentration of Fe(III)(mM) T1 (ms) T2  (ms) 
0.1 1190±0.2 428.4±0.001 1 244±0.03 225.9±0.001 
0.3 467±0.04 148.5±0.001 2 149.9±0.002 137.3±0.002 
0.5 283±0.03 87.56±0.007 3.5 81.6±0.003 74.67±0.001 
1.0 147±0.01 46.21±0.004 10 27.11±0.009 24.43±0.003 
 
r1 of Fe(TMPyP) in the literature has been reported in the range of 4.4-1.3 mM
-1
.s
-1 
(at 10 
MHz) which decreased by pH varied between 1-10 [274]. The dependency of Fe(TMPyP) 
complex’s r1 to pH was related to its spin moments. This complex possesses typical high spin 
moments S=5/2 at pH < 5, and dropped to lower spin S=1/2 at higher pH>7 due to the 
formation of Fe-O-Fe and dimerization of Fe(TMPyP) which causes the decrease of the 
relaxivitiy [274]. The equilibrium behavior of Fe(TMPyP) in aqueous media as a function of 
pH has been studied by Gandini et al. using UV-visible spectroscopy [275]. They have 
observed five different Fe coordinations in the equilibrium state such as: Fe-H2O (Fe1), H2O-
Fe- H2O (Fe2), H2O-Fe-OH
-
 (Fe3), μ-oxo dimer Fe-O-Fe (Fe4) and OH--Fe-OH- (Fe5).  
Our results are in the range of the reported values. The relaxivity of Fe(TMpyP) arises from 
inner sphere contribution such as hydration number and the residency of water molecules 
[276].  As explained above the hydration number of Fe(TMpyP) depends on the pH of 
solution which can be followed by UV-visible spectroscopy. Thus, in order to understand the 
coordination of Fe ions with water molecules in our study, small quantities of Fe(TMPyP) 
have been dispersed in distilled water and examined, with UV-visible spectroscopy. As shown 
in Fig. 42, the spectrum of Fe(TMPyP) in water contains an envelope Soret band at 401 nm 
 
 
93 
 
(shoulder at 418 nm) which is consistent with the spectrum of Fe1 species reported by 
Gandini et al. [275]. Furthermore, due to positively charged nitrogen in ortho positions of 
Fe(TMPyP), the complex has a tendency to withdraw electrons which strengthens the metal-
axial water bonds. This strengthening could cause the long water residency time which has 
been reported as long as 1.3 s at room temperature [276]. One molecule of water in inner 
sphere with long residency time could cause the r1 of 3.7 mM
-1
s
-1 
at 0.47T for Fe(TMPyP). 
 
 
 
Figure 42. Right: UV-vis spectrum of Fe(TMPyP in water and Left: r1 and r2 of Fe(TMPyP) 
in water at B0=0.47 T and T=37°C 
 
In comparison with relaxivities of Fe(TMyP), Mn(TSPP) exhibits higher r1 of 6.63 mM
-1
.s
-1
, 
consistent with those of previous reported values [82], [277], presented in Fig. 43. High 
relaxivity of anionic Mn(TSPP) complex also comes from the inner sphere contribution [277]. 
Mn(III) ion coordinates axially with two water molecules [277]. Additionally, due to the 
strong electron donor of peripheral 4-sulfonatophenyl substituent of Mn(TSPP), electron 
density at the center of the complex is high which could labialize metal-axial water bonding 
and promote the limiting dissociative water-exchange mechanism. This labialization causes 
short water residency time, reported as short as 36 ns at room temperature [277]. Furthermore, 
the short distance between Mn ions and coordinated water (~2.26Ǻ) could also increase the 
dipolar interaction, improving r1 [278]. Thus, one more water molecule in inner sphere with 
short water residency time are the reasons that Mn(TSPP) possesses higher relaxivity than r1 
of Fe(TMPyP). 
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Figure 43. Longitudinal and transverse relaxation rates [(1/T1) and (1/T2)] of Mn(TSPP)   
versus the Mn(III) concentration in water at B0=0.47 T and T=37°C 
 
A.3.2.   T1 and T2 relaxation times of Gd-DOTA at 20 MHz 
 
Relaxation times and relaxivities of commercial Gd-Dota diluted in water and in the mixture 
of water and ethanol are tabulated in Table 13 and in Fig. 44, respectively. 
 
Table 13. T1 and T2 relaxation times of Gd-DOTA diluted in water and in the mixture of 
water/ethanol at 20 MHz and 37°C 
Relaxation time of Gd-Dota in water  Relaxation time of Gd-Dota in ethanol+water  
Concentration of 
Gd(III) (mM) 
T1  
(ms) 
T2  
(ms) 
Concentration of 
Gd(III) (mM) 
T1 
(ms) 
T2 
(ms) 
0.6 450±0.07 395.8±0.002 1 446±0.06 381.8±0.002 
3 92±0.01 98.9±0.003 ---- ---- ---- 
4 71.8±0.005 68.6±0.001 ---- ---- ---- 
5 43.1±0.002 44.17±0.006 5 75.3±0.002 53.7±0.006 
7 35.6±0.002 31.6±0.003 7 48.8±0.002 39.4±0.003 
9 27.3±0.002 22.23±0.004 9 32.1±0.002 27.35±0.004 
 
Gd-Dota diluted in the mixture has shown r1 of 3.51 mM
-1
.s
-1
 which is slightly lower than the 
one of Gd-Dota (4.1 mM
-1
.s
-1
) in water which is in good agreement with the reported one 
[255]. This small difference could be related to the structure of ethanol. In the mixture of 
ethanol/water, there are four chemically distinctive sites that are occupied by hydrogen such 
as methyl (CH3), methylene (CH2) and bonding to oxygen in ethanol and in water. It has been 
reported that the resonance frequency offset of methyl and methylene results in chemical shift 
displacement which causes the relaxation time enhancement [255]. 
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Figure 44. Longitudinal and transverse relaxivities r1 and r2 of Gd-DOTA in water and in the 
mixture of water/ ethanol at B0=0.47 T and T=37°C 
 
A.3.3.  T1 and T2 relaxation times of developed Gd(TPyP) at 20 
MHz 
 
As listed in Table 14, T1 and T2 of Gd(TPyP) in ethanol are varied between 194-33 ms and 
167-15 nm, respectively, with the Gd(III) concentration in the range of 0.1-1 mM. T1 and T2 
values of Gd(TPyP) are much smaller than those of manganese and iron porphyrins and Gd-
Dota. The order of longitudinal relaxation time of these three metaloporphyrins at 1mM from 
least to greatest is Gd(TPyP) with T1=33 ms, Mn(TSPP) with T1=147 ms and Fe(TMPyP) 
with T1=244 ms. Comparing with relaxation times of Gd-Dota, Gd(TPyP) at the 
concentration almost 10 times lower exhibits much shorter T1 and T2 (≤ 11 times). r1 and r2 
of Gd(TPyP) in ethanol are presented in Fig. 45. Gd(TPyP) in ethanol has shown a high r1 of 
26 mM
-1
.s
-1 
and r2 of 68 mM
-1
.s
-1
 at 20 MHz. 
 
Table 14. Longitudinal (T1) and transverse (T2) relaxation times of Gd(TPyP) at 20 MHz and 
37°C 
Relaxation time of Gd(TPyP) in ethanol at 0.47 T 
Concentration of Gd(III) (mM) T1 (ms) T2 (ms) 
0.1 194±0.09 167.7±0.005 
0.2 92±0.06 82.6±0.003 
0.3 66±0.04 55.4±0.004 
0.4 56±0.03 43.6±0.004 
0.5 62±0.02 32.7±0.002 
0.7 45±0.02 22.4±0.001 
0.9 37±0.01 17.82±0.001 
1 33±0.01 15.69±0.003 
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The coordination geometry of Gd(TPyP)(acac) (acac=acetylacetonate) has already been 
studied via extended x-ray absorption and molecular dynamic simulations [7]. It has been 
reported that three oxygen atoms are coordinating with Gd(III) of Gd(TPyP)(acac) at the 
average distance of 2.41 Å, one from water and two from acetylacetonate), referring to its 
octacoordinated structure [7], [279]. Due to the similar structure of Gd(TPyP)(acac) with 
Gd(TPyP)(OAc), we could suppose that Gd(III) of Gd(TPyP)(OAc) is also coordinated with 
one water molecule and one molecule of acetate at a distance of 2.41 Å. The coordination of 
one acetate molecule with Gd(III) of Gd(TPyP)(OAc) has been confirmed by measuring its 
molecular weight (833 g/mol) using MALDI-TOF spectroscopy. 
One coordinated water at the distance of 2.41 Å and owing the molecular weight of 833 g/mol 
are not the only reasons that Gd(TPyP)(OAc) possesses this high relaxivity. Some other 
parameters such as water residency time, well-located metal ion in the center of chelate [280], 
[281], high isotropic structure of complex [280], [281], and rigidity of linking between metal 
ions and chelate [282] could also contribute to this high relaxivity. It has been reported that 
well-located metal ion in the center of the complex causes the tumbling of such carrier 
transfer to the rotation of metal-water proton which decreases the longitudinal relaxation time 
[280]. Furthermore, rigidity of linking plays an important role in determining the relaxivity. 
The flexible linking allows the metal-water proton vector rotate independently and faster than 
the whole complex, resulting in the decrease of r1[281], [283]. It is known that Gd(III) of 
Gd(TPyP) could coordinate with one nitrogen of another porphyrin molecule, resulting in 
modifying its structural environment, and stretching of macrocycle. The coordination with 
nitrogen of another porphyrin could reduce the flexibity of the complex, which results in 
improving r1. 
 
Figure 45. r1 and r2 of Gd(TPyP) in ethanol at B0=0.47 T and T=37°C 
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One of developed Gd-porphyrin, which possesses high relaxivity  (r1=16.9 mM
-1
.s
-1
 at 50 
MHz) and high stability, is Gd-texaphyrin (Motexafin gadolinium). Texaphyrin is pentaaza, 
expanded porphyrin [284], which contains five nitrogen atoms in their central core. It has 
been reported that Gd(III) ion of Gd-texaphyrin coordinated with four water molecules [285], 
[286]. Gd-texaphyrin with higher molecular weight (1148.4 g.M
-1
) and coordinated with 4 
water molecules possesses lower r1 (16.9 mM
-1
.s
-1
 at 50 MHz and 25°C) compared with r1 of 
developed Gd(TPyP) (r1=26 mM
-1
.s
-1
  at 20 Mhz) in our work.  
The other commercially developed Gd(III)-porphyrin as MRI CA is Gadophrin-2 (bis-Gd-
DTPA-mesoporphyrin). Gd(III) Mesoporphyrin-IX-13,17-bis[2-oxo-4,7,10,10-
tetra(carboxylatomethyl)-1,4,7,10-tetraazadecyl]-Diamide, Gadophrin-2, is composed of two 
Gd-DTPA which are covalently linked to the mesoporphyrin. This compound of chelated 
porphyrin derivatives contains two Gd
3+ 
ions per molecule. The coupling of porphyrin with 
DTPA increases the molecular weight of the complex (1697.25 g/mol) which leads to an 
increase in the correlation time (τc), and enhanced r1 relaxivity [287]. This complex in 
aqueous solution has shown r1 of 8.3 mM-¹.s
-
¹ at 0.47T and 39°C [74], which is much lower 
(almost 3-fold) than r1 of Gd(TPyP). The evaluation of NMR relaxivity permits us to assume 
the potential of the developed Gd(TPyP) as MRI CA. Further studies in the efficiency of 
metalloporphyrins as MRI CA have been conducted using MRI at 3T. 
 
A.4. In-vitro Magnetic Resonance Imaging studies at 60 MHz 
 
T1 and T2 weighted images of Mn(TSPP) and Fe(TMPyP) are presented in Fig. 46. The 
signal intensity on T1 weighted images of both Mn(TSPP) and Fe(TMPyP) solution increases 
with concentration of paramagnetic ions, and conversely on the signal intensity on T2 images. 
From Fig. 46, T2 effect of Mn(TSPP) solution at lower concentration (~10-fold)  is much 
more  pronounced compared with those of Fe(TMPyP).  
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Figure 46. T1 (TR=400 ms, TE=8 ms) and T2 (TR=1500 ms, TE=40 ms) weighted spin echo 
MR images of different concentration of Mn(TSPP) and Fe (TMePyP) in water at 3T and 
25°C 
 
Figure 47 represents T1 and T2 weighted images of Gd(TPyP) and Gd-Dota in aqueous 
media. The signal intensity on T1 images increased progressively with Gd concentrations in 
Gd(TPyP) and Gd-Dota solution, and conversely for those on T2 images . We observed (Fig. 
47) that Gd(TPyP) with lower concentration produces brighter T1 and darker T2, compared 
with those of both Gd-DOTA solutions. These images confirm the efficiency of Gd(TPyP) in 
contrast enhancement of MR images.  
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Figure 47. T1 (TR=400 ms and TE=8 ms) and T2 (TR=1500 ms, TE=40 ms) weighted spin 
echo MR images of different concentration of Gd(TPyP) in ethanol and Gd-Dota in water and 
Gd-Dota in water/ethanol at 3T and 25°C 
 
A.5. Relaxivity of metalloporphyrins and Gd-Dota solution at 3T 
 
Relaxivity depends on external parameters such as applied field and temperature [288]. 
Thereby, r1 and r2 relaxivities of three metalloporphyrins in aqueous media have been 
evaluated from treating MR images at 3T. The evaluated r1 and r2 of Mn(TSPP) and 
Fe(TMPyP) via MRI and NMR relaxometry are summerized in Fig. 48. It can be observed 
that the values of r1 and r2 obtained from MR images are respectively smaller and larger 
compared with those values measured via NMR relaxometry. 
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Figure 48. r1 and r2 relaxivities of Mn(TSPP) and Fe(TMPyP) colloids measured via MRI at 
3T and 25°C and NMR relaxometry at 0.47T and 37°C 
 
The evaluated r1 and r2 relaxivites of Gd(TPyP) and Gd-DOTA via MRI and NMR 
relaxometry have been presented in Fig. 49. As presented in Fig. 49, the evaluated r1 and r2 
of Gd(TPyP) using NMR and MRI did not significantly change. 
 
Figure 49. The r1 and r2 relaxivity of Gd(TPyP) and Gd-DOTA solution at 3T and 25°C and 
0.47T and 37°C 
 
In our study, we have observed that r1 of all three metalloporphyrins and Gd-DOTA solution 
measured using MR images are slightly lower than those measured by NMR relaxometry, and 
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in the opposite sense for r2 relaxivity. Among all the complexes, the difference between 
measured r2 relaxivity of Mn(TSPP) via NMR and MRI is much more pronounced.  
The relaxivity of Gd-based MRI contrast agents at multiple field strengths has already been 
studied by other researchers. For instance, magnevist ([Gd(DTPA)(H2O)]
2-
), exhibited a 
modest longitudinal relaxivity of 4.70 mM
-1
.s
-1
  at 0.47T, which decreased to 3.80 mM
-1
.s
-1
 
with increasing applied field to 1.5T [289]. Whereas, its transverse relaxivity increased 
drastically from 5.60 mM
-1
.s
-1
 at 0.47T to 18.80 mM
-1
.s
-1 
at 1.5T [289]. Serum albumin 
binding of Gd-phostriamine contrast agent has also shown a decrease in longitudinal 
relaxivity with field strength [288], [290].  The effect of applied field on relaxivity of Mn and 
Fe-based contrast agents has also been investigated; for instance, r1 and r2 of Resovist 
(magnetite) in water have been studied at three different magnetic fields (0.47, 1.5 and 9.4T ) 
[291]. r1 of magnetite decreased from 8.30 to 5.14 mM-¹.s-¹ whereas r2 drastically increased 
from 9.27 to 15.7 mM-¹.s
-
¹ with increasing field strength from 1.4T to 9.4T [291].  r1 of 
ultrasmall iron oxide (USPIOs) in water decreased from 14.152 to 2.097 mM-¹.s-¹ meanwhile 
its r2 increased from 10.71 to 84.57 mM-¹.s-¹ with magnetic field varied between 10 mT-14.1 
T [292]. Nonetheless, Troughton et al. has reported the reduction of r1 and r2 of Mn(EDTA) 
with applied field [293]. The decrease of r2 of Mn(EDTA)  with magnetic field was attributed 
to the short residence time of water (5 ns at 20°C) in Mn(EDTA) solution [293].  
The decrease of r1 relaxivity above 1.5T is related to negligible contribution of electronic 
relaxation time at high magnetic field (above 1.5T) [294]. Thereby, the contribution from 
rotational correlation time and water residency time play the major role in r1 relaxivity of 
paramagnetic-based agents at high magnetic field [294]. While, increase of r2 with magnetic 
field is due to linear increase of the metal complex magnetization which results in greater 
susceptibility contrast at higher fields [288].  
Temperature can also have a dramatic effect on the relaxivity of contrast agents. It is known 
that  relaxation rate decreases with the temperature [295], [296]. Based on Stokes-Einstein-
Debye equation, the drop of r1 relaxivity is related to the relation between rotational 
correlation rate and temperature [297]. The rotational correlation time increases with 
temperature, thereby it causes the relaxivity to decreases [298]. Another temperature 
dependent parameter contributing to relaxivity is water exchange rate. The relaxivity would 
be limited at low temperature while the water-exchange rate is fast enough [295].  Thus, the 
slow water exchange rate could also lead to a decrease in relaxivity with temperature. 
Thereby, in our study, temperature could also influence the relaxivity of Mn(TSPP), 
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Fe(TMPyP), Gd(TPyP), and Gd-DOTA. The relaxivity of all solutions were measured at two 
different magnetic fields with different temperature. Thus, the reduction of r1 relaxivity could 
be attributed to decreasing the temperature and simultaneously increasing the magnetic field. 
 
B. Gd(TPyP) conjugated with Chitosan nanoparticles 
 
Chitosan is one of the most promising polymers for pharmecutical and biomedical area due to 
its unique properties such as biocompatibility, biodegradability, nontoxicity, and 
mucoadhesive properties [141], [299], [300]. It was observed that encapsulation of the poorly 
water-soluble drug through CNs could enhance the drug solubility [301]–[303]. In our study, 
CNs are considered as suitable polymeric carriers to enhance the water-solubility of 
Gd(TPyP). Firstly, we tried to optimize the preparation procedure of CNs to obtain the small 
particle with narrow size distribution. Afterward, the loading of Gd(TPyP) into CNs was 
investigated. 
 
B.1. Physicochemical Characterization of Chitosan nanoparticles 
 
The important role of chitosan and TPP concentrations in forming CNs has been reported by 
several researchers [109], [257]. They have reported that the microparticles could form at 
chitosan concentration above 1.5 mg/mL and TPP concentration above 1.0 mg/mL [257].  
Above 1.5 mg/mL chitosan concentration, there are plenty of chitosan molecules involved in 
cross linking of a single particle which leads to form the micro particles. Some researchers 
have studied the aggregation behavior of chitosan in aqueous media [304]–[307]. They 
confirmed that the critical aggregation concentration is about 1 mg/mL [308]. Herein, the 
different chitosan concentrations less than 2mg/mL have been prepared to study the effect of 
chitosan concentration on average particle size.   
The particle size and PdI of CNs obtained from different bulk chitosan concentrations have 
been measured via dynamic light scattering (DLS) and the results obtained were listed in 
Table 15. As listed in Table 15, size and PdI of CNs decrease with increasing concentration of 
chitosan solution from 0.5 mg/mL to 0.7 mg/mL. For CNs obtained from bulk chitosan with 
medium molecular weight (MMv), mean particle size decreased from 9.1 μm for 0.5 mg/mL 
chitosan solution to 305 nm for 0.7 mg/mL chitosan solution. The same trends have been 
observed for CNs obtained from bulk chitosan with low molecular weight (LMv), decreasing 
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from 8.9 μm to 120 nm. Afterward, for further increasing of chitosan concentration, the mean 
diameter of CNs obtained from MMv and LMv increases from 305 nm-24 μm and 120 nm-12 
μm, respectively. The increase of particle size for higher chitosan concentration than 1 mg/mL 
could be related to the aggregation formation of chitosan in solution which has been 
previously reported [308]. The smallest CNs with narrow size distribution was obtained from 
chitosan concentration of 0.7 mg/mL for both MMv and LMv.  
 
Table 15. Mean particle size (nm) and PdI values of CNs in distilled water from different 
chitosan concentration (mg/mL) with two different deacetylation degree (85% and 93%), 
TPP=1.25 mg/mL,  T=20°C 
Chitosan Concentration (mg/mL) Bulk Chitosan DD=85%. MMv Bulk Chitosan DD=93%. LMv 
PdI Average Size CNs (nm) PdI Average Size CNs (nm) 
0.5 0.319 9158 0.289 8991 
0.7 0.201 305 0.139 120 
1.0 0.789 980 0.687 684 
1.7 1 23860 1 12230 
 
The effect of chitosan concentration on particle size of CNs was investigated by Fan et al. 
[257]. They succeeded to prepare CNs with mean hydrodynamic diameters of 138 nm and PdI 
of 0.026 from chitosan (LMv and DD=91%) concentration of 0.5 mg/mL and TPP 
concentration of 0.5 mg/mL.  Due to the modification performed during the synthesis of CNs, 
we achieved a reduction in the hydrodynamic radius of CNs to 120 nm. The difference 
between PdI value obtained and Fan’s result might be related to the purity and different 
deacetylation degree of bulk chitosan used.  
Referring to the results obtained, particle size and size distribution of CNs depends on 
chitosan solution concentration as well as molecular weight and/ or deacetylation degree of 
bulk chitosan. It has been reported that the average diameter and dispersity of CNs increased 
with the molecular weight of chitosan [308], [309]. The effect of chitosan concentration with 
different molecular weights on the average diameter and homogeneity of CNs has been 
studied by some researchers. The effect of chitosan concentrations with high (HMv), medium 
(MMv) and low (LMv) molecular weights on particles size has been studied by Gan et al. 
[308]. They observed that the particle size of CNs linearly increased with chitosan 
concentration. They observed that the size of CNs obtained from HMv chitosan was 
significantly affected with increasing chitosan concentration [308]. The smallest particle size 
(~152 nm) with high zeta potential (+31 mV) was obtained from LMv chitosan at 0.5 mg/mL 
concentration [308]. In aother work, the effect of chitosan concentration and chitosan 
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molecular weight, in the range of 140–160, 240–270 and 280–320 kDa, on the diameter of 
chitosan microspheres has been studied by He et al. [310]. They also reported that at the same 
chitosan concentration the particle size increased with molecular weight unlike the zeta 
potential [310]. Referring to these studies, our results are consistent. 
As listed in Table 15, size and polydispersity values of CNs from LMv chitosan are much 
lower than MMv at the same concentration. This could be attributed to the effect of molecular 
weight on the conformation of chitosan chains in solution [311], [312]. Tsaih and Chen 
suggested that the occurrence of conformational transition of chitosan related to their 
molecular weight could be attributed to the difference in intramolecular hydrogen bonding 
and/or the difference in charge distribution [311]. Considering Tsaih’s study, the high 
molecular weight chitosan have more intermolecular hydrogen bonding and chitosan 
molecules could entangle with each other easily which leads to the formation of large 
particles. While for the small molecular weight, the conformational of chitosan in solution is 
stiff and extended which could lead to smaller particle size.  
The other parameter, which could also affect the particle size of CNs, is acetylation degree of 
chitosan. There are a lot of contradicting results have been published about the effect of 
acetylation degrees of chitosan on chain conformation of chitosan. Some researchers have 
reported that the stiffness of chitosan chains increased with increasing acetylation degree 
[306], [313], [314] whereas Errington and coworkers have described the opposite effect [315]. 
Wang has also reported that the stiffness of chitosan chain decreased with decreasing 
acetylation degree of chitosan [316]. On the other hand, other researchers indicated that the 
rigidity of chitosan chain does not depend on the acetylation degree of chitosan [317]–[319].  
The effect of acetylation degree on chitosan solution have systematically studied by Schatz et 
al. [305], [320] and Sorlier et al. [312], [321]. They defined three distinct groups of 
acetylation degree (DA) to demonstrate the behavior of chitosan in solution. First group is 
chitosan with DA less than 20% which displays a polyelectrolyte. The hydrophilic and 
hydrophobic interactions are moderate for chitosan with DA between 20 and 50%. For higher 
acetylation degree, the hydrophobic interaction will arise.  
The electrostatic, hydrophobic interaction, hydrogen bonding, and strict interaction could 
change with changing deacetylation degree of chitosan [322]. The rigidity of the chain may 
increase at higher content of acetyl groups. Hence, more hydrophobic interaction and 
hydrogen bonding could be formed. Meantime, it has been reported that the higher charged 
polycation could be formed at lower acetylation degree. The accumulation of charges causes 
expansion of polymer chains [323]. The acetylation degrees of chitosan used in our study 
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were 7% and 15% (deacetylation degree (%)=1-acetylation degree (%)). Hence, referring to 
Schatz studies, we could suppose that the both chitosans display polyelectrolyte behavior in 
solution. Therefore, the higher deacetylation degree (lower acetylation degree) could cause 
the formation of smaller CNs due to its higher charged polycation, causing the expansion of 
polymer.  
After optimization of the chitosan concentration, the impact of stirring rate and time of 
stirring on the formation of CNs has been studied: The particle size and PdI of CNs obtained 
at different stirring rates and timing have been studied via DLS, listed in Table 16. It has been 
observed that the increase of stirring rate up to 700 rpm leads to a decrease in CNs average 
diameter while further increase leads to larger particle with higher PdI which could be 
attributed to the formation of CNs aggregates. The aggregation at high stirring rate might be 
caused by the destruction of the repulsive force between particles which leads to the 
aggregation [257]. Fan et al. have observed the same trend that the CNs particle size 
decreases with increasing stirring rate varied between 200-800 rpm, further increase causes 
larger particle [257]. 
 
Table 16. Effect of stirring rate and time of stirring on average CNs particle size and PdI  
Stirring rate (rpm) particle size (nm) PdI Time of stirring (min) particle size (nm) PdI 
300 705 0.593 5 225 0.463 
500 323 0.407 10 120 0.139 
700 120 0.129 20 164 0.29 
1000 147 0.265 30 194 0.320 
1200 198 0.35 60 1600 0.791 
 
It has been reported that the time of reaction also affecte the particle size and polydispersity of 
CNs [324]. The DLS results represent small particles with low PdI after 10 min of magnetic 
agitation. Above 15 min of agitation, the hydrodynamic radius of CNs and its PdI increases 
referring to the formation of CNs aggregation. Yang et al. has also reported the aggregation of 
particles with increasing time of interaction [324].  
Compared with high molecular weight chitosan, low molecular weight chitosan shows better 
solubility, biocompatibility, biodegradability and even less toxicity [325], [326]. Furthermore, 
referring to the main aim of our work to prepare small nanoparticles, further studies have been 
performed on CNs obtained from chitosan (LMv) concentration of 0.7 mg/mL and TPP 
concentration of 1.25 mg/mL. 
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B.1.1.  Morphology of Chitosan nanoparticles  
 
The morphology of optimized chitosan nanoparticles (CNs) was examined using SEM. SEM 
images of CNs before and after sonication are presented in Fig. 50. From these images, 
nanoparticles exhibited a spherical shape with a narrow size distribution in the range of 35-45 
nm. CNs aggregation could be observed before sonication while using sonication leads to 
destruction of the aggregates, as presented in Fig. 50. The discrepancy in size measured with 
DLS and SEM can be attributed to the different measurement techniques. In DLS, we 
measured the hydrodynamic radius of particles while SEM gives an actual diameter of 
nanoparticles in their dry state.  
  
 
Figure 50. CNs SEM images a) before and b) after sonication. Particle preparation conditions: 
LMv chitosan concentration = 0.7 mg/mL. TPP concentration=1.25 mg/mL 
 
B.1.2.  FT-IR spectroscopy of bulk chitosan (93%) and CNs  
 
In acidic solution, chitosan is protonated and can interact with negatively charged counter 
ions of TPP dissociated in water. Thereby, NH3
+
 of chitosan ionically reacts with OH
-
 and 
P3O10
5-
 ions of TPP in solution which leads to the formation of CNs. The FT-IR spectra of 
bulk chitosan and CNs were recorded to investigate the interaction between chitosan and 
sodium tripolyphosphate (TPP), presented in Fig. 51. FT-IR spectrum of bulk chitosn contains 
the feature sharp peak of amide II (N-H bending vibration) at 1581 cm
-1
 and low intensity 
peak of amide I (–CO stretching vibration) at 1643 cm-1 which could confirm the high 
deacetylation degree of bulk chitosan [327], [328]. Moreover, IR spectrum of bulk chitosan 
contains the peak of amino group (–NH2 and –OH) stretching vibration at 3340 cm
-1
 [327], 
a) b) 
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[328], [329]. Whereas in IR spectrum of CNs, this characteristic peak becomes wider and 
shifts to 3230 cm
-1
, indicating that the majority of amino groups of bulk chitosan participate 
in the electrostatic interaction with TPP [327]. The flattening of –NH2 and –OH band has 
already been observed in FT-IR spectra of prepared CNs via ionic gelation method [309], 
[327], [330], [331]. 
 
 
Figure 51. FT-IR spectra of bulk chitosan (Mw=60-120 kDa, degree of deacetylation≥93%),  
and Chitosan nanoparticles 
 
Moreover, –CO stretching vibration peak of bulk chitosan disappears in the IR spectrum of 
CNs which could be ascribed to the linkage between phosphoric and ammonium group of 
chitosan [332]. Similar results were observed for CNs prepared via ionic gelation in different 
studies [328], [330], [332]–[334]. The new peak at 1211 cm-1 in IR spectrum of CNs  could be 
assigned to the P═O stretching. The appearance of P=O stretching peak in CNs could confirm 
the interaction between positive charged amino groups of chitosan with negative charged 
phosphate group of TPP. 
 
B.2.  Gd(TPyP)-encapsulated through Chitosan nanoparticles 
 
After optimization the procedure of CNs synthesis to obtain small chitosan nanoparticles, the 
encapsulation of Gd(TPyP) into chitosan nanoparticles has been studied. 
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B.2.1.  UV-Vis spectroscopy of Gd(TPyP)-loaded Chitosan 
nanoparticles via active and passive routes 
 
Firstly, we studied the loading of Gd(TPyP) into CNs by chemical conjugation. As described 
in Chapter IV, chemical conjugation of Gd(TPyP) with CNs has been performed by adding 1 
mL of Gd(TPyP) either to acetic acid (NPs-1) or to TPP solution (NPs-2). UV-visible spectra 
of prepared nanoparticles (NPs-1) and (NPs-2) are presented in Fig. 52, comparing with 
Gd(TPyP) spectrum in ethanol. As presented in Fig. 52, the spectrum of NPs-2 is similar to 
the spectrum of NPs-1 with slight shift and broader Soret band. The spectrum of NPs-1 
contains the intense Soret band at 445 nm followed by 3 Q bands (522 nm, 552 nm and 588 
nm) while the spectrum of prepared NPs-2 contains a broad and low intense Soret band at 416 
nm followed by 3Q bands (516, 556, and 587 nm).  
The disappearance of the characteristic Q band of Gd(TPyP) at 554 nm and the growth of 
characteristic Q band of (TPyPH2)  at 517 nm in both NPs-1 and NPs-2 has been observed 
that could be marked as a structural deformation of Gd(TPyP). According to the large ionic 
radii of Gd(III), Gd(III) can not fit in the central cavity of porphyrin and thus it locates out of 
the porphyrin plane. Hence, the complex could be easily demetallated in acidic media. For 
example, the demetallation of Sn(TPyP) in acidic solution has been studied by UV-visible 
spectroscopy [269]. It has been observed that the Soret band of Sn(TPyP) shifted from 424 
nm to 417 nm with changing the solvent from dimethylformamide (DMF) to hydrochloric 
acid solution HCl-H2O following with four Q bands. Referring to the demetallation 
probability of Gd(TPyP) during chemical conjugation of Gd(TPyP) to CNs, chemical 
conjugation would not be an appropriate method for encapsulation of Gd(TPyP) into CNs.  
From Fig. 52, electronic absorption spectrum of Gd(TPyP) conjugated with CNs via passive 
method is similar to Gd(TPyP) in ethanol. The nanoparticles’ spectra display an intense sharp 
Soret band at 419 nm followed by a typical Q band at 552 nm. The slight observed shift 
should be related to the solvent. The absorption spectrum of the chemical species in solution 
strongly depends on the solvent-solute interaction and solvent nature (polarity of solvent) 
[335]. The intermolecular solvent-solute interaction alters the energy difference between 
ground and excited state of chemical species [336]. Thus, the solvent nature has an impact on 
the UV-visible spectrum of chemical species. 
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Figure 52. UV-Vis spectra of Gd(TPyP) in ethanol, NPs-1 and NPs-2: Gd(TPyP)-CNs via 
chemical conjugation, NPs-3: Gd(TPyP)-CNs via passive method 
 
B.2.2.  Evaluation of Gd(III) concentration loaded into Chitosan 
nanoparticle 
 
Different quantities of Gd(TPyP) were conjugated through CNs via passive method. As 
presented in Fig. 53, all samples showed high water solubility and purple color which 
increased with the Gd(TPyP) concentration.  Sample 1, 2, 3, and 4 referred respectively to the 
CNs:Gd(TPyP) ratio of 1:0.5 , 1:1, 1:2 and 1:3 which were dispersed in 4 ml of distilled 
water. UV-visible spectroscopy was used to determine the concentration of Gd(TPyP) into 
nanoparticles. Figure 53 exhibited the electronic absorption of Gd(TPyP)-CNs after 
adsorption of different quantities of Gd(TPyP) to CNs. It can be seen that the Soret band 
intensity of Gd(TPyP)-CNs enhances with the concentration of Gd(TPyP) except for sample 
4. In order to prepare the clear solution for UV-visible measurements, sample 1 to 3 was 
diluted by adding 40μl of prepared colloids to 960 μl of distilled water. While for sample 4, 
regarding to its high absorption intensity (≥2.5%), 20 μl of solution were added to 980 μl of 
distilled water.  
The concentration of analyte in solution could be determined by measuring the absorbance at 
the fixed wavelength by applying Beer-Lambert law.  From Beer Lambert law, absorbance of 
solution is directly proportional to the concentration of analyte as follows 
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While L is the path length through the sample, c is the molar concentration of species in the 
solution and ε is the molar absorptivity (extinction coefficient). 
 
Figure 53. UV-visible spectra of Gd(TPyP)-CNs with different concentration of Gd(TPyP) 
 
The Soret band intensity of all four samples (at 419 nm) was measured from UV-visible 
spectra. It is required to evaluate the molar absorptivity of Gd(TPyP) in water to determine 
precisely the concentration of Gd(TPyP) in the prepared nanoparticles.  
The molar absorptivity of Gd(TPyP) in water, however, is an obstacle due to the poor 
solubility of Gd(TPyP) in water. Thus, 1 mg of Gd(TPyP) was first dissolved in 1 mL of 
ethanol. Afterwards, 50 μL of Gd(TPyP) solution was diluted with 1.95 mL of distilled water. 
Next, a series of concentrations was prepared from the main solution. From Beer-Lambert law 
and their UV-visible spectra, the molar absorptivity of Gd(TPyP) in water was calculated. The 
details are summarized in Table 17. 
 
Table 17. The concentration of Gd(TPyP) in water and UV-visible absorbance (a.u.) 
Final concentration of Gd(TPyP) (μM) Absorbance at 419 nm (a.u.) 
4.5 0.486 
6 0.873 
9 1.283 
10.5 1.467 
 
The molar absorptivity of Gd(TPyP) in water at 419 nm was determined by a linear fit of 
absorption intensity as a function of Gd(TPyP) concentrationwhich is 1.582x10
5
 L.mol
-1
.cm
-1
 
as presented in Fig. 54. 
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Figure 54. Evaluate molar absorptivity of Gd(TPyP) in water at 419 nm 
 
Referring to evaluated molar absorptivity of Gd(TPyP) in water, we are able to calculate the 
concentration of conjugated Gd(TPyP) in the nanoparticles from their UV-visible spectra. 
Furthermore, quantitative measurements with inductively coupled plasma mass 
spectrometry (ICP-MS) were performed for the same samples. This method gives the real 
value of Gd loaded in CNs. The two analytical methods show the increase of the amount of 
Gd(TPyP) adsorbed into chitosan nanoparticles from sample 1 to 4. A one-to-one linear 
correlation between the values obtained via UV-vis and ICP-MS was observed, Fig. 55.  
 
 
Figure 55. ICP results versus absorbance of Gd(TPyP)-CNs after conjugation of different 
quantities of Gd(TPyP) with CNs 
 
Entrapment efficiency (EE), loading capacity (LC) and yield percentage of prepared samples 
were evaluated, as described in the experimental section (B.4.7). The effect of different 
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concentrations of Gd(TPyP) on EE, LC and yield (%) of Gd(TPyP)-CNs is presented in Fig. 
56. It can be observed that the maximum EE (87%) was achieved at CNs:Gd(TPyP) ratio  of 
1:2 while LC (%) and yield (%) reach their maximum values at the ratio of 1:3. 
 
 
Figure 56. Entrapment efficiency (EE), loading capacity (LC) and yield % for different CNs: 
Gd(TPyP) ratios 
 
B.2.3.  Physicochemical properties of Gd(TPyP)-loaded CNs 
 
The morphology of Gd(TPyP)-CNs has been analyzed via SEM, presented in Fig. 57. From 
SEM images, Gd(TPyP) -CNs are of uniform spherical shape and the absorption of Gd(TPyP) 
into CNs does not cause any changes in the shape of CNs. The particle size of Gd(TPyP)-CNs 
from SEM images is determined in the range of 45-65 nm. 
 
 
Figure 57. SEM image of Gd(TPyP)-CNs with ratio of 3:1 
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The hydrodynamic radius and polydispersity of prepared Gd(TPyP)-CNs have been 
studied via DLS. The typical size distribution by scattering intensity graph of CNs and 
Gd(TPyP)-CNs are presented in Fig. 58. The size distributions of CNs and Gd(TPyP)-CNs 
in water consist of a single peak with maximum  at 120 and 412 nm, respectively. It is 
noteworthy to indicate that the size of Gd(TPyP)-CNs measured either by SEM or by DLS 
remains unchanged for nanoparticles with different Gd(TPyP) concentrations. The 
increase of the average particle size can be attributed to the association of the macrocycle 
to the chitosan nanoparticles. 
 
 
Figure 58. DLS results of optimized chitosan nanoparticles and Gd(TPyP)-CNs with ratio of 
3:1 
 
Figure 59. EDX spectra of Gd(TPyP)-CNs with different ratio of Gd(TPyP):CNs a) sample 1 
(0.5:1 mg), b) sample 2 (1:1 mg), c) sample 3 (2:1 mg) and d) sample 4 (3:1 mg)  
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The presence of Gd(III) in prepared Gd(TPyP)-CNs was investigated using EDX-SEM. As 
presented in Fig. 59, EDX spectra confirm the existence of Gd(III) in all four Gd(TPyP)-CNs 
particles. 
 
B.2.4.  Fourier Transform Infrared Spectroscopy of prepared 
CNs-Gd(TPyP) 
 
FT-IR studies of Gd(TPyP) and Gd(TPyP)-CNs were performed to characterize the chemical 
structure of Gd(TPyP)-CNs nanoparticles. The infrared spectra of prepared Gd(TPyP)-CNs, 
Gd(TPyP), and CNs are shown in  Fig. 60. The FT-IR spectrum of Gd(TPyP)-CNs is similar 
to the CNs spectrum with additional peaks referring to IR of Gd(TPyP). The IR spectrum of 
Gd(TPyP)-CNs contains a peak at 1641 cm
-1
 due to carbonyl vibration of CNs. Moreover, the 
typical pyridyl vibration peak of Gd(TPyP) at 1540 cm
-1 
disappears in the IR spectrum of the 
Gd(TPyP)-CNs. This could demonstrate the interaction of chitosan with the pyridyl following 
hydrogen binding. Furthermore, after conjugation of Gd(TPyP) with CNs, IR band of CNs 
amido group C═O was shifted from 1631 to 1641 cm-1 which could be related to coordination 
between chitosan and Gd(TPyP). 
 
 
Figure 60. FT-IR spectra of a) CNs, b) Gd(TPyP), c)Gd(TPyP)-CNs 
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B.2.5.  Magnetic Resonance Imaging of Gd(TPYP)-CNs 
 
The potential of Gd(TPyP)-CNs in water as MRI contrast enhancement was studied via MRI 
at 3T and 25°C. T1 and T2 weighted images of Gd(TPyP)-CNs solution are presented in Fig. 
61. T1 signal intensity increases with increasing the loading amount of Gd(TPyP) as well as 
the Gd(III) concentrations, and conversely for the T2 signal intensity.  
 
Figure 61. T1 (TR=400 ms, TE=8 ms) and T2 (TR=1500 ms, TE=40 ms) weighted spin echo 
MR images of different concentration of Gd(TPyP)-CNs in water at 3T and 25°C 
 
The longitudinal and transverse relaxivities (r1 and r2) of Gd(TPyP)-CNs were evaluated and 
represented in Fig. 62. r1 of Gd(TPyP)-CNs in water (38.35 mM
-1
.s
-1
) is 56% higher than 
Gd(TPyP) in ethanol (r1=24.5 mM
-1
.s
-1
)  while its r2 (33.43 mM
-1
.s
-1
) decreases by 52% 
compared with the one of Gd(TPyP) in ethanol (r2=69.97 mM
-1
.s
-1
) at 3T and 25°C. The 
measured r1 of Gd(TPyP)-CNs is ~12 times greater than the r1 of Gd-Dota at 3T. 
The relaxivity enhancement of contrast agents conjugated to CNs has already been reported in 
some works. It was found that r1 of Gd-DTPA improved with conjugation to CNs from 3.62 
mM
-1
.s
-1
 to 11.62 mM
-1
.s
-1
 at 0.5T and 32°C [146]. In another examlpe, Mn-DTPA-CNs in 
aqueous solution showed high r1 of 7.21 mM
-1
.s
-1
 at 0.5T and 32°C [155]. In the other 
research, Gd-Dota attached to bimodal chitosan nanoparticles with small size (22 nm) 
exhibited high r1 of 41.1 mM
-1
.s
-1
 at 4.7T [337]. Gd-phostriamine (MS-325) chelated with 
chitosan– β –cyclodextrins (CD) in aqueous solution also showed higher r1 of 27.5 mM-1.s-1 
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compared with the one of MS-325 binding toward β-CD monomers (11.5 mM-1.s-1)  at 0.47T 
and 25°C [338]. 
 
 
Figure 62. Longitudinal and transverse relaxation rates [(1/T1) and (1/T2)] of Gd(TPyP)-CNs  
versus the Gd(III) concentrations in water at B0=3T and T=25°C 
 
Thereby, the enhancement of r1 relaxivity with conjugation of Gd(TPyP) to CNs, as presented 
in Fig. 63, is consistent with published values. The enhancement of relaxivity with 
conjugation of agent to CNs could be  explained as a result of a combination of factors: i) a 
decrease in rotational correlation time by attachment of the complex to the CNs, ii) an 
increase in the exchange rate of nearby coordinated water molecules and iii) an increase in the 
amount of paramagnetic ion loaded into the nanoparticles [152].  
 
Figure 63. r1 and r2 relaxivity of Gd(TPyP) encapsulated with chitosan nanoparticles, 
Gd(TPyP) and Gd-DOTA at 3T and 25°C 
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It has been found that the water diffusion in the presence of particles with hydrophilic shells 
decreased which causes r2 to increase [339]. Additionally, we could assume that more than 
one Gd(III) has been loaded into nanoparticles, leading to an increase in r2. Nonetheless, our 
obtained result is inconsistent with these explanations. We observed that the r2 decreased 
from 69.97 mM
-1
.s
-1
to 33.43 mM
-1
.s
-1
 after conjugation of Gd(TPyP) with CNs. The problem 
of Gd(TPyP) solubility in organic solvent can lead to the formation of aggregates. It is known 
that r2 relaxivity is very sensitive to the aggregation in which r2 relaxivity increases with 
aggregation [340]. Thus, the high r2 of Gd(TPyP) in ethanol could be ascribed to its 
aggregation during measurements. Whereas, loading of Gd(TPyP) to CNs with great water 
solubility leads to prevent the formation of the aggregates. 
 
C. Mn-doped ZnS ultrasmall Nanoparticles  
 
ZnS is recognized as one of the most promising materials for a number of optoelectronic 
applications. Thus, different transition metal (TM) ions can be introduced into their lattices, 
which not only serve as the luminescent centers to bring new emissions, but also make QDs 
exhibit ferromagnetic properties [341], [342]. ZnS:TM quantum dots have exhibited their 
potential in a number of promising applications in biomedicine, including magnetic resonance 
imaging, luminescence labeling, therapeutic for hyperthermia and targeted drug delivery. In 
this section, we demonstrate the physicochemical, photoluminescence and relaxivity results of 
developed Mn:ZnS with different dopant concentrations. 
 
C.1. Structural and Elemental analysis of MnxZnx-1S (x=0.1, 0.2, 0.3) 
 
The structural characterization of MnZnS QDs with different Mn contents was performed 
using X-ray diffraction (CuKα radiation). The recorded X-ray powder diffraction (XRD) 
pattern of MnxZn1-xS nanoparticles are represented in Fig. 64. The diffraction patterns of 
MnZnS are consistent with the JCPDS data of ZnS (card No. 05-0566). From Fig. 64, XRD 
patterns contain three main broad peaks corresponding to the (111), (220) and (311) planes in 
which the strongest peak corresponds to (111) plane.  MnZnS nanoparticles possess a single-
phase cubic crystal structure with MF 34 symmetry. This indicates that the doping Mn2+ions 
has no effect on the crystal structure of ZnS. No additional peak corresponding to any other 
crystallographic phase or unreacted ingredient was observed. Moreover, the broad peak 
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clearly indicates the small nanocrystal sizes. The mean diameter of particle size was 
determined via MAUD software (Table 18). The average particle sizes of MnxZnx-1S 
(0.1≤x≤0.3) are in the range of 1.6 - 1.9 nm. 
 
 
Figure 64. The XRD patterns of the as-prepared MnxZn1-xS (x=0.1, 0.2, and 0.3) 
 
The microstructures of the Mn-doped ZnS nanoparticles were characterized by TEM. Figure 
65 shows the TEM images of Mn:ZnS with different Mn(II) content. TEM images exhibit 
spherical nanoparticles with nearly uniform size of ~1.55 nm, which is consistent with the 
XRD results with slight differences. The evaluated particle size from TEM images are listed 
in Table 18. The inset of Fig. 65 shows the representative selected area electron diffraction 
pattern, confirming the crystalline planes of MnZnS. The electron diffraction of the selected 
area shows two rings which correspond to the (111) and (220) planes of cubic ZnS.  
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Figure 65. TEM image of Mn-doped ZnS nanoparticles with different Mn content 
 
In addition, EDX and XRF measurements were carried out to determine the overall 
composition and spatial distribution of Mn ions in Mn:ZnS as listed in Table 18. EDX of all 
three samples confirmed the presence of Mn (II) and the evaluated weight percent (wt%) are 
very close to the nominal value.  Moreover, the concentration of Mn(II) content in Mn:ZnS 
was precisely investigated with XRF. The percent composition of Mn and Zn in Mn:ZnS are 
listed in Table 18. The measured Mn contents in all three samples by XRF are consistent with 
the EDX results. 
 
Table 18. Physico-chemical characteristics of MnxZn1-xS such as chemical composition from 
EDX and XRF analyses, and the average crystal size <LXRD> from XRD and <DTEM>  the 
average particle diameters from statistical analysis of TEM images 
Samples 
Mn/(Zn+Mn) 
at.-% 
Zn/(Zn+Mn)  
at.-% 
Nanoparticles size 
EDX  XRF EDX XRF <LXRD> (nm) <DTEM> (nm) 
Mn0.1Zn0.9S 10 9.2 90 90.8 1.6 1.54  0.15 
Mn0.2Zn0.9S 20 17.0 80 83 1.8 1.63  0.26 
Mn0.3Zn0.7S  30 26.0 70 74 1.9 1.55 0.25  
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C.2. Optical properties of MnxZn1-xS(x=0.1, 0.2, and 0.3) 
 
Room temperature photoluminescence (PL) emission spectra of all three MnZnS samples are 
presented in Fig. 66.  From Fig. 66, all three samples exhibited a broad blue emission band 
with a distinct peak around 465 nm. 
  
Figure 66. Photoluminescence emission spectra of MnxZn1-xS (0.1≤x≤0.3) recorded for 
λexc=405 nm at room temperature , inset the emission observed from a) Mn0.1Zn0.9S and b)ZnS 
at 325 wavelength 
 
The PL emission of Mn:ZnS with different concentration of Mn [343]–[352] and at different 
excitation wavelengths [343], [345], [346] has been extensively studied by many groups. Due 
to the literature review, the entire PL spectrum of Mn-doped ZnS nanoparticles is dominated 
by two-emission bands, blue in the range of 400-500 and yellow emissions around 580-600 
nm. The blue emission should be associated with the emission of defect of ZnS host [353], 
[354] while yellow emission is associated with 
4
T1 – 
6
A1 transition within 3d Mn(II). Due to 
Bhargava and Gallagher studies [355], yellow-orange emission in MnZnS is ascribed to the 
energy transfer from ZnS host to Mn(II) ions. As illustrated in Fig. 67, during PL process, the 
electron from valence band of ZnS crystal is excited across the band gap. Due to 
recombination processes, the photoexcited electron subsequently decays. With doping Mn in 
the ZnS host lattice, Mn(II) occupies a tetrahedral site and the photoexcited electron may be 
captured by Mn(II) ions. Thereby, the transition of 
4
T1 – 
6
A1 is partially possible due to the 
mixing of s-p electrons of ZnS with d electrons of Mn(II) ions, resulting in characteristic 
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emission of Mn(II) [356]. In comparison with the reported emission spectrum of Mn-doped 
ZnS, in all three PL emissions of Mn:ZnS, we observed just one broad peak at ~470 nm with 
no yellow emission. The luminescence emission includes band-edge emission and trap-state 
emission – which originate in defects containing vacancies and interstitials. The Peak 
emission around 465 nm, can be attributed to dangling Sulphur bonds that there are the Zn 
and S interstitial transitions and S or Zn vacancies – which would lie close to the band edge. 
Lü et al.[345] have been studied the PL spectrum of ZnS:Mn nanoparticles at different 
excitation wavelength. They have observed that the intensity of blue emission peak was 
stronger than intensity of yellow emission peak after the excitation wavelength reached 340 
nm and the yellow emission band vanished at the excitation wavelength of 376 nm. 
Meanwhile, Zhang et al.[343] have also observed that Mn emission could be observed at 
excitation wavelength in the ultraviolet region (280 nm≤λexc≤370 nm). Referring to their 
studies, the maximum emission intensity of Mn(II) was observed at excitation wavelength of 
320 nm [343]. The PL emission of Mn:ZnS has also been studied Marandi et al. [352]. They 
found that the irradiation time during fluorescence studies has an effect on PL spectrum of 
Mn:ZnS. They have reported that the PL emission of Mn(II)  at 585 nm emerged at longer 
irradiation times (≥2 min) [352]. Moreover, they observed that the emission peak of Mn 
increased by increasing Mn:Zn ratio up to 1% and after that the luminescence decreased and 
vanished at higher Mn:Zn ratios (at 10%) [352]. Furthermore, it has been accepted that thiol 
ligands is a PL quencher [357], [358]. The highest occupied molecular orbital (HOMO) of 
thiol ligands has the higher energy level compared with quantum dots (QDs) valence bands 
which results in transfering of photoexcited holes from top of QDs valence band to HOMO 
level of thiol ligands [359], [360]. Thereby, thiol ligands act as the hole scavengers which 
could lead to reduced PL emission intensity. 
Due to the above discussions, PL emission of Mn:ZnS could be influenced by the following 
issues: i) the excitation wavelength, ii) the irradiation time during florescence studies, iii) 
concentration of Mn dopant, and iv) the effect of thiol ligands. Furthermore, location of 
Mn(II) could also affect the photoluminescence properties of Mn:ZnS. Theoretically, Mn(II) 
ions should incorporate in the ZnS nanocrystals and occupy Zn
2+
ion sites in the host lattice 
(ZnS) regarding to their similar sizes and charges [361]. It has been reported that a part of 
Mn(II) ions could be located on the surface of ZnS nanocrystal [362]–[364]. Sooklal et al. 
have found that Mn(II) ions incorporated into ZnS lattice or on the surface of ZnS would yield 
the orange and ultraviolet emission, respectively [365]. They have observed the blue emission 
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at 390 nm for MnZnS nanoparticle when Mn(II) distributed on the surface of ZnS [365]. 
Photographs of PL emission of Mn0.1Zn0.9S and ZnS under UV excitation (325 nm) are 
presented in inset of Fig. 66. Remarkably, we observe the blue emission of Mn:ZnS which 
indicates the incorporation of Mn(II) on the surface of ZnS. Thereby, no orange-yellow 
emission in PL spectra of all three prepared Mn:ZnS in our study could be referred to the 
distribution of Mn(II) partially on or close to the surface of ZnS.  
 
Figure 67. The schematic diagram of energy-level of Mn doped ZnS nanoparticles 
corresponding to photoluminescence spectra[348]  
 
C.3. Magnetic properties of MnxZnx-1S (x=0.1, 0.2, 0.3) 
 
 
Figure 68 shows the magnetization of MnxZnx-1S (0.1 ≤x ≤0.3) versus magnetic field. The M-
H curves of all Mn-doped ZnS reveals no saturation magnetization up to 50kOe with zero 
coercivity and remanence values. All three samples exhibited characteristic paramagnetism at 
room temperature. 
 
Figure 68. Magnetization versus magnetic field up to 50 kOe for MnxZn1-xS nanoparticles 
with different Mn contents (x=0.1, 0.2, and 0.3) at 300K 
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The magnetizations of as prepared Mn-doped ZnS (0.1≤x≤0.3) are much higher than the 
magnetization of bulk Mn-doped ZnS[366]. We observed that the magnetization of Mn:ZnS 
increased with Mn dopant content. From M-H curves of Mn doped ZnS, magnetization 
increased linearly from 0.24 emu.g
-1
 to 1.44 emu.g
-1
 (Fig. 68) with increasing Mn doping 
concentrations from 0.1 to 0.3, respectively. This enhancement is attributed to the enhanced 
exchange interactions referring to higher density of Mn
2+
 in samples [367]. 
 
Figure 69. Susceptibility versus temperature and in the inset the temperature dependence of 
inverse magnetic susceptibility of Mn-doped ZnS with different dopant concentrations 
(0.1≤x≤0.3) at 2kOe 
 
The susceptibility of Mn:ZnS with different Mn(II) contents was investigated at different 
temperatures under an applied magnetic field of 2 kOe. As shown in Fig. 69, all three samples 
exhibited the smooth and featureless curves. Moreover, susceptibility decreases with 
increasing temperature which is the characteristic paramagnetic behavior. 
The magnetic properties of Mn-doped ZnS crucially depend on Mn doping concentration. At 
low Mn content, Mn atoms replaced the host lattice cations, while at high Mn concentration 
the Mn atoms cannot be considered as isolated one. At higher Mn concentrations, Mn clusters 
can form which could cause the antiferromagnetic behavior [368]. Thereby, the stable states 
of electron spins have opposite directions with nearest neighbors, which causes the 
antiferromagnetic behavior. This feature was observed for Mn:ZnSe nanoparticles [368]. 
They have observed the linear dependency of M-H at 5K which is paramagnetism attitude, 
meanwhile, the negative paramagnetic curie temperature has been obtained [368]. Bulk 
MnZnS with Mn(II) concentration of 0.28% also showed a negative Curie-Weiss temperature 
-31K which suggests the presence of antiferromagnetism [366]. In our study, a small negative 
curie constant was obtained which could be due to the existence of Mn-Mn clusters. 
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C.4. Magnetic Resonance Imaging of MnxZnx-1S (x=0.1, 0.2, 0.3) 
colloids 
 
The capability of prepared MnZnS colloids on enhancing MRI signal has been studied using a 
3T MRI. T1 and T2 weighted images of prepared Mn:ZnS colloids (in water) are presented in 
Fig. 70. From Fig. 70, Mn-doped ZnS shows appreciable signal enhancement on T1 weighted 
images compared to ZnS solution. The signal intensity on T1-weighted images of Mn:ZnS 
increased with increasing Mn(II) concentration. From T2 images, no significant T2 effect 
could be observed, and T2 images of Mn0.3Zn0.7S were bright compared to those of 
Mn0.1Zn0.9S and Mn0.2Zn0.8S . 
 
   
Figure 70. T1 (3T, TR=400 ms and TE=8 ms) and T2(3T.,TR=1500 ms and TE=40 ms) 
weighted images of ZnS as reference and MnxZn1-xS (0.1≤x≤0.3) at 3T and 25°C 
 
Relaxivity is one of the most important parameter to evaluate the efficiency of contrast agents. 
Thus, longitudinal and transverse relaxation times (T1 and T2) of MnxZn1-xS (x=0.1, 0.2, and 
0.3) solutions were evaluated from their T1 and T2 weighted images. Figure 71 displays the 
evaluated relaxivities of MnxZn1-xS (0.1≤x≤0.3) in aqueous media. r1 relaxivity increased 
from 20.34 mM
-1
.s
-1
 to 86.08 mM
-1
.s
-1
 and slightly decreased to 75.5 mM
-1
.s
-1
 with increasing 
Mn-dopant. The same trend has been observed for r2, increasing from 37.37 mM
-1
.s
-1
 to 54.95 
mM
-1
.s
-1
 and decreased to 40.4 mM
-1
.s
-1 
for further increase of Mn content (Mn=0.3). 
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Figure 71. Longitudinal and transverse relaxation rates (1/T1) of  a) Mn0.1Zn0.9S, b) 
Mn0.2Zn0.8S   and c) Mn0.3Zn0.7S versus the Mn(II) concentrations in aqueous solution at 
B0=3T and T=25°C 
 
Relaxivity of paramagnetic-based nanoparticles is attributed to three key parameters, 
including the number of unpaired spins, paramagnetic properties of metal ions and high 
surface to volume ratio of nanoparticles [369]. The main advantage of paramagnetic 
nanoparticles compared to macromolecular chelates is their large surface to volume ratio 
which causes the majority of paramagnetic ions to accumulate on the surface of the particles 
[369]. Thereby, the development of the paramagnetic nanoparticles has attracted much 
attention in clinical imaging technique. For instance, MnO nanoparticles coated via D-
glucuronic acid, with average particle diameter in the range of 2 nm to 3 nm and 
hydrodynamic radius of 5 nm, has shown high r1 and r2 relaxivity of 7.02 mM
-1
.s
-1
 and 47.97 
mM
-1
.s
-
1, respectively, at 1.5 T [369]. Its high r1 was ascribed to high surface to volume ratio 
(~0.35), high value of S=5/2 and its paramagnetic characters [369].  
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Beside the size of particles, the coating of nanoparticles is considered as an important factor 
on enhancing the relaxivity of paramagnetic-based nanoparticles. For example in the other 
studeis, MnO (with average diameter of 20 nm) coated with dopamine and human serum 
albumin (HAS) bilayer induced larger r1 of 1.97 mM
-1
.s
-1
 (almost 5 times) than r1of the 
phospholipid coated one (r1=0.37 mM
-1
.s
-1
) [370]. Both dopamine and HAS are known as 
hydrophilic ligand which allows for efficient water penetration, causing the r1 enhancement 
of MnO. 
In our study Mn:ZnS exhibits high r1, varying between 20.34-75.5 mM
-1
s
-1
 with increasing 
Mn dopant contents. The measured r1 of Mn-doped ZnS is much higher than those of 
clinically approved Mn contrast agents such as Mn(II) dipyridoxyl diphosphate (Mn-DPDP) 
(Teslascan®, r1=2.1 mM
-1
.s
-1
 at 1.5T and 20°C) [371] and MnCl2 (r1=8 mM
-1
.s
-1
 at 0.47T and 
40°C) [372] in aqueous solution. Comparing with the r1 of CdTe/Mn:ZnS with the Mn dopant 
concentration of 10%,  the Mn0.1Zn0.9S in our study shows higher r1 of 20.34 mM
-1
.s
-1
. The 
high r1 of MnxZn1-xS could be attributed to the ultrasmall size of nanoparticles which caused 
the accumulation of Mn ions on the surface of ZnS ( supported by PL studies of Mn:ZnS), 
increasing relaxivity. The localization of Mn(II) on or close to the nanoparticle surface would 
cause the reduction of the distance between paramagnetic ions and bound water molecule 
which leads to enhanced r1.  On the other hand, the coating could also have an impact on 
relaxivity. The sulphur head of mercaptoacetic acid group coordinates with zinc ions at the 
surface of MnZnS and its exterior, carboxylic acid group, links to water molecules which lets 
MnZnS to be soluble in water (as shown in Fig. 72). The hydrophilic mercaptoacetic acid 
allows water to become accessible to the inner sphere of Mn:ZnS [373], enhancing r1 
relaxivity. Thus, mercaptoacetic acid could play a role in obtaining this high relaxivity.  
 
Figure 72. Schematic of Mn:ZnS capped with mercaptoacetic acid and enlarge carboxylic acid 
interaction with water molecules 
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Furthermore, second and outer sphere contributions have a significant fraction of total 
relaxivity for the complex with low molecular weight [276]. Notable second sphere 
contribution on relaxivity has been studied for 20 different Gd-DOTA derivatives [374]. Each 
compounds had one water molecule in the inner sphere and in order to promote hydrogen 
bonding with the second sphere water molecule, nitrogen of amide group of Gd-DOTA was 
substituted with different groups. The highest r1 (58.1 mM
-1
.s
-1
 at 0.47 T in serum albumin) 
was obtained for the compound in which the nitrogen of the amide group was substituted with 
carboxylate [374]. This high relaxivity was attributed to strong bonding of carboxylate with 
water molecules in the second sphere which enhances r1 [374]. In other words, the high r1 of 
Mn:ZnS in our study could be attributed to second sphere contributions. Carboxylic group of 
mercaptoacetic acid with a high number of strong dipoles is considered as a highly polar 
organic functional group [375]. Hence, it favorably participates and forms strong H-bonding 
with water molecules [376]. These strong interactions lead to increase the water residency 
time in the second sphere [376]. Thereby, the carboxylic group of mercaptoacetic acid can 
promote the second sphere contribution and resulting in enhancement of the relaxivity of 
Mn:ZnS.  
We observe that r1 and r2 increase with Mn dopant content up to 20% then decrease for 
further increase. Some researchers have reported this drastic change of relaxivity. For 
instance, r1 of zeolite GdNaY nanoparticles of 37.7 mM
-1
.s
-1 
reduces to 11.4 mM
-1
.s
-1 
at 60 
MHz and 37°C with increasing Gd loading into zeolite [377]. The authors have ascribed the 
relaxivity reduction to a lower number of water molecules per Gd ions inside the zeolite 
cavity at higher Gd loading and reduction in outer sphere hydration contributions [377].  In 
other research, r1 of Gd-incorporated mesoporous silica drastically decreased from 23.6 mM
-
1
.s
-1
 to 7.2 mM
-1
.s
-1 
with increasing incorporation of Gd(III) from 1.6% to 3.1% [378]. This 
reduction has been attributed to shortening electronic relaxation due to enhancing the dipole-
dipole interaction between Gd ions at high loading [378]. In our work, the decrease of 
relaxivities upon Mn content of 0.3 could be related to significant dipole-dipole interaction at 
this Mn dopant concentration (0.3) which is shortening electronic relaxation times and reduce 
the overall relaxivity.  
After observing the decrease of r1 and r2 of Mn0.3Zn0.7S compared to those of Mn0.1Zn0.9S and 
Mn0.2Zn0.8S, different particle sizes of Mn0.3Zn0.7S have been synthesized to study whether by 
increasing the particle size the dipole-dipole interaction of Mn(II) atoms at this concentration 
could be reduced. 
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C.5. Physicochemical characterization of Mn0.3Zn0.7S with different 
particle sizes 
 
The different particle sizes of Mn0.3Zn0.7S nanoparticles have been synthesized and collected 
from ultrahigh speed centrifugation. The average crystallite sizes of Mn0.3Zn0.7S were 
estimated from TEM image and XRD spectra. The evaluated results are listed in Table 19. 
The diameter of different Mn0.3Zn0.7S particles evaluated from TEM images agree well with 
the XRD data. 
 
Table 19. Particle size of Mn0.3Zn0.7S evaluated from TEM images and XRD spectrum  
Sample Particle size by TEM Particle size by XRD 
Mn0.3Zn0.7S (S1) 1.55 1.8 
Mn0.3Zn0.7S (S2) 1.85 1.9 
Mn0.3Zn0.7S (S3) 2.1 2.3 
Mn0.3Zn0.7S (S4) 2.6 2.5 
 
Figure 73 shows the magnetization of Mn0.3Zn0.7S with different core diameters varied 
between 1.8-2.5 nm versus magnetic field. M-H curves of all four samples reveal the linear 
dependency of M with H with zero coercivity and remanence values and no saturation 
magnetization. All samples exhibited paramagnetic properties at room temperature.  
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Figure 73. Magnetization versus magnetic field up to 50 kOe for Mn0.3Zn0.9S nanoparticles 
with different particle sizes at 300K 
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C.6. Size dependent r1 and r2 relaxivities of Mn0.3Zn0.7S nanoparticles 
 
T1 and T2 weighted images of four samples (S1, S2, S3, and S4, as listed in Table 19) in 
aqueous solution at 3T are presented in Fig. 74. As shown in Fig. 74, Mn0.3Zn0.7S induced a 
signal intensity enhancement on T1 weighted images with increasing the Mn(II) 
concentrations. It is noteworthy that at the same imaging parameters and same concentrations 
of Mn(II) ions, the signal intensity on T1 weighted images increase with particle size of 
nanoparticles. Moreover, the signal intensity on T2 weighted images increases with Mn(II) 
concentration until 70 μM. Signal intensity loss on T2 weighted images could be observed for 
samples with concentration of 100 μM which increases with particle size. 
 
 
Figure 74. T1 (TR=400 ms, TE=8 ms) and T2 (TR=1500 ms, TE=50 ms) weighted spin echo 
MR images of different concentrations of Mn0.3Zn0.7S with different particle size in water at 
3T and 25°C 
 
r1 and r2 relaxivities of the different particle sizes of Mn0.3Zn0.7S are presented in Fig. 75. r1 
relaxivity decreased dramatically with increasing the particle size from a value of 75.5 mM
-
1
.s
-1
 for S1, with diameter of 1.55 nm, to 42.81 mM
-1
.s
-1
 for S4 with average diameter of 2.5 
nm. Simultaneously, r2 decreased from 40.4 to 31.4 and subsequently, it remained unchanged 
with further increase of particle size. 
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Figure 75. The longitudinal and transverse relaxation rates (1/T1 and 1/T2) of Mn0.3Zn0.7S 
with different particle sizes versus the Mn(II) concentration in water at B0=3 T and T=25°C 
 
The number of paramagnetic ions cooperated on the surface of nanoparticles are responsible 
for shortening of T1 relaxation time [379]. Thus, the surface of nanoparticles plays an 
important role on relaxivity r1. Hyeon and co-workers have observed that longitudinal 
relaxivity of MnO nanoparticles decreases from 0.37 to 0.12 mM
-1
s
-1
 with increase in particle 
size [380]. The decrease of r1 relaxivity with increasing diameter of Gd2O3 nanoparticles has 
also been reported. The small Gd2O3 with diameter of 3 nm exhibited r1 of 2.64 mM
-1
.s
-1
 at 
20 MHz and 37°C while it decreased to 1.86 mM
-1
.s
-1
 for aggregated nanoparticles with 
hydrodynamic radius of 105 nm [381]. Moreover, Rahman et al. found that r1 of Gd2O3 
increased with decreasing particle size until the nanoparticle size reached 2.3 nm afterward a 
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further reduction in the particle size caused a reduction of r1 [382]. On the other hand, r1 of 
different cobalt nanoparticles coated with polymer have also been investigated [383]. It was 
reported that r1 of largest cobalt nanoparticles (28 nm) in water was almost doublet (7.4 mM
-
1
s
-1
) than the one (3.9 mM
-1
s
-1
) of smaller nanoparticles (13 nm) at 1.5T whilst their r2 
relaxivities were the same [383]. In our study, r1 of Mn0.3Zn0.7S decreased with increasing 
particle size, with coating thickness of 0.5 nm, consistent with previous reported ones. The 
decrease of surface area by increasing particle size could be responsible for the decrease of r1 
relaxivity.  
Due to size dependency of r1 and r2 relaxivities, r2 changes are less pronounced than r1 in 
our study. The decrease of r2 from 40 mM
-1
s
-1
 (S1) to 31 mM
-1
s
-1
 (S2) could be attributed to 
the decrease of surface to volume ratio with increasing particle size. Meanwhile, r2 of S3 and 
S4 did not change. Roohi et al. has also observed the same trend for relaxivity of SPIO [384]. 
They have reported that r2 of SPIO changes with increasing the hydrodynamic radius of SPIO 
up to 60 nm while for larger particles r2 remains constant [384].  
 
D. Molecular Dynamics simulation (MDs) 
 
Molecular dynamics give us the ability to study the real dynamics of the system during time 
of simulation. Thus, in order to obtain better understanding of the microscopic behavior of 
MnZnS in aqueous solution (water), the structure of MnZnS in vacuum and in water have 
been estimated via molecular dynamic simulation. 
 
D.1. ZnS and MnZnS zincblende structure 
 
As mentioned in the previous chapter, shell model of ZnS [260] has been adopted for 
numerical simulation of ZnS structure. Figure 76 displays the simulated radial distribution 
function (RDF), and the snapshot of its crystal structure. The characteristic RDF peaks and 
their corresponding coordination number (CN) of Zn-Zn and Zn-S pairs have been tabulated 
in Table 20. RDF of Zn-S and Zn-Zn pairs contain sharp peaks which demonstrate the crystal 
structure of ZnS. Zn-Zn RDF exhibits four peaks at 3.78 Å, 5.42 Å, 6.62, and 7.57 Å with 
corresponding integration number of 12, 18, 42, and 54. Moreover, RDF of Zn-S pairs 
exhibits four peaks at 2.32, 4.425, 5.82, and 6.92Å. Referring to Zn-S RDF, Zn atoms 
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coordinated with 4, 12 and 12 atom of S at 1
st
, 2
nd
 and 3
rd
 coordination shells, respectively. 
Benkabou et al. have simulated ZnS crystal structure using MD simulation while the 
interaction between atoms were described by tersoff potential [261]. They reported the 1
st
, 2
nd
, 
and 3
rd
 RDF of ZnS zincbelnde structure at 2.31, 3.81, and 4.46 Å, respectively [261], 
consistent with our results. 
 
 
Figure 76. Radial distribution of Zn-Zn and Zn-S and associated coordination numbers 
 
The lattice constant and cell volume of simulated ZnS are calculated as listed in Table 20 
which are 1.04% smaller than the experimental one. These two crystal parameters have been 
theoretically studied by some researchers using force field modeling [249] and linearized 
augmented planewave (LAPW) method [385]. The unit volume and lattice constant of ZnS 
using  LAPW and force field methods have been reported of v=152.80 Å
3
 and a=5.345 Å, and 
v=161.93 Å
3 
and a=5.45Å, respectively [249],[385]. In comparison with experimental and 
other theoretical studies, it could be deduced that ZnS crystal structure is successfully 
reproduced. 
Next step, incorporation of Mn atoms into ZnS lattice is simulated from developed potential 
by Wright [250], as mentioned in previous chapter (section D.4). RDF and corresponding 
integration of sphalerite MnZnS have been presented in Fig. 77 and summarized in Table 20.  
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Figure 77. RDFs and corresponding coordination number of  a) Mn-Mn, b) Mn-Zn, c) Mn-S, 
d) Zn-Zn and e) Zn-S, S-S of MnxZn1-xS (x=0.1, 0.2, 0.3) at 300 K and 1 bar 
 
As listed in Table 20, the shortest Mn-S interaction is occurs at the distance of 2.42 Å, which 
is in good agreement with the reported Mn-S distance measured by X-ray absorption 
spectroscopy (2.43-2.45 Å) [264]. From simulated Mn:ZnS crystal structure with different Mn 
dopant concentrations (10 to 30%), the first interaction of Mn-Mn atoms is at 3.87 Å. 
Referring to the calculated RDF, incorporation of Mn atoms into ZnS lattice affect the crystal 
structure of ZnS and causes the expansion of the tetrahedron structure of ZnS. This expansion 
has an effect on lattice constant. 
a) b) 
c) d) 
e) 
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As listed in Table 20, the lattice constant increases from 5.394 Å (Mn0.1Zn0.9S) to 5.429 Å 
(Mn0.3Zn0.7S) with increasing Mn concentration. Wright et al. has studied the crystal structure 
of Mn impurity incorporated within ZnS sites [250]. They have reported the shortest Mn-S 
distance at 2.41 Å and an increase of lattice constant of about +0.00064 Å per MnS% for 
substitution of one Mn atom in (ZnS)4 [250]. While for incorporation a second Mn into ZnS4, 
they have reported the first coordination of Mn-Mn pairs at the distance of 3.87 Å and less 
distortion of crystal structure [250]. The Mn-Mn first coordination in our study is at the 
distance of 3.87Å, consistent with the reported values by Wright et al [250]. Thereby, the 
increase of lattice constant with Mn dopant concentrations in our study is reliable and 
reasonable and in agreement with Wright and coworkers studies [250]. Moreover, some 
experimental studies have also reported the increase of lattice parameter and cell volume of 
Mn:ZnS with Mn dopant. For instance, Van et al. have reported an increase of lattice constant 
from 5.41 to 5.43 Å for the fabricated MnZnS with Mn dopant of 1%-15% [386]. The 
increase of lattice constant from 5.37-5.373 Å and cell volume from 154.9-155.15 Å3 of 
synthesized Mn-doped ZnS with different Mn concentrations in the range of 1% to 10% have 
also been reported by Mote et al. [387]. Due to the reported crystal parameters of Mn:ZnS 
either from simulations or from characterization, our simulated MnZnS nanoparticles with 
different Mn dopant concentrations are consistent.  
Table 20 . Characteristic sphalerite structure of MnZnS and ZnS from simulation and 
experiments 
 Mn0.1Zn0.9S Mn0.2Zn0.8S Mn0.3Zn0.7S ZnS Expt. 
Pair atoms 1
st
 g(r) 1
st
 n(r) 1
st
 g(r) 1
st
 n(r) 1
st
 g(r) 1
st
 n(r) 1
st
 g(r) 1
st
 n(r) 1
st
 g(r) 1
st
 n(r) 
Mn-Mn 3.87 0.22 3.87 2.90 3.87 3.80 ---- ----   
Mn-Zn 3.82 11.77 3.82 9.09 3.82 8.19 ---- ----   
Mn-S 2.42 4 2.42 4 2.42 4 ---- ----   
Zn-S 2.32 4 2.32 4 2.32 4 2.32 4 2.34 4 
Zn-Zn 3.77 10.08 3.77 9.67 3.77 8.62 3.78 12 3.82 12 
a (Å) 5.394 5.407 5.429 5.39 5.409 
Unit cell 
Volume (Å
3
) 
156.99 158.10 160.04 156.68 158.34      
*Expt. Results [249] 
 
Visualization of MD simulation was performed using the Aten software [388]. The structure 
of [110] surface of ZnS and MnZnS after relaxation are illustrated in Fig. 78. As observed in 
Fig. 78, S atoms are in upward in position compared with either Zn or Mn atoms in both 
structures. The movement of Zn and S atoms after relaxation of ZnS crystal structure has been 
studied by Wright et al. [247] and Duke et al. [389]. Both have reported the upward 
movement of S atom compared with downward movement of corresponding Zn atom. The 
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movement of atoms was attributed to the relative spacing changes between layers and atoms 
[247]. 
 
 
Figure 78. Surface [110] crystal structure of a) ZnS and b) MnZnS, yellow : S atom, red : Zn, 
and grey color : Mn 
 
Energy time-dependent of ZnS and MnZnS systems are presented in Fig. 79. It can be 
observed that the energy of all systems slightly fluctuates, with difference less than 0.05 eV, 
during simulation time, which infers all systems are fully relaxed. Employing the shell model 
developed by Wright et al. [246], the energy of ZnS system fluctuates around -30.15 eV, with 
reported values of -32.64 eV [248] and -33.46 eV [249].  While the incorporation of Mn 
atoms into ZnS system, the energy of the system per ZnS reduces to -33.61 (Mn=10%), -
33.53 (Mn=20%) and -33.43 eV (Mn=30%) with increasing Mn. In order to investigate the 
effect of Mn incorporation on the energy of system, we employed the complicated potential 
parameters used to simulate MnZnS structure. We observed that ZnS energy is fluctuating 
around -33.31 eV, which is close to those reported values [248], [249]. By comparing the 
simulated energy of ZnS and MnZnS using same potential parameters, it can be induced that 
the incorporation of Mn atoms in ZnS sites did not affect the energy of system. Referring to 
these results, reliability and accuracy of the generated sphalerite MnZnS structure can be 
demonstrated.  
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Figure 79. Time-dependent of potential energy (eV) of simulated ZnS and MnxZn1-xS (x=0.1, 
0.2, 0.3) crystal structure at 300K and 1bar 
 
D.2. Molecular dynamic simulation of water molecule 
 
The RDFs of water molecules are displayed in Fig. 80. As observed, the RDF of liquid is 
quite different from solid one. The RDF of liquid possesses broad peak and non-zero values at 
all separations compared with sharp peaks and zero minimum of crystal structure.  RDF of O-
O for SPC/E and TIP3P models shows respectively a first broad peak at 2.98 and 3.23 Å 
followed by a second peak at 5.65 and 6.13 Å. Referring to Fig. 80, O-O RDF of liquid water 
does not exhibit distinct minima after the first peak in both models. This suggests that there is 
interaction between water molecules in first and second coordination spheres which could 
facilitate the exchange of water molecules between those coordination shells.  Due to RDF of 
water, oxygen coordinated with two hydrogen atoms at distance of 0.95Å (SPC/E) and 0.98 Å 
(TIP3P).  
The diffusion coefficient of liquid water is one of the interesting properties. As presented in 
Table 21, the calculated diffusion coefficients of water from TIP3P and SPC/E models are 
respectively 38% and 2.7% lower compared to the experimental value of 2.30 (10
-5
cm
2
/s). 
Additionally, density of simulated water molecules are 1.021(g.cm
-3
) for TIP3P and 0.997 
(g.cm
-3
) for SPC/E models which are very close to the experimental density of 0.997 g.cm
-3
 
298 K. 
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Figure 80. Radial distributions gO-O(r), gO-H(r), and gH-H(r) with corresponding coordination 
number of water using SPC/E, and TIP3P models 
 
Table 21. Comparison of the characteristic properties of various water models and experiment 
at 298K 
Simulation )(rg OO  )(rg HO  deg,HOH
 D(x10
-5
cm
2
/s) ρ(g.cm-3) Ref. 
SPC/Fw ---- 1.012 113.24 2.32 ----- [392] 
SPC/E ---- 1.0 109.47 2.41 ---- [266] 
TIPS 2 2.79 0.9572 104.52 3.2 0.927 [393] 
TIP3P 2.74 0.9572 104.52 5.1 1.002 [393] 
TIP4P 2.74 0.9572 104.52 3.22 1.001 [393] 
TIP4P/EW ---- 0.9572 104.52 2.4 0.9954 [394] 
TIP4P/2005 ---- 0.9572 104.52 2.08 0.9979 [395] 
TIP5P ---- 0.9572 104.52 2.6 0.999 [393] 
TIP4P-FQ 2.92 0.9572 104.52 1.9 1.000 [396] 
TIP4P-QDP 2.91 0.9572 104.52 2.2 0.9951 [397] 
SPC 2.75 1.0 109.47 3. 6 0.964 [398] 
SPC/FQ 2.94 1.0 109.47 1.7 ---- [396] 
BF 2.72 0.96 105.7 4.3 1.181 [399] 
SPC/E 2.75 1.8 ---- 2.6 0.326 [400] 
GCPM 2.877 0.9572 104.52 2.26 1.004 [401] 
Shell  2.97 0.98 104.5 1.15 1.30 [402] 
SPC/E 2.98 0.98 --- 2.24 0.945 present work 
TIP3P 3.225 0.95 --- 1.41 1.021 Present work 
Exp. 2.97 0.98 104.5 2.30 0.997 [390], [391] 
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Since 1982, different potential functions have been developed to simulate liquid water. In 
order to compare our results obtained with those reported ones, different simulated water 
models and their characteristic RDF, diffusion coefficient, and density at 298K have been 
summarized in Table 21. In comparison, the results obtained herein show a very good 
agreement with the experimental and those reported ones [390], [391]. 
 
D.3. Molecular Dynamics simulation of ZnS molecules in water  
 
After reproducing the ZnS sphalerite nanoparticles within a few percent of the experimental 
values, a ZnS nanosphere with diameter 2.5 nm has been immersed to the center of the 
simulated cubic box of water. While each box contains the same number of water molecules 
but different models are used. The interaction of 228 (ZnS) surrounded with 1689 water 
molecules has been tracked by MDs. No distinguishable difference has been observed in RDF 
and corresponding CN of systems containing TIP3P or SPC/E water models.  Thereby, one of 
the calculated RDF is represented in Fig. 81 and in Table 22. As tabulated in Table 22, the 
radial distribution function of ZnS has been changed while it surrounded with water 
molecules. The RDF of Zn-Zn and Zn-S containes a sharp peak at 3.82 Å and 2.38 Å, 
respectively, followed by several small and broad peaks (Fig. 81). This chang can be 
attributed to the interaction of water molecules with Zn or S atoms. 
 
Table 22. RDFs of ZnS interaction with water molecules 
 ZnS in aqueous 
solution 
ZnS 
     
1
st
 peak g(r) n(r) g(r) n(r) 
Zn-Zn 3.82 10.28 3.82 12 
Zn-S 2.38 3.46 2.32 4 
Zn-O 2.025 1.28 ---- ---- 
Zn-H 2.80 1.17 ---- ---- 
S-O 3.38 5.45 ----- ---- 
S-H 2.73 1.91 ----- ---- 
 
There are three possible ways for bonding of water molecules with ZnS nanoparticles, such as 
Zn-O, S-O, and S-H. RDF curves of Zn-H and S-H contain several low-intensity peaks with 
nonzero g(r) minimum, attributing to the labile interaction of Zn and S atoms with H atom of 
waters. While RDFof Zn-O and S-O containes one sharp peak followed by several low-
intense peaks with nonzero minimum, ascribing to the rigid interaction between Zn and S 
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atoms with oxygen of waters in the first coordination sphere. As presented in Fig. 81, Zn-O 
pair contains one sharp peak at ~2.025 Å with a shoulder at 2.58 Å. While RDF of S-O pair in 
aqueous solution contain a relatively broad peak at ~3.38 Å.  The results obtained from MDs 
suggest that the interaction between Zn atoms with water molecules are stronger than S atoms 
with water. This could be related to the larger Zn and O Pauline electronegativities (3.44-
1.65=1.79) than S and H atoms (2.58-2.20=0.38) [267]. Thereby, the predominate interaction 
of water molecules and ZnS nanoparticles occurs between O and Zn atoms.  
 
   
 
 
Figure 81. RDFs and corresponding integration of  a) Zn-Zn, Zn-S, b)Zn-O, Zn-H, and c)S-H, 
S-O 
 
From MDs results, we observed that surface Zn atoms could bond with an average of two 
water molecules. The interaction of ZnS nanoparticles with water molecules has also been 
studied by Zhang et al. using temperature-programmed desorption (TPD) and MDs [267]. 
They reported that Zn atoms could adsorb 1 to 4 water molecules which depends on local 
structure of Zn atoms in the surface of ZnS nanoparticles [267]. For instance, Zn atoms on the 
surface could interact with higher number of water molecules [267]. 
a) b) 
c) 
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Furthermore, suspension of uncoated ZnS nanoparticles (diameter of 3 nm) in water has been 
characterized by EXAFS [403]. It has been reported that EXAFS spectrum of dispersed 
nanoparticles in water exhibited a peak at 2.348Å corresponding to Zn-S pair [403].  On the 
other hand, XRD studies of ZnSO4 in aqueous solution demonstrated that Zn ion at 2.083Å 
could coordinate with 6 water molecules [404]–[406] and with 8-13 water molecules at the 
second coordination shell [407]. On the other hand, Kawada et al. have demonstrated that Zn 
ions of ZnSO4 in aqueous solution coordinated with 2 water molecules at distance of 2.10Å 
referring to raman spectroscopy measurements [408]. In another research work, hydration of 
Zn ions in aqueous solution has been investigated by x-ray absorption spectroscopy [409]. 
The calculated multiple scattering and related EXAFS signals of Zn in aqueous solution 
revealed a first and second hydration shells at 2.06Å and 4.26Å with corresponding 
coordination number of 6.02 and 11.6, respectively.  Referring to the experimental reported 
results, the first coordination of Zn-O pair is at the distance about 2.06 Å, which is close to our 
results (2.02 Å). The coordination number of Zn with water molecules in our study is close to 
reported Raman spectroscopy measurements.  
 
Figure 82. Time -dependent of potential energy (eV), Temperature (K), and pressure (kbar) of 
ZnS in aqueous solution  
 
Time-dependence of temperature, pressure and potential energy of the system including ZnS 
nanoparticles and SPC/E or TIP3P water models have been exhibited in Fig. 82. The 
significant difference is observed in energy of the system. Energy of system with SPC/E water 
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(-5449,11)  is ~ 100 eV lower than the one of TIP3P water (-5356,56). This difference in 
energy is attributed to the different water models. 
 
D.4. Molecular dynamics simulation of Mn atoms interaction with 
water molecules 
 
In order to study the structure of MnZnS within the liquid, we need to study the interaction 
between Mn ions and water molecules. Mn-H and Mn-O RDFs with their running integration 
have been presented in Fig. 83. The first RDF peak of Mn-O and Mn-H are centered at 2.12 Å 
and 2.67 Å, respectively. The second hydration shell of Mn atom appeared ranging from 3.08 
Å to 5.63 Å with maximum at 4.075 Å.   In RDF of Mn-H, the second peak appears in the 
range of 3.48-6.03 Å with the maximum at 4.72 Å. Compared to first shell, second RDF peak 
of both Mn-O and Mn-H pairs are much broader with nonzero value at the minimum.  
Referring to running integration of Mn-O RDF, Mn atom is surrounded with the  six water 
molecules at first hydration shell. Moreover, number of coordination at second shell exhibits a 
mean value of 18.5 water molecules. From Mn-H RDF integration, Mn atom surrounded with 
12.03 and 38.26 hydrogen atoms at first and second shell, respectively. 
 
 
Figure 83. RDFs and corresponding coordination number of  Mn-O, Mn-H 
 
From RDF of Mn-O, the inter shell region between first and second shell maintains at zero 
with distinguishable distance. Thus, it could be inferred that no exchange occurred during 
simulation time between these hydration shells. The broad peak with nonzero g(r) minimum 
at second shell indicates rapid exchange between water molecules during simulation times. 
 
 
142 
 
From coordination number of Mn-O at first and second hydration shell, we could induce that 
each water molecule at first shell interacts with 3.08 water molecules at second shell.  
The structure of Mn atom surrounded with water molecules has been little studied. The 
interaction of Mn atom with water molecules have been simulated via classical Monte Carlo 
(MC), Molecular dynamic simulation (MD), and Quantum mechanical and molecular 
mechanical (QM/MM) types [410]. The reported results are summarized in Table 23. 
Schewank and colleagues have also studied Mn-water interaction via QM/MM simulation 
including three body potential [411]. The first and second RDF of Mn-O has been reported at 
2.25Å  (CN= 6) and 4.4Å (CN=15.9), respectively [411]. Among the results obtained from 
different method of simulations, the results obtained from QM/MM simulations are reported 
to be much closer to the experimental values [410]. 
 
Table 23. The characteristic RDF obtained from MC, MD, QM/MM simulations 
method Pair atoms r1 n1 r2 n2 
MC
1 
Mn-O 2.23 8.90 4.59 22.83 
Mn-H 2.92 17.4 4.82 53.44 
MD
2 
Mn-H 2.22 8.74 4.42 22.74 
Mn-O 2.94 19.11 4.98 53.13 
QM/MM
3 
Mn-O 2.28 6.74 4.00 18.06 
Mn-H 2.84 13.67 4.80 48 
1. One Mn(II) ion and 199 water molecules, 298.16 K, cutoff=9.117 Å, ρ=0.997 g cm
-3
, NVT,  CF2[412] 
potential for water-water interaction and MCY[413] for ion-water interaction 
2 same as MC with time step=0.2fs 
3 same as MC, system equilibrated at 4.2 ps, NVT ensemble, ab initio molecular orbital calculation, Hartee-
Fock energy for many body effects 
 
Furthermore, X-ray scattering spectroscopy studies of Mn ions in aqueous solution approves 
the octahedrally coordination of Mn ions with water molecules at first coordination shell at 
2.20Å [414]. Compared with those published results, our results are in good agreement with 
RDF of QM/MM MD simulation. Thereby, the interaction of Mn ion with water molecules 
has been successfully simulated using Buckingham potential for describing the Mn-water 
interactions which agrees adequately with experimental values.  
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D.5. Molecular dynamics simulation of MnZnS molecules interaction 
with water molecules 
 
Finally, the interaction of MnZnS with water molecules has been studied by MDs. The RDF 
calculated from MD is presented in Fig. 84 and in Table 24. By comparing the RDF of 
Mn:ZnS nanoparticles in water, RDF of all three systems are similar and RDF of all atomic 
pairs contain a sharp peak at the first coordination and small broad peaks at the second and 
third coordination spheres with nonzero g(r) minimum. Referring to RDF curves, Mn-Mn, 
Mn-Zn and Mn-S curves significantly change compared with those of MnZnS crystal Mn-Mn 
RDF contains one sharp peak following two broad peaks while each broad peak includes 
several low-intense peaks. In comparison with RDF of ZnS-surrounded with water molecules, 
Zn-O, S-H, and S-O RDF peaks of MnZnS-H2O shifted to lower r-distance. Moreover, RDF 
peak of Zn-Zn, Zn-S, S-O, and S-H pairs did not significantly change in MnZnS-H2O and 
ZnS- H2O, Table 24. As listed in Table 24, the CN of Mn-Mn pair of MnZnS decreases to ~1 
from solid state to aqueous systems. This could be attributed to strong interaction of Mn 
atoms on the surface with water molecules which reduces the Mn-Mn interactions. 
 
Table 24. RDF and CN of first coordination shell obtained for MnxZn1-xS -H20 (x=0.1, 0.2, 
0.3) and ZnS+ H2O 
Atomic 
pairs 
Mn0.1Zn0.9S +H2O Mn0.2Zn0.8S +H2O Mn0.3Zn0.7S +H2O ZnS+ H2O 
1
st
 g(r) 1
st
 n(r) 1
st
 g(r) 1
st
 n(r) 1
st
 g(r) 1
st
 n(r) g(r) n(r) 
Mn-Mn 3.87 1.04 3.77 0.57 3.87 1.59 ---- ---- 
Mn-Zn 3.77 5.22 3.77 5.92 3.77 6.22 ---- ---- 
Mn-S 2.37 2.74 2.37 2.74 2.37 2.74 ---- ---- 
Zn-S 2.20 3.68 2.27 3.65 2.32 3.59 2.38 3.46 
Zn-Zn 3.79 8.41 3.77 8.49 3.72 8.58 3.82 10.28 
Mn-H 2.62 7.25 2.72 7.25 2.77 7.25 ---- ---- 
Mn-O 2.37 2.74 2.37 2.74 2.37 2.74 ---- ---- 
Zn-H 2.62 0.82 2.62 0.82 2.62 0.82 1.88 0.55 
Zn-O 1.97 0.36 1.97 0.36 1.97 0.36 2.48 1.17 
S-O 3.27 3.07 3.27 3.07 3.27 3.07 3.38 5.45 
S-H 2.62 2.70 2.62 2.70 2.62 2.70 2.73 1.91 
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Figure 84. RDFs and corresponding CN of Mn-Mn, Mn-S, Mn-Zn, Mn-O, Mn-H, Zn-O, Zn-
H, and S-O of MnxZn1-xS (x=0.1, 0.2, 0.3) nanoparticles in aqueous solution 
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Mn atoms at first coordination shell coordinated with ~3 oxygen and ~7 hydrogen atoms. The 
sharp and intense peak of Mn-O RDF could confirm the strong interaction between these two 
atomic pairs. If we consider the number of oxygen as the number of coordinated water 
molecules, Zn atoms at ~2Å coordinated with 0.5 water molecules while Mn atoms 
coordinated with ~3water molecules.  
From a snapshot of MnZnS presented in Fig. 85, each Mn bonds with higher water molecules 
(1 to 3 ), compared with 1 to 2 water molecules bonded with Zn sites in ZnS-H2O system. 
From the high CN and short distance of Mn-H2O, the short relaxation time is acceptable. 
Moreover, the long distance of ~1Å between 1st  and 2nd coordination sphere could confirm the 
strong bonding of Mn atoms with water molecules in 1
st
 sphere with long residency time 
while these water molecules are still in exchange with water molecules of 2
nd
 sphere due to 
nonzero g(r) minimum. On the other hand, 2
nd
 coordination sphere of Mn-O is very labile 
which leads to faster exchange rates with those of outer sphere referring to close 2
nd
 and 3
rd
 
RDF peaks of Mn-O pairs. Although we need to improve the simulation conditions of 
nanoparticles by including the mercaptoacetic acid coating around nanoparticle to exactly 
predict the relaxation mechanism of MnZnS in aqueous solution, these primarily RDF results 
could explain very well the short relaxation times of MnZnS in aqueous solution (high 
relaxivity).  
 
Figure 85. Snapshot of relaxed system containing water molecules and MnZnS nanoparticles 
 
 
In Fig. 86, we have presented the energy of MnZnS-H2O system over 30 ps (simulation time). 
Energy of system increases from -67691 eV to -66927 eV with increasing the Mn doping 
concentrations from 10% to 20% then reduce to -67685 eV for Mn=30%.  
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Figure 86. Time-dependent of potential energy (eV) of Mn0.1Zn0.9S, Mn0.2Zn0.8S, and 
Mn0.3Zn0.7S surrounded with water molecules 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter V: Conclusion 
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A. Conclusion 
 
Recently, molecular imaging has received tremendous attention referring to their ability to 
visualize the cellular function of organisms which could help in the diagnosis of disease, 
including cancer and neurodegenerative disease, meantime simultaneously providing 
biological information [415]. MRI is emerging as a powerful diagnostic tool by providing 
high resolution anatomical images. The source of the most of contrast observed in MRI is the 
relaxation time differences. One way to enhance the contrast of MR images is to administer 
the paramagnetic substances, which could alter the proton relaxation times. After the first 
report of administration of paramagnetic substance to enhance the relaxation of water protons 
in 1946 [416], great efforts have been spent on developing the paramagnetic MRI contrast 
agents providing high contrast, low toxicity, high stability, tumor targeting and longer 
imaging time window. On the other hand, due to increasing the interest towards high-field 
MRI, designing the CA, which possesses the high relaxivity at high magnetic field, is a 
crucial issue in designing the contrast agents referring to decrease the relaxivity of majority 
MRI CA at high magnetic field. The work presented in this thesis is the development of two 
novel MRI contrast agent such as macromolecules and nanoparticle paramagnetic contrast 
agents exhibiting high solubility, and high efficiency (high relaxivity) at high field (3T).  
The first compound studied is Gd (III) meso-tetrakis (4-pyridyl) porphyrin (Gd(TPyP))(OAc). 
The potential of Gd(TPyP) in aqueous solution has been studied via NMR relaxometry (20 
MHz) and MRI (60 MHz), meanwhile, its efficiency has been compared with those of 
cationic iron(III) meso-tetrakis(4-N-methyl-pyridiniumyl) (Fe(TMPyP)) and ionic 
manganese(III) meso-tetra(4-sulfonatophenyl)porphyrins (Mn(TSPP)) in aqueous media. 
Compared with evaluated relaxivity of Fe(TMPyP) and Mn(TSPP) in water, Gd(TPyP) has 
shown the highest relaxivity of 26 mM
-1
s
-1
 which is 8 times greater than r1 of commercial Gd-
DOTA ( ~4.1 mM-1s-1) at 20 MHz. While with increasing magnetic field to 60 MHz, r1 of 
Gd(TPyP) did not change significantly (~24 mM
-1
s
-1
). The in-vitro relaxivity studies of 
Gd(TPyP) have shown the feasibility of Gd(TPyP) to be used as MRI CA. Thus, in order to 
enhance the biomedical application of Gd(TPyP) and its water solubility, Gd(TPyP) has been 
conjugated to synthesized chitosan nanoparticles (CNs).  The potential of spherical 
Gd(TPyP)-CNs as MRI contrast enhancement, with a diameter in the range of 45-64 nm and 
hydrodynamic radius of 412 nm, has been investigated via MRI 3T. The nanoparticles of 
Gd(TPyP)-CNs exhibit r1 of 38 mM
-1
s
-1
with r1/r2 ratio of almost 1 (0.86). Thereby, 
conjugation of Gd(TPyP) complex with chitosan nanoparticles leads to enhanced water 
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solubility and relaxivity of Gd(TPyP) referring to increase the rotational correlation time, 
enhancing the accessibility of water, and an increase in the amount of paramagnetic ion 
loaded into a nanoparticle. Thus, this novel nanosized macromolecular contrast agent could be 
a good candidate as T1 contrast agents for further studies.  
The second developed contrast agents is Mn-doped ZnS QDs that the majority of Mn atoms 
are localized on the surface of atoms. The relaxivities of Mn:ZnS with Mn dopant content in 
the range of 10% to 30% have been performed. MnxZn1-xS colloids (x=0.1, 0.2, 0.3) have 
shown great ability to enhancing the signal intensity on T1 images at low concentrations (less 
than 0.1 mM). Owing to the high r1 which increases from 20 to 84 mM
-1
s
-1
 with increasing 
Mn content is confirmation of our hypothesis to enhance the efficiency of nanoparticles by 
conjugating of metal ions close or on the surface of nanoparticles.  Meanwhile, for further Mn 
dopant of 30% the r1 decreases to 75 mM
-1
s
-1
. This reduction could be attributed to the 
dipolar interaction of Mn atoms, causing the decrease of electronic relaxation times and 
reduction in the overall relaxivity. In order to study the effect of particle size of nanoparticles 
on reducing this dipolar interaction, different sizes of Mn0.3Zn0.7S nanoparticles have been 
synthesized and their potential as enhancing MR contrast images has been studied. We 
observed that the volume to surface ratio has the predominant affect on their relaxivity which 
causes the decrease of r1 from 75 mM
-1
s
-1
 to 40 mM
-1
s
-1
 with increasing diameter of 
nanoparticles. Comparing with r1 of conventional Mn contrast agents (Mn-DPDP) 
(Teslascan®, r1=2.1 mM
-1
.s
-1
 at 1.5T ), the relaxivities of synthesized Mn-doped ZnS are 
much higher (20 times). Thereby, the high relaxivity of Mn:ZnS nanoparticles could be 
attributed to the high surface to volume ratio, high accessibility to water molecules, and short 
distance between Mn ions and water molecules.  
In order to obtain further insight into relaxivity mechanism of Mn:ZnS nanoparticles in 
solution, molecular dynamic simulation (MDs) has been carried out. The crystal structure 
Mn:ZnS with different Mn dopant in the range of 10% to 30%, incorporating on the outer 
surface of ZnS sites, has been reproduced very well using MDs. The calculated lattice 
parameter and cell volume of MnZnS crystal increase from 5.40 to 5.42Å and 156 to 160 Å3 
with Mn dopant which are in good agreement with the experimental reported ones [386]. 
After confirming the reliability of the modeled MnZnS crystal, we developed the potential to 
describe the interaction of MnZnS nanoparticles with water molecules. The simulated radial 
distribution and corresponding coordination number of MnZnS-H2O system give us the 
preliminary explanation of relaxivity mechanism of MnZnS nanoparticles in aqueous solution. 
The water molecules could form the bond with MnZnS nanoparticles via formation of Mn-O, 
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S-O, S-H, Zn-O. Referring to the calculated RDF, the interaction between Mn and O atoms is 
the predominant.  The Mn interacts with ~3 water molecules at shortest distance of 2.37Å for 
all three different MnZns nanoparticles. Due to the sharp RDF and distinguishable distance 
between 1
st
 and 2
nd
 hydration shells, it could be predicted that those water molecules in first 
sphere form strong bond with Mn atoms. Meanwhile, there is still an exchange between water 
molecules in 1
st
 and 2
nd
 sphere shell due to minimum nonzero RDF. The results obtained from 
MD could give us the primary insight about the short relaxation mechanism of MnZnS 
nanoparticles. 
 
B. Prospective 
 
Incorporation of metallated porphyrin into chitosan nanoparticles is a relatively new class of 
complex that is in the early stage of the research. Thereby, the extensive work shall be 
performed to promote this new type of complex to be used in molecular imaging and 
nanomedecine contexts. Several key parameters such as their toxicity, biodistribution, 
pharmacokinetics and ability in enhancing the tumor cell visualization could be considered as 
future work direction. The chitosan could interact with the negatively charged of neoplastic 
cells membrane due to its positive charge of amino group. This interaction leads to inhibit the 
growth of cancer cells, reduce the membrane permeability, and decrease the spread of cancer 
cells by metastasis. However, chitosan could interact with healthy and normal cell membrane 
without such effects. This is so interesting for cancer therapy. Thus, metallated porphyrin 
incorporated into chitosan nanoparticles could be considered as a diagnostic imaging and 
simultaneously as a therapeutic agent. Furthermore, the surface of the compound could be 
encapsulated with folic acid (FA) in order to improve their cellular uptake. Combination of 
targeting capability of FA and biocompatibility of chitosan [417] could greatly enhance the 
uptake of metalloporphyrin-conjugated chitosan nanoparticles into tumor cells combined with 
prolonged blood circulatory time of nanoparticles.  
Although, localization of paramagnetic ions on the surface of QDs opens a new window in 
improving their potential as MRI CA, the study the toxicity, kinetic stability of nanoparticles 
and improving their tumor targeting would be stated as the second prospective.  Moreover, in 
order to improve the reliability of the molecular dynamic simulation results with experimental 
in-vitro MRI studies, the future direction of the simulation studies could be conducted by 
studying the interaction of MnZnS-coated with mercaptoacetic acid with water molecules. 
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1. Introduction 
 
L’imagerie par résonance magnétique (IRM) est une technique de diagnostic très utilisée. 
Malheureusement, la différence entre tissus sains et altérés est souvent insuffisante pour 
provoquer une variation sensible de l’intensité du signal, ce qui a motivé le développement  
des agents de contraste (AC) d’augmenter  le  contraste  entre  les  parties  saines  et  malades  
des  tissus. Un effort considérable a été consacré à la conception des agents de contraste, qui 
présente à la fois une relaxivité élevée, une haute stabilité, une faible toxicité , et une grande 
spécificité tissulaire.  
Le ligand macrocyclique est un chélateurs de métaux intéressant en raison de sa stabilité 
thermodynamique et cinétique élevée [1]. Parmi le chélateur macrocyclique étudié en 
préclinique, la porphyrine a été très analysée en raison de sa fonction de capture préférentielle 
par les cellules tumorales (y compris les sarcomes , les carcinomes, et la plaque d'athérome ) 
[2] , alors que les mécanismes de cette sélectivité restent un obscur jusqu'à maintenant. Après 
le premier travaux sur l’efficacité élevée de la Mn (II)–méso-porphyrine soluble dans l’eau [3] 
, le potentiel de divers Mn (II) et Fe (II) méso-porphyrins soluble dans l’eau comme agents de 
contraste IRM a été exploré. Néanmoins, la faible stabilité de la Gd (III)–méso-porphyrine 
soluble dans l’eau a limité le développement de ces complexes [4]. La métallo-méso-tétra-
pyridyle porphyrine (MMTPyP) comprend un étirement axial ligand du fait de la coordination 
du métal avec un atome d'azote provenant d’une molécule de porphine adjacente [5].  La 
solubilité du complexe MMTPyP pourrait être obtenue chimiquement par encapsulation ou 
par liaison covalente à la surface des nano vecteurs, conduisant à améliorer la 
biocompatibilité et à éviter la libération d'ions paramagnétiques. Parmi les polymères étudiés 
pour réaliser un ciblage cellulaire, le chitosane a reçu beaucoup d'attention dans les domaines 
de la délivrance ciblée de médicaments et de l'imagerie moléculaire [6]. Nous proposons 
d’utiliser des nanoparticules de chitosane formant un complexe conjugué de la Gd(III) méso -
tétra- pyridyle porphyrine pour améliorer sa biocompatibilité médicale, sa solubilité dans 
l’eau et d’augmenter son efficacité en IRM. 
 
Le développement actuel de sondes d’imagerie multifonctionnelles permet d’avoir accès à des 
sources d’information complémentaires. Les quantum dots (QD) dopés par des ions 
paramagnétiques sont particulièrement étudiés pour être utilisés dans ce cas. Les QD dopé par 
des ions Mn(II) est l'un des QD les plus étudiés dans le domaine d’imagerie médicale. Bien 
que, la recherche a surtout été axée sur son potentiel comme un bio-marqueur fluorescent [7], 
 
 
xvi 
 
son efficacité comme un agent de contraste IRM est moins bien étudié. En plus, la majorité 
des QD dopés par Mn(II) se présentent sous la forme de particules constituées d’un cœur 
recouvert d’une coquille. Envisager le griffage des ions sur la surface des nanoparticules 
constituerait une nouvelle approche de conception des sondes multimodales (IRM et 
fluorescence) qui pourraient améliorer l’efficacité des nanoparticules en IRM et parallèlement 
ne pas changer les propriétés de fluorescence de QDs.  
Outre les études expérimentales, l’utilisation de simulations pourraient être une technique 
utile pour obtenir des informations détaillées sur la structure, le comportement 
intramoléculaire en solution aqueuse et la dynamique des molécules [8]. La simulation en 
Dynamique Moléculaire (DM) est une des techniques numériques les plus utilisées pour 
rapprocher les propriétés macroscopiques du système en permettant de simuler son évolution. 
Par conséquent, la modélisation de l’eau au voisinage des AC par Dynamique Moléculaire 
aide à l’obtention d’un aperçu fiable sur leur relaxivité grâce à l'interaction entre les ions 
paramagnétiques et l'eau. 
 
Objectif de la thèse  
 
Ma thèse a été consacrée à concevoir et à développer deux classes d’agents de contraste 
(AC) intrinsèquement efficace en IRM.  
1. Développer un complexe de Gd-méso-tétra-pyridyle porphyrine conjugué avec des 
nanoparticules de chitosan, susceptible d’avoir des applications biomédicales grâce 
au chitosane capable d’améliorer la biocompatibilité, la biodégradabilité, et muco-
adhésif in-vivo.  
2. Développer le concept de greffage de Mn dopé à la surface de nanoparticules ZnS, 
avec des concentrations de Mn élevés, afin d’améliorer l’accessibilité de l’eau au 
moment magnétique du Mn. Afin d'obtenir un aperçu significatif sur l’interaction de 
Mn: ZnS avec des molécules d'eau environnantes, la simulation dynamique 
moléculaire sera effectuée pour mieux comprendre les mécanismes de relaxation de 
nanoparticules de Mn :ZnS  dispersés dans l'eau. Les résultats de la relaxivité r1 
expérimentale en fonction de la concentration de la teneur en Mn sont mis en 
corrélation avec les résultats obtenus par dynamique moléculaire. 
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2. Protocole 
2.1. Synthèse de Gd(TPyP)-NC 
 
Les Gd(TPyP) ont été synthétisées selon la méthode développée par Adler [9]. Les 
nanoparticules de chitosane (NC) ont été préparées à partir de la méthode décrite par Fan et al. 
[10]. Ensuite, la Gd(TPyP) a été encapsulée par des nanoparticules de chitosane (NC) par 
conjugaison chimique et absorption passive. En conjugaison chimique, la Gd(TPyP) peut être 
directement ajoutée à la solution de chitosane ou de sodium triphosphate pentabasic (TPP), 
précédant la procédure de formation des NC. Le chargement passif a été étudié en mélangeant 
les NC avec la métalloporphyrine pendant 15 minutes. Le mélange a été dissout dans l'eau 
distillée sous agitation magnétique pendant 15 minutes à 4°C. La centrifugation a été utilisée 
pour séparer la Gd(TPyP) et ainsi recueillir le complexe Gd(TPyP)-NC. 
 2.1.1. La Caractérisation du Gd(TPyP)-NC 
L’efficacité de la Gd(TPyP) dans l’éthanol a été étudiée par relaxométrie RMN à 20 MHz 
(37°C) et IRM à 60 MHz (25°C). Leurs relaxivités ont été comparées avec deux produits de 
référence : la Mn(III)-méso-tétra(4-sulfonatophenyl) porphyrine (Mn(III)TSPP) et la Fe(II)-
méso-tétra(N-methylpyridinium) porphyrine (Fe(II)TMPyP). Les dimensions et la 
morphologie de surface des NC et de la Gd(TPyP) ont été caractérisées par diffusion 
dynamique de la lumière et microscopie électronique à balayage (MEB). Un spectromètre 
d'absorption ultraviolet-visible et un spectromètre de masse couplé à un plasma inductif ont 
été utilisés pour déterminer les concentrations de Gd(TPyP) dans les particules. Les types de 
liaisons dans le Gd(TPyP)-NC ont été étudiés à l’aide de la spectroscopie d’absorption 
infrarouge en comparant les spectres IR à ceux des Gd(TPyP) et des NC. Les pourcentages 
d’efficacité (%LE), de capacité de chargement (%LC), et du rendement des nanoparticules ont 
été calculés en utilisant les équations (4), (5), (6) suivantes : 
Efficacité de chargement (%) =(
𝐴−𝐵
𝐴
) 𝑥100                                   (4) 
Capacité de chargement (%) = (
𝐴−𝐵
𝐶
) 𝑥100                                   (5) 
Rendement (%) = 
𝑊1
𝑊2
𝑥100                                             (6) 
A, B, et C sont respectivement la quantité initiale de Gd(TPyP), la quantité de Gd(TPyP) 
après centrifugation, et le poids de NC. W1 correspond au poids du Gd(TPyP)-NC récupéré 
après lyophilisation alors que W2 réfère à la somme du poids sec initial de NC et Gd (TPyP). 
L’IRM de Gd(TPyP)-NC dispersés dans l'eau a été réalisée avec un appareil IRM 3T (Philips 
ACHIEVA TX) à 25°C. Les relaxivités longitudinale et transversale des colloïdes préparés 
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ont été évaluées à partir des images pondérées en T1 et T2. Les images pondérées en T1 et T2 
sont obtenues à partir de la séquence en spin écho. 
 
2.2. Nanoparticules de Mn : ZnS 
 
Les nanoparticules de MnxZn1-xS avec x= 0,1 ; 0,2 ; 0,3 ont été synthétisées par la méthode de 
polyol en utilisant le protocole décrit en [10]. Les différentes tailles de Mn0.3Zn0.7S ont été 
recueillies par centrifugation à différentes vitesses de rotation.   
2.2.1. La caractérisation 
La structure cristalline et la microstructure de Mn:ZnS ont été caractérisées en diffraction des 
rayons X (DRX) avec un rayonnement Cu Ka (=1,54 Å) et par microscopie électronique en 
transmission à haute résolution (TEM). L’efficacité du dopage et les variations de 
composition chimique de l’échantillon ont été vérifiées à l'aide d'un spectromètre à dispersion 
d'énergie (EDX) et d’un spectromètre de fluorescence X. Ensuite, l’efficacité des 
nanoparticules de Mn:ZnS pour l’IRM et la fluorescence optique a été étudiée en utilisant la 
spectroscopie de fluorescence et l'IRM 3T à 25°C. 
 
2.3. Simulation de Dynamique Moléculaire  
 
La dynamique moléculaire nous donne la possibilité d'étudier la dynamique réelle du système 
pendant le temps de la simulation. En dynamique moléculaire, la position atomique du 
système est prévue en appliquant les équations du mouvement de Newton. Par conséquent, 
l'état du système à tout moment peut être prédit à partir de son état actuel. Une discrétisation 
du temps permet de calculer, à chaque pas et pour chaque atome, les forces d’interaction qui 
résultent de potentiels préétablis. Ainsi, le principe fondamental de la dynamique donne accès 
aux accélérations, aux vitesses et donc aux déplacements de chaque atome. Il est par ailleurs 
possible de contrôler la température et/ou la pression du système simulé en corrigeant les 
vitesses et trajectoires sur des périodes limitées.  Une telle technique de simulation peut donc 
permettre d’aboutir à une meilleure compréhension de la dynamique microscopique de 
MnZnS en solution aqueuse. C’est pourquoi nous avons simulé par dynamique moléculaire le 
système MnZnS, d’une part dans le vide, et d’autre part dans l’eau. 
La configuration initiale des atomes MnZnS a été construite à partir des coordonnées 
atomiques de la structure crystalline de ZnS-blende. On a utilisé les potentiels interatomiques 
de Wright pour l'incorporation des impuretés dans la structure ZnS. Deux modèles tels que la 
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TIP3P (transferable intermolecular potential 3 potentiel) [11], et la SPC / E (extended simple 
point charge) [12] ont été utilisés pour la simulation des molécules d'eau.  
Dans le modèle cœur-coquille de MnZnS, Zn et S atomes dans la molécule ont été modélisés 
par un cœur avec la masse nulle (ou très léger) relié à un coquille, qui contient toute la masse 
atomique, par un ressort harmonique. La somme des charges de cœur-coquille doit être égale 
à la charge totale des atomes. Le potentiel est décrit comme suit  
2
2
1
ijij Kru   
Où K est la force constante et rij est la distance entre l'atome i et j. L’interaction des termes à 
courte portée entre l'atome i et j atome a été démontrée par le potentiel de Buckingham 
6
)exp(
ij
ij
ij
ij
ijij
R
CR
Au 

 
Où Rij est la distance entre deux atomes i et j, et Aij, ρij, Cij sont trois paramètres fixés du 
modèle dépendent des atomes en interaction. Le potentiel des trois corps a été considéré entre 
S-Zn-S 
2)(
2
1
ijkijkij Ku    
Lorsque θijk est l'angle formé par un atome de Si et Znj (au centre) et Sk, θ est la valeur de 
l'angle à l'équilibre (109,4 °), et k est le paramètre du modèle. Ces paramètres ont été 
répertoriés dans le tableau 1. 
 
Tableau 1. Paramètres du potentiel pour la simulation de la structure blende MnZnS. 
Buckingham  
Atomic Pair A (eV) ρ(Å) C(eVÅ6) Cutoff(Å) 
Mn-S 750.686175 0.390889 0.0 12.0 
S-S 1200.0 0.149 0.0 12.0 
Zn-S 528.8990 0.4110 0.0 12.0 
Trois Coeur  
Atomic Pair K(eVrad-2) Θ0(deg) ρ1/ρ2(Å) Cutoff(Å) 
SS-Zn-SS 9.4283e-6 109.47 0.3 6.0 
cœur-coquille 
Atomic Pair Mass Charge K(eVÅ-2)  
S(Core) 30.0 1.357 --  
S(Shell) 2.0 -3.357 13.302743  
Mn 54.0 2.0 --  
Zn 65.0 2.0 --  
 
Enfin, les interactions des nanoparticules MnxZn1-xS (x = 0,1 ; 0,2 ; 0,3) avec les molécules 
d'eau ont été simulées en utilisant le potentiel de Buckingham dont les valeurs sont indiquées 
dans le tableau 2.  
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Tableau 2. Valeurs du potentiel pour modéliser les interactions entre les nanoparticules de 
MnZnS et les molécules d’eau. 
Atomic pair A(eV) r(Å) C(eVÅ
6
) 
S-O 41399.49  0.2039  0 
S-H 4268.15  0.3686  965.33 
Zn-O 14974.51  0.186011 0.0 
Mn-O 25974.51 0.188011 20 
 
3. Résultats 
3.1. Efficacité de Gd(TPyP) en IRM 
 
L’efficacité de la Gd(TPyP) dans l’éthanol a été évaluée par relaxométrie RMN à 20 MHz 
(37°C) et IRM à 60 MHz (25°C) en comparant les résultats avec les produits de référence : 
Mn(TSPP), Fe(TMPyP), et Gd-Dota. Les résultats de relaxométrie RMN obtenus sont 
représentés dans le tableau ci-dessous (tableau 4). Parmi les complexes étudiés, le T1 et le T2 
de la Gd(TPyP) sont plus courts à ceux du Mn(TSPP), du Fe(TMPyP) et du Gd-Dota. Le T1 
varie de 194 ms à 33 ms pour une concentration Gd(III) allant de 0,1 mm à 1 mm. Les 
relaxivités de Fe(TMPyP), Mn(TSPP) et Gd(TPyP) ont été regroupées dans le tableau 4. 
Parmi les trois métalloporphyrines étudiées, la Gd(TPyP) montre la r1 la plus élevée, 26 mM
-
1
s
-1
, tandis que la Fe(TMPyP) exhibe la r1 la plus basse avec 3,7 mM
-1
s
-1
. 
 
Tableau 4. Valeurs de T1, T2, r1 et R2 pour les porphyrines Mn(TSPP), Fe(TMPyP) et 
Gd(TPyP) et Gd-Dota à 20 MHz. 
Mn(TSPP) dans l’eau Fe(TMPyP) dans l’eau Gd(TPyP) dans l’éthanol Gd-Dota dans l’eau Gd-Dota dans Les 
mélanges eau-éthanol 
mM T1(ms) T2(ms) mM T1(ms) T2(ms) mM T1(ms) T2(ms) mM T1(ms) T2(ms) mM T1(ms) T2(ms) 
0.1 244 226 1 1190 428 0.1 194 167 0.6 484 395 1 446 381 
0.3 149 137 2 467 148 0.3 66 55.4 5 41.1 34.1 5 75.3 53.7 
0.5 81.6 74.6 3.5 283 87.5 0.6 45 22.4 7 28.6 23.6 7 48.8 39.4 
1 27.1 24.4 10 147 46.2 1 33 15.6 9 24.3 20.2 9 32.1 27.3 
  Relaxivité (mM-1s-1) 
r1 r2 r1 r2 r1 r2 r1 r2 r1 r2 
6.63 21.43 3.70 4.12 26.43 68.47 4.1 5.02 3.51 4.12 
 
D'autres études de l'efficacité de trois métalloporphyrines ont été réalisées en utilisant l'IRM à 
3T. Les images pondérées en T1 et T2 de Mn (TSPP) et Fe (TMPyP) en solution aqueuse ont 
été présentés à la figure 1. On peut noter une augmentation de l'intensité des signaux en T1 
avec la concentration d'ions paramagnétiques, inversement pour T2. 
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Figure 1. Écho de spin pondérée T1 (TR = 400 ms, TE = 8 ms) et T2 (TR = 1500 ms, TE = 40 
ms) de concentration différente de Mn (TSPP) et Fe (TMePyP) dans l'eau à 3T 
 
Aussi bien, figure 2 représente T1 et T2 pondérés de Gd(TPyP) et Gd-Dota dans des milieux 
aqueux. Nous avons observé (figure 2) que la Gd(TPyP) avec une concentration faible (10 
fois) produit des signaux plus intenses en T1 et plus bas en T2, par rapport à ceux des Gd-
DOTA. 
 
 
Figure 2. Écho de spin pondérée T1 (TR = 400 ms, TE = 8 ms) et T2 (TR = 1500 ms, TE = 40 
ms) de concentration différente de Gd(TPyP) dans l'éthanol, Gd-Dota dans l’eau et dans le 
mélange de l’eau et l’éthanol à 3T 
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Par ailleurs, comme la relaxivité dépend des paramètres comme le champ magnétique 
appliqué et la température.  On a évalué les valeurs de r1 et r2 de Gd(TPyP) en milieu aqueux 
en comparant avec ceux de Gd-Dota à 3T (figure 3). Ces valeurs sont comparées à celles 
mesurées à 0.47T (37°C) à la figure 3. On a observé une diminution (très petit) de r1 et une 
augmentation de r2 avec le champ magnétique. 
 
 
Figure 3. r1 et r2 relaxivité de Gd (TPyP) et Gd-DOTA solution à 3T (25 °C) et 0.47 T (37 
°C) 
 
Dans la littérature, la r1 de Fe(TMPyP) a été rapporté dans la gamme entre 4,4 et 1,3 mM
-1
s
-1
 
(à 10 MHz) avec une augmentation respectée du pH de 1 à 10 [13]. Cette dépendance est liée 
aux moments de spin de la Fe(TMPyP) pour différents pH. Elle possède un spin de 5/2 à pH 
<5 et le spin chute à 1/2 à un pH supérieur de 7 à cause de la formation de Fe-O-Fe et de la 
dimérisation de la substance [13]. Nos résultats sont situés dans la plage des valeurs 
rapportées avec une faible différence qui est liée aux variations du champ magnétique 
appliqué.  Le nombre de molécules d'eau coordonnées au Fe(II) en première sphère dépend du 
pH de la solution qui peut varier entre 1 et 2. Dans nos conditions d’étude (pH), le Fe(II) 
coordonne avec une molécule d’eau si on en compare son spectre UV-visible avec celui 
mentionné par Gandini et al. [14]. De plus, en raison de la charge positive de la position ortho 
de la Fe(TMPyP), les électrons ont tendance à être retirer et à renforcer les liaisons eau-métal. 
Cela risque de provoquer l'augmentation du temps de résidence d’une molécule d’eau jusqu’à 
1,3s à température ambiante [15] Ainsi, une molécule d’eau coordonnée en première sphère 
avec un temps de résidence long entraine une valeur de r1 de 3,7 mM
-1
s
-1
 à 0.47T et 37°C.  
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Mn (TSPP) présente une forte r1 de 6,63 mM
-1
s
-1
, conformes à celles déclarées 
antérieurement [16],[17]. Mn (III) ion coordonnées axialement avec deux molécules d'eau en 
1
 iére 
sphère [18]. Surtout, grâce à la grande densité électronique au centre de Mn(TSPP), les 
liaisons de l’eau au centre métallique (Mn) labialise qui promeut le mécanisme de l'échange 
chimique de la molécule d’eau entre la 1 iére sphère de coordination et du solvant. Cela conduit 
à avoir un temps de résidence court, déclarée de 36 ns à température ambiante [18]. De plus, 
la courte distance minimale d’approche entre entre le Mn(II) et le proton d'une molécule d'eau 
(~ de 2.26Ǻ) pourrait pousser à augmenter l'interaction dipolaire [14].  
La r1 de Gd-DOTA dilué dans le mélange eau/éthanol (3,51 mM
-1
s
-1
) est légèrement inférieur 
à celle de Gd-Dota dilué dans l'eau, qui est en bon accord avec celle rapportée [19]. Cette 
petite différence pourrait être liée à la structure de l'éthanol. Dans le mélange eau/éthanol, 
quatre sites distincts chimiquement existent qui étaient occupées par l'hydrogène, tels que les 
groupes méthyle (CH3), méthylène (CH2), une liaison H-O polaire de l'éthanol et un 
hydrogène de l’éthanol avec un oxygène de l'eau. Par conséquent, il est signalé l’artefact de 
déplacement chimique du méthyle et méthylène est du à un décalage de la fréquence de 
résonance qui provoque l’augmentation de la relaxation [19]. 
La structure moléculaire de Gd(TPyP) a déjà été étudié par la spectroscopie infrarouge et la 
diffractométrie de rayons X, en supposant que on a une molécule d'eau coordonnée avec Gd 
(III) [20]. Par ailleurs, sa masse moléculaire de 833 g/mol n’est pas assez haute pour avoir une 
haute relaxivité. Ainsi, la masse moléculaire et une molécule d’eau en 1iére sphère de 
Gd(TPyP) ne pouvaient pas les seuls paramètres déterminant la relaxivité. Cette r1 haute peut 
être attribuée à d'autres paramètres comme le temps de résidence de l'eau, la distance entre Gd 
(III) et de la molécule d'eau coordonnée, ainsi que le temps de corrélation de la rotation. De 
plus, d'autres propriétés de la structure moléculaire, comme bien situés de l'ion métallique au 
centre de chélate [21],[22], l’isotrope de complexe [21],[22], et la rigidité de la liaison entre 
des ions métalliques et des chélates [23] pourrait influencer la relaxivité de Gd (TPyP). 
Par ailleurs, la diminution de r1  de Gd(TPyP) et Gd-Dota avec le champs magnétique a été 
associée à une contribution négligeable du temps de relaxation électronique à champ 
magnétique élevé (au-dessus 1.5T) [24]. De plus, l’accroissement de leur r2 avec le champ 
magnétique est dû à l'augmentation linéaire de l'aimantation [25]. La température peut aussi 
avoir un effet significatif sur la relaxivité. Il est connu que la relaxivité diminue lorsque la 
température augmente [26]. Sur la base de l'équation Stoke-Einstein-Debye, la baisse de la r1 
est due à la relation entre le temps de corrélation de la rotation avec la température [27]. Ce 
temps croît avec la température, ce qui provoque une diminution de relaxivité [28]. Un autre 
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paramètre dépendant de la température est le temps d’échange de la molécule d’eau au 
voisinage du Gd. A basse température, la r1 serait limitée tandis que la vitesse d'échange 
d’eau est assez rapide [26]. 
 
3.2. Caractérisation physico-chimique de Gd(TPyP)-NC 
 
Nous avons étudié le chargement de Gd(TPyP) en NC par conjugaison chimique. Comme 
décrit dans le protocole, la conjugaison chimique de Gd(TPyP) avec NC a été effectuée en 
ajoutant 1 ml de Gd(TPyP) soit dans l'acide acétique (NP-1) ou dans la PPT (NP-2) solution. 
Les spectres UV-visible des nanoparticules préparées (NP-1) et (NP-2) ont été présentés dans 
la figure 4, en comparant avec celui de Gd(TPyP) dans l'éthanol. Le spectre de NP-2 est 
similaire au spectre des NP-1. Le spectre de NP-1 contient la bande de Soret intense à 445 nm 
suivie par 3 bandes Q (522 nm, 552 nm et 588 nm), tandis que le spectre de NP-2 presente 
une bande de Soret large et basse à 416 nm suivie par 3Q bandes (516, 556, et 587 nm). Dans 
les deux spectres de NP-1 et NP-2, la disparition de la bande caractéristique de Gd(TPyP) à 
554 nm et simultanément l’accroissant du pic de la bande Q de H2(TPyP) à 517 nm ont été 
observée, qui pourraient être marqué comme structurelle déformation de Gd (TPyP). Se 
référant à la probabilité de démétallation de Gd(TPyP) cours de la conjugaison chimique de 
Gd(TPyP) à NC, cette technique n'est pas bonne pour l'encapsulation de Gd(TPyP) par NC. 
D'après la figure 4, le spectre de Gd(TPyP) chargé à NC via la méthode passive est semblable 
à celui de Gd(TPyP) dans l'éthanol qui affiche une bande de Soret intense à 419 nm suivie par 
une bande Q à 552 nm. Le léger décalage observé du pic de Soret devrait être liée à la 
différence de solvant utilisé.  
 
Figure 4. Les spectres UV-Vis de Gd (TPyP) dans l'éthanol, les NP-1 et NP-2 : Gd (TPyP) -
NC par conjugaison chimique, NP-3: Gd (TPyP) -NC via la méthode passive 
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Comme présenté dans la figure 5, tous les échantillons ont montré solubilité dans l'eau. Les 
échantillons 1, 2, 3, et 4 respectivement correspondent à 2, 4, 8, et 12 mg de Gd(TPyP) 
chargés à 4 mg de NC. La spectroscopie UV-visible a été utilisée pour déterminer la 
concentration de la Gd(TPyP) en NC. Figure 5 expose l'absorption de Gd(TPyP)–NC après 
charger quantité différente de Gd(TPyP) à NC. On peut voir que l'intensité de la bande de 
Soret  de Gd(TPyP) -NC augmente avec la concentration de Gd (TPyP).  
 
Figure 5. Les spectres UV-visible de Gd (TPyP) -NC après le chargement de la quantité 
différente de Gd(TPyP) en NC 
 
En outre, des mesures quantitatives avec spectrométrie de masse couplée à un plasma 
inductif ICP-MS) ont été effectuées. Cette méthode donne la valeur réelle de Gd chargé en 
NC. La corrélation linéaire entre la valeur obtenue par mesure UV et ICP-MS a été observée.  
Le pourcentage de l’efficacité (%LE) et de la capacité de chargement (%LC), et du rendement 
des nanoparticules ont été évalués. Effet de différentes concentrations de Gd(TPyP) sur l'LE, 
LC et le rendement (%) de Gd(TPyP) -NC a été présenté à la Figure 6. Il a été observé que LE 
maximal (87%) était réalisés au taux 1/2 cependant LC et le rendement (%) atteignent leur 
maximum à un rapport de 1/ 3. 
 
Figure 6. Le pourcentage de l’efficacité (%LE) et de la capacité de chargement (%LC), et du 
rendement des nanoparticules pour différents rapports de Gd (TPyP) -NC 
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L’efficacité des échantillons avec le chargement de différant contenu dans l'eau distillée ont 
été étudiés par IRM à 3T. Les images pondérées en T1 et T2 de Gd (TPyP) -NC dans l'eau ont 
été présentés à la figure 7. L’intensité du signal en T1 accroît, alors que le signal en T2 
diminue avec le chargement de Gd(TPyP) ainsi que les concentrations de Gd(III). 
 
 
Figure 7. Écho de spin pondérée T1 (TR = 400 ms, TE = 8 ms) et T2 (TR = 1500 ms, TE = 40 
ms) de concentration différente de Gd(TPyP)-NC dans l'eau à 3T, et r1 et R2 relaxivité de Gd 
(TPyP)-NC, Gd(TPyP) et Gd-DOTA solution 
 
En comparant les valeurs r1 et r2 de Gd(TPyP)-NC avec celle de DOTA-Gd, une valeur de r1 
haute de 38 mM
-1
s
-1 
à 60 MHz a été obtenue qui est 12 fois plus élevée que celle de Dota-Gd. 
Ainsi, la mise en valeur de la valeur de r1 avec la conjugaison de Gd(TPyP) à NC est 
conforme à ceux que l'on a publiés. Le renforcement de la relaxivité avec la conjugaison de 
AC avec NC pourrait être expliqué comme : une diminution du temps de corrélation de 
rotation par attachement du complexe à NC, une augmentation de la vitesse d'échange des 
molécules d'eau et une augmentation de la quantité d'ions paramagnétique chargé dans une 
nanoparticule. 
Nous avons observé que la r2 est baissée de 69,97 mM
-1
s
-1 
à 33,43 mM
-1
s
-1 
après conjugaison 
de Gd(TPyP) avec NC. La diffusion de la molécule de l'eau en présence de particules 
hydrophiles diminue ce qui augmente la valeur de r2 [20]. En outre, nous pourrions supposer 
que plus d’un ion de Gd (III) est chargé dans les nanoparticules qui sont dû une augmentation 
de r2. Notre résultat obtenu est incompatible avec ces explications. La r2 élevée de Gd(TPyP) 
dans l'éthanol pourrait être attribuée à son agrégation pendant les mesures a cause de sa peine 
soluble dans un solvant organique. Cela pourrait conduire à la formation de l'agrégation 
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moléculaire, qui cause un accroissement de la r2. Alors que, la formation de l'agrégation 
diminue avec le chargement Gd(TPyP) à NC. 
 
3.3. Mn :ZnS quantum dots  
 
L’étude structurale de nanoparticules Mn :ZnS a montré, à partir des pics du diagramme de 
DRX, que toutes les nanopartiucles sont parfaitement indexables dans la structure belnde sans 
aucune impureté crystalline ni amorphe. Par ailleurs, la taille de nanoparticules est estimée par 
affinement des diagrammes en utilisant le logiciel MAUD. Les résultats obtenus sur la taille 
de nanoparticules par DRX et MEB et d’analyse des teneurs en Mn (II) par EDX et XRF sont 
regroupés et présentés dans le tableau 4. 
 
Tableau 4. Caractéristiques physico-chimiques de MnxZn1-xS tels que la composition 
chimique mesurée par la fluorescence X et l' analyse EDX , et la taille moyenne des cristaux < 
LXRD > mesurée par DRX < DTEM > et à partir des images MEB 
 
Samples 
Mn/(Zn+Mn) 
at.-% 
Zn/(Zn+Mn)  
at.-% 
Nanoparticles size 
EDX  XRF EDX XRF <LXRD> (nm) <DTEM> (nm) 
Mn0.1Zn0.9S 10 9.2 90 90.8 1.6 1.54  0.15 
Mn0.2Zn0.9S 20 17.0 80 83 1.8 1.63  0.26 
Mn0.3Zn0.7S  30 26.0 70 74 1.9 1.55 0.25  
 
L’analyse EDX et XRF confirme clairement la présence du Mn. Notons que la composition 
des nanoaprticules mesurée par EDX est pratiquement identique à celle par XRF.   La 
variation de la composition en Mn n’incite pas de différences structurales et de tailles notables 
par rapport aux résultats de MEB et DRX. 
Les spectres de photoluminescence ( PL ) des trois échantillons de Mn :ZnS ont été présentés 
dans la figure 8 . De Figure 66, les trois échantillons présentaient une large bande d'émission 
bleue avec un pic distinct autour de 465 nm. Notons que l’intensité du pic diminue lorsque la 
concentration de dopage en Mn augmente. Normalement, le spectre PL est constitué des 
émissions bleu et jaune respectivement, dans les intervalles 400-500 nm et 580 à 600 nm. 
L’émission bleue de MnZnS doit être associée à la lutte contre les émissions de défauts de 
ZnS hôte [29] alors que l'émission jaune est incorporée à 
4
T1 - 
6
A1 transition de Mn (II). 
Théoriquement, des Mn (II) ions prennent la place des ions Zn
2+
 à condition de posséder la 
même taille et la charge ainsi que les mêmes propriétés chimiques [30]. Il a été rapporté 
qu'une partie de Mn (II) pourrait être située en surface, ou plus exactement en interface des 
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cristallites [31]. Sooklal et al. [32] ont reporté que l’émission orange de Mn :ZnS 
nanoparticules est associée au Mn ion qui est  incorporé dans une matrice ZnS et l’émission 
bleue associée à celle qui est sur la surface de ZnS. Des photographies d'émission de 
Mn0.1Zn0.9S et ZnS sous excitation UV (325 nm) ont été présentées dans la figure 8. Nous 
avons observé l'émission bleue pour Mn: ZnS qui indique l'incorporation de Mn (II) sur la 
surface de ZnS. De ce fait, une émission orange-jaune à 590 nm n’est pas toujours observée 
dans le spectre de PL des Mn: ZnS de nos études.  
 
Figure 8. Les spectres d'émission de photoluminescence de MnxZn1-xS (0.1≤x≤0.3) enregistré 
à 300K, le médaillon émission observée pour a) ZnS et b) Mn0.1Zn0.9S) à λ=325  
 
La capacité de MnZnS colloïdes à accélérer ainsi les vitesses de relaxation des protons de 
l’eau a été étudiée à l'aide d'un scanner IRM à 3T. Les concentrations de Mn (II) ont été 
mesurées par la spectroscopie de masse couplée à un plasma inductif (ICP-MS). Le T1 et T2 
pondérés de Mn: ZnS (dans l'eau) sont présentés dans la Figure 9. L’IRM montre en T1 et en 
T2 l’augmentation du signal en présence du Mn :ZnS nanoparticules par rapport à la solution 
ZnS. L'intensité des signaux en T1 pour trois colloïdes augmente progressivement avec la 
concentration de Mn (II). La relaxation est l'un des paramètres le plus important pour montrer 
l'efficacité de colloïdes préparés comme un agent de contraste IRM. Ainsi, r1 et r2 de 
MnxZn1-xS (x = 0,1, 0,2, et 0,3) en solution à différentes concentrations ont été évaluées. 
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Figure 9. Écho de spin pondérée T1 (TR = 400 ms, TE = 8 ms) et T2 (TR = 1500 ms, TE = 40 
ms) de concentration différente de MnxZn1-xS (x = 0,1 ; 0,2 ; 0,3) dans l'eau à 3T 
 
Les temps de relaxation longitudinale et transversale (T1 et T2) de MnxZn1-xS (x = 0,1 ; 0,2 ; 
0,3) des solutions à différentes concentrations ont été montrés dans la figure 10. Une 
augmentation de r1 de 20,34 à 86,09 mM
-1
.s
-1
 et r2 de 37,37 à 54,95 mM
-1
.s
-1
 avec 
l'accroissement de Mn(II) de 10% à 20%. Pour une teneur en Mn plus élevée (Mn = 0,3), r1 et 
r2 diminuent. 
  
 
Figure 10. La r1 et la r2 de MnxZn1-xS (x=0,1 ; 0,2 ; 0,3) à 3T 
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La haute relaxivité r1 de tous les trois nanoparticules de Mn :ZnS variant de 20 à 75 mM
-1
s
-1
 
peut être attribuer à la taille petite (≤ 2 nm) des nanoparticules qui a provoqué l'accumulation 
des ions Mn(II) sur la surface de ZnS. La localisation de Mn (II) sur la surface de ZnS 
provoquerait la réduction de la distance (r) entre les molécules d’eau et Mn(II). La distance 
entre les ions paramagnétiques et molécule d'eau joue un rôle important sur la relaxivité. 
D'autre part, l’enrobage des nanoparticules pourrait également avoir un impact sur la 
relaxivité. L'acide thioglycolique hydrophile permet à l'eau de pénétrer à la sphère intérieure 
de Mn: ZnS [33], et contribue l'amélioration de r1. Ainsi, la grande valeur r1 de Mn: ZnS dans 
notre étude pourrait être liée à des ions Mn localisées sur la surface de ZnS, qui est grande par 
rapport au volume, l’enrobage avec l'acide thioglycolique et le nombre élevé de surface 
coopérative de Mn(II). En outre, la contribution des sphères secondaires et externes est 
importante dans la relaxation totale de nanoparticules [5]. Le groupe carboxylique de l'acide 
thioglycolique est fortement polaire [34]. Par conséquent, favorablement il fait des liaisons 
hydrogène fortes avec les molécules d'eau [35]. Ces interactions fortes entraînent 
l'augmentation de temps résidence des molécules d'eau en sphère secondaire [35]. De ce fait, 
le groupe carboxylique de l'acide thioglycolique peut favoriser la contribution de sphère 
secondaire qui va améliorer la relaxivité du Mn: ZnS. Nous avons observé un abaissement de 
r1 et r2 de Mn:ZnS pour le dopage de Mn de 30%. Cela pourrait être lié à une interaction 
dipôle-dipôle significative à cette concentration de la teneur en Mn (30%) qui raccourcit les 
temps de relaxation électronique et de réduire la relaxation globale. 
Après avoir observé la diminution de r1 et r2 pour Mn0.3Zn0.7S par rapport à celles de 
Mn0.1Zn0.9S et Mn0.2Zn0.8S ; Mn0.3Zn0.7S a été choisi pour les études ultérieures. Les 
Mn0.3Zn0.7S nanoparticules de taille différentes (dans le tableau 5 ) ont été synthétisés et 
recueillies par la centrifugeuse. Les tailles de nanoparticules ont été estimées à partir de 
l'image MEB et les spectres DRX. Les résultats obtenus ont été répertoriés dans le tableau 5. 
Le diamètre moyen des particules Mn0.3Zn0.7S évalué par MEB montre un accord raisonnable 
avec les données de DRX. 
 
Tableau 5. La taille des particules de Mn0.3Zn0.7S évalué à partir de MEB et DRX 
Sample Particle size by TEM Particle size by XRD 
Mn0.3Zn0.7S (S1) 1.55 1.8 
Mn0.3Zn0.7S (S2) 1.85 1.9 
Mn0.3Zn0.7S (S3) 2.1 2.3 
Mn0.3Zn0.7S (S4) 2.6 2.5 
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Les images pondérées en T1 et T2 des quatre échantillons (S1, S2, S3, et S4), comme indiqué 
dans le tableau 5, en solution aqueuse à 3T ont été présentées dans la figure 11. Les images 
pondérées en T1, les nanoparticules induisent une amélioration de l'intensité du signal avec 
l'augmentation des concentrations de Mn (II) et la taille de nanoparticules.  
 
 
Figure 11. Écho de spin pondérée T1 (TR = 400 ms, TE = 8 ms) et T2 (TR = 1500 ms, TE = 
40 ms) de Mn0.3Zn0.7S avec granulométrie différente 
 
Les r1 et r2 de la taille différente de Mn0.3Zn0.7S ont été exhibées dans la figure 12. La r1 
diminue considérablement avec l'accroissement de la taille des particules, à partir d'une valeur 
de 75,5 mM
-1
.S
-1
 pour les plus petites particules (1,55 nm) à 42,81 mM
-1
.s
-1
 pour les plus 
grandes particules (2,5 nm). Parallèlement, la r2 diminue de 40,4 pour S1 à 31,4 mM
-1
.s
-1
 pour 
S2 colloïdes, alors qu'aucun changement observé pour celle de S3 et S4. 
 
L’abaissement de r1 avec la taille des particules est en accord avec ceux rapportés 
précédemment. La réduction du rapport surface/volume des particules pourrait être 
responsable de cette diminution. En raison de la dépendance des relaxivités r1 et r2 avec la 
taille de nanoparticules, le changement de r2 est moins prononcée que r1. La diminution de r2 
de S1 à S2 pourrait être attribuée à la diminution du rapport surface sur volume. Bien que, la 
r2 de S3 et S4 n'a pas changé. Roohi et al. ont également observé la même tendance pour la r2 
de SPIO [36] qui change avec l'augmentation de rayon hydrodynamique de SPIO jusqu'à 60 
nm alors que pour celles qui sont plus grandes, la r2 reste constante [36].  
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Figure 12. la r1 et la r2 de Mn0.3Zn0.7S avec granulométrie différente 
 
3.4. Simulation par dynamique moléculaire (DM)  
3.4.1. DM de nanoparticules Mn :ZnS 
 
Dans un premier temps, nous avons simulé la structure blende de MnZnS. Les caractéristiques 
structurales peuvent s’analyser au moyen de fonctions de distribution radiale g(r) et fonctions 
de distribution cumulée n(r), lesquelles sont évaluées pour chaque paire de types d’atome. 
Elles sont représentées dans la figure 13 et les valeurs caractéristiques synthétisées dans le 
tableau 5. 
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Figure 13. g(r) et n(r) de la structure blende de MnxZn1-xS (x=0,1 ; 0,2 ; 0,3) dans le vide 
 
Tableau 5. Les caractéristiques structurales de MnxZn1-xS (x=0,1 ; 0,2 ; 0,3) simulées tels 
que : les fonctions de distribution radiale g(r), les fonctions de distribution cumulée n(r) pour 
chaque paire de types d’atome, paramètre de maille et le volume de maille 
 Mn0.1Zn0.9S Mn0.2Zn0.8S Mn0.3Zn0.7S ZnS Expt. 
Pair atoms 1
st
 g(r) 1
st
 n(r) 1
st
 g(r) 1
st
 n(r) 1
st
 g(r) 1
st
 n(r) 1
st
 g(r) 1
st
 n(r) 1
st
 g(r) 1
st
 n(r) 
Mn-Mn 3.87 0.22 3.87 2.90 3.87 3.80 ---- ----   
Mn-Zn 3.82 11.77 3.82 9.09 3.82 8.19 ---- ----   
Mn-S 2.42 4 2.42 4 2.42 4 ---- ----   
Zn-S 2.32 4 2.32 4 2.32 4 2.32 4 2.34 4 
Zn-Zn 3.77 10.08 3.77 9.67 3.77 8.62 3.78 12 3.82 12 
a (Å) 5.394 5.407 5.429 5.39 5.409 
Unit cell 
Volume (Å
3
) 
156.99 158.10 160.04 156.68 158.34      
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Comme indiqué dans le tableau 5, la coordination de Zn par Zn diminue légèrement avec 
l’augmentation de la teneur en Mn. Par ailleurs, la plus courte distance pour la paire Mn-S est 
relevée à 2,42 Å, ce qui est en bon accord avec la distance Mn-S mesurée par spectroscopie 
d'absorption des rayons X (2,43 à 2,45 Å) [12]. Dans la structure cristalline de Mn:ZnS, et 
pour différentes concentrations de Mn (10 à 30%), la première interaction d'atomes de Mn-
Mn est à 3,87 Å. En se référant à la RDF calculée, l'incorporation d'atomes de Mn dans ZnS 
n'affecte pas la structure blende de ZnS et provoque seulement l'expansion de la structure de 
tétraèdre de ZnS. Cette expansion a un effet sur le paramètre de maille, comme observé avec 
son augmentation de 5,394 Å pour Mn0.1Zn0.9S à 5.429 Å pour Mn0.3Zn0.7S. Wright et al. ont 
étudié la structure cristalline de ZnS dans laquelle Mn est introduit comme impureté dans les 
sites ZnS [37]. Ils ont rapporté une distance Mn-S de 2,41 Å et une augmentation du 
paramètre de maille de 0,00064 Å par % de MnS, c’est-à-dire pour la substitution d'un atome 
Mn dans (ZnS)4 [37]. Alors que pour l'incorporation d’un deuxième Mn dans (ZnS)4, ils ont 
rapporté moins de distorsion avec une distance entre les Mn qui évolue jusqu’à 3,87 Å [37]. 
De ce fait, l'accroissement du paramètre de maille avec l’augmentation du dopage en Mn dans 
notre étude est cohérent. En outre, des études expérimentales ont également rapporté 
l'augmentation du paramètre de maille et du volume des cellules de Mn:ZnS avec la teneur en 
Mn. En raison des paramètres cristallins rapportés de ZnS: Mn, soit à partir de simulations ou 
de caractérisations expérimentales, les nanoparticules MnZnS simulées avec différentes 
teneurs en Mn sont donc fiables. 
 
 
Figure 14. Les structures de surface (110) de a) ZnS et b) MnZnS , Zn : rouge , S : jaune , et 
Mn : gris 
 
Une visualisation des structures simulées par DM a pu être obtenue en utilisant le logiciel 
ATEN [38]. Les structures de surface (110) de ZnS et MnZnS après relaxation sont illustrées 
dans la Figure 14. Comme on l’observe dans la figure 14, les atomes de S s’écartent de leurs 
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positions naturelles avant relaxation, et ceci dans les deux structures. Le mouvement des 
atomes de Zn et S après relaxation de la structure des cristaux de ZnS a été étudié par Wright 
et al. [39]et Duke et al. [40]. Tous deux ont rapporté ce décalage des atomes de S par rapport 
à Zn. 
 
3.4.2. DM de nanoparticules Mn :ZnS en solution  
 
L'interaction de MnZnS avec des molécules d'eau, SPC/E et TIP3P, a été étudiée par DM. Les 
fonctions de distribution radiale et cumulées obtenues à partir de la simulation sont présentées 
dans la figure 15. Les valeurs caractéristiques sont reportées dans le tableau 6. Avec 
l’évolution de la teneur en Mn, on note toutefois que les fonctions de distribution radiale 
relatives aux paires Mn-Mn, Mn-Zn et Mn-S présentent des différences notables avec celles 
obtenues pour la structure solides sans eau. Ainsi, on constate que l’hydratation de la 
nanoparticule altère sensiblement sa structure cristalline. Plus particulièrement, la distribution 
radiale de la paire Mn-Mn présente un pic fort après deux larges pics tandis que chaque pic 
comprend plusieurs pics de faible intensité. Et pour toutes les paires atomiques, la fonction de 
distribution radiale présente un premier grand pic relatif à la première coordination et des pics 
moins intenses et plus larges correspondant à la deuxième ou à la troisième sphère de 
coordination sphère. On note aussi que les minima sont non nuls. Ces indications sont la 
signature d’une légère déstructuration du cristal qui, a priori, doit prendre lieu à l’interface 
avec l’eau. 
 
Tableau 6. Les fonctions de distribution radiale g(r), les fonctions de distribution cumulée n(r) 
simulées de MnxZn1-xS (x=0,1 ; 0,2 ; 0,3) dans l’eau pour chaque paire de types d’atome 
comparant avec ceux de ZnS dans l’eau 
 
Atomic 
pairs 
Mn0.1Zn0.9S +H2O Mn0.2Zn0.8S +H2O Mn0.3Zn0.7S +H2O ZnS+ H2O 
1
st
 g(r) 1
st
 n(r) 1
st
 g(r) 1
st
 n(r) 1
st
 g(r) 1
st
 n(r) g(r) n(r) 
Mn-Mn 3.87 1.04 3.77 0.57 3.87 1.59 ---- ---- 
Mn-Zn 3.77 5.22 3.77 5.92 3.77 6.22 ---- ---- 
Mn-S 2.37 2.74 2.37 2.74 2.37 2.74 ---- ---- 
Zn-S 2.20 3.68 2.27 3.65 2.32 3.59 2.38 3.46 
Zn-Zn 3.79 8.41 3.77 8.49 3.72 8.58 3.82 10.28 
Mn-H 2.62 7.25 2.72 7.25 2.77 7.25 ---- ---- 
Mn-O 2.37 2.74 2.37 2.74 2.37 2.74 ---- ---- 
Zn-H 2.62 0.82 2.62 0.82 2.62 0.82 1.88 0.55 
Zn-O 1.97 0.36 1.97 0.36 1.97 0.36 2.48 1.17 
S-O 3.27 3.07 3.27 3.07 3.27 3.07 3.38 5.45 
S-H 2.62 2.70 2.62 2.70 2.62 2.70 2.73 1.91 
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Figure 15. g(r) et n(r) de nanoparticule de MnxZn1-xS (x=0,1 ; 0,2 ; 0,3) dans l’eau 
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En outre, le pic intense de RDF de Mn-O pourrait confirmer l’interaction forte entre ces deux 
types d’atome. Si l'on considère le nombre d'oxygène comme le nombre de molécules d'eau 
coordonnées, les atomes de Zn sont en moyenne coordonnées avec 0,5  molécules d'eau à 2 Å, 
tandis que des atomes Mn se coordonnent avec ~ 3 molécule d’eau à la même distance. 
 
 
Figure 16. la vue 3D de nanoparticules de Mn :ZnS dans l’eau  
 
Comme indiqué dans le tableau 6, la coordination de Mn en Mn au sein des nanoparticules 
MnZnS est diminuée de ~ 1 de dans le système hydraté par rapport dans la structure blende 
non hydratée. Cela pourrait être dû à l’interaction forte des atomes de Mn positionnés à 
l’interface avec l’eau, réduisant d’autant les interactions Mn-Mn. A partir de la vue 3D de 
MnZnS hydraté (figure 16), on peut constater que chacun des Mn situés à l’interface fait des 
liaisons avec de 1 à 4 molécules d'eau.  
La longue distance (~ 1 Å) entre la 1
ère
 et la 2
ème
 sphère de coordination de Mn pourrait 
confirmer la liaison forte des atomes de Mn avec les molécules d'eau en 1
ère
 sphère. Cela 
prolongerait le temps de résidence des molécules d’eau en 1ère sphère alors que ces molécules 
d'eau sont toujours en échange avec des molécules d'eau situées dans la 2
ème
 sphère puisque le 
minimum de g(r) est non nul sur cet intervalle. Par ailleurs, le recouvrement des deuxième et 
troisième pics, correspondant respectivement à la 2
nde
 et 3
e
 sphère d’hydratation autorise à 
penser que les échanges de molécules d’eau entre ces deux sphères sont très favorisés. Donc a 
priori le temps de résidence des molécules d’eau dans la seconde sphère d’hydratation doit 
être court. Bien que nous pourrions rendre plus réalistes ces simulations en envisageant un 
enrobage d'acide thioglycolique autour de nanoparticules afin, dans l’idéal, de pouvoir prédire 
exactement le mécanisme de relaxation des nanoparticules MnZnS en solution aqueuse, ces 
 
 
xxxviii 
 
résultats expliquent déjà très bien les temps de relaxation courts de MnZnS en solution 
aqueuse. 
 
4. Conclusion 
 
Cette thèse est réalisée sous la direction du Pr Soraya Benderbous au laboratoire INSERM-
U825 Imagerie Cérébrale et Handicap Neurologique au sein de l’équipe 1 Neuro- Imagerie 
Clinique et Cognitive de l’université de Toulouse.  Elle concerne  le  développement  de  deux  
nouveaux  agents  de contraste IRM macromoléculaires et nanoparticulaires présentant une 
solubilité élevée, et une efficacité élevée (haute relaxivité) à haut champ ( 3T ).  
Les travaux ont fait l’objet de plusieurs collaborations scientifiques : 
- Pour le développement des nanoparticules, avec le laboratoire chimie des matériaux, 
Nanoscience de l’université de Paris-7 sous la direction du Prof Souad Ammar Merah, 
- Pour le développement des complexes de Gd-Porphyrrines liées au chitosan, avec le 
laboratoire de chimie bioorganique et bioinorganique de l’université de Paris-sud sous la 
direction du Dr Hafsa Korri-Youssoufi  
- Pour les simulations en dynamique moléculaire avec  laboratoire de Photonique LPHIA | 
UPRES EA 4464 ( université d’Angers ) sous la direction du Pr Stéphane Chaussedent.  
La première substance développée est la Gd (III)-méso-tétra (4-pyridyl) porphyrine (Gd 
(TPyP)) macromoléculaire. Le complexe obtenu présente une grande relaxivité r1 de 24 mM
-
1
s
-1
à 60 MHz soit une efficacité au moins 6 fois plus importante que celles des agents 
conventionnels. Afin d’améliorer sa biocompatibilité médicale, sa solubilité de l’eau, et 
augmenter son efficacité en IRM, la Gd-porphyrine a été conjuguée avec les nanoparticules de 
chitosan. Ainsi, une valeur de 38 mM
-1
s
-1
 à 60 MHz  9 fois plus élevée que celle de Dota-Gd a 
été obtenue.  
Parallèlement, nous  avons  développé le concept de greffage de Mn dopé à la surface de 
nanoparticules ZnS afin d’améliorer l’accessibilité de l’eau au moment magnétique du Mn. 
Les nanoparticules ont une relaxivité r1 variant de 20 à 75 mM
-1
s
-1
 pour un taux de Mn 
passant de 0.1 à 0.3, par rapport au produit commercial Mn DPDP (r1=2.8 mM
-1
.s
-1
 à 42 
MHz). Par la suite, l’influence de la granulométrie de Mn0.3Zn0.7S sur son efficacité a été 
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étudiée. Leur r1 a diminué de 75 à 42 mM
-1
s
-1
 avec l'augmentation de la dimension 
particulaire.  
Pour expliquer le mécanisme, une simulation numérique de la dynamique moléculaire de 
l’eau au voisinage des nanoparticules de MnZnS a été développée pour aboutir à une 
meilleure compréhension du mécanisme de relaxivité de MnZnS en solution aqueuse.  En se 
référant à la RDF calculée, l'incorporation d'atomes de Mn dans ZnS n'affecte pas la structure 
blende de ZnS et provoque seulement l'expansion de la structure de tétraèdre de ZnS. Cette 
expansion a un effet sur le paramètre de maille, comme observé avec son augmentation de 
5,394 Å pour Mn0.1Zn0.9S à 5.429 Å pour Mn0.3Zn0.7S. En outre, des études expérimentales 
ont également rapporté l'augmentation du paramètre de maille et du volume des Mn:ZnS avec 
la teneur en Mn. En raison des paramètres cristallins rapportés de ZnS: Mn, soit à partir de 
simulations ou de caractérisations expérimentales, les nanoparticules MnZnS simulées avec 
différentes teneurs en Mn sont donc fiables. L'interaction de MnZnS avec des molécules 
d'eau, SPC/E et TIP3P, a été étudiée par DM. On constate que l’hydratation de la 
nanoparticule altère sensiblement sa structure cristalline. En outre, le pic intense de RDF de 
Mn-O pourrait confirmer l’interaction forte et la liaison forte entre ces deux types d’atome. 
Cela prolongerait le temps de résidence des molécules d’eau en 1ère sphère alors que ces 
molécules d'eau sont toujours en échange avec des molécules d'eau situées dans la 2
ème
 sphère 
puisque le minimum de g(r) est non nul sur cet intervalle. Par ailleurs, le recouvrement des 
deuxième et troisième pics, correspondant respectivement à la 2
nde
 et 3
ème
 sphère 
d’hydratation autorise à penser que les échanges de molécules d’eau entre ces deux sphères 
sont très favorisés. Si  l'on  considère le  nombre  d'oxygène comme représentatif  du nombre  
de molécules  d'eau coordonnées, des atomes Mn se coordonnent avec ~ 3 molécule d’eau à 2 
Å. A partir de la vue 3D de MnZnS hydraté, on peut constater que chacun des Mn situés à 
l’interface fait des liaisons avec de 1 à 4 molécules d'eau.  
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-1
s
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compared to r1 of Gd-DOTA). In the next step, Gd(TPyP) has been conjugated to chitosan 
nanoparticles in order to improve its biocompatibility and water solubility. The small water-soluble 
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-1
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 at 3T than 
the one of Gd(TPyP) in ethanol and 9-fold greater than r1 of Gd-DOTA.  
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to volume ratio from 75.5 to 42.81 mM
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. In order to obtain the insight through the relaxivity of 
Mn:ZnS nanoparticles, computational technique has been carried out to predict the interaction and 
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RESUME en français 
L’objectif du travail de thèse est de concevoir et développer 2 classes d’agent de contraste 
(AC) intrinsèquement efficace en IRM. La première classe comprend le Gd (III)-méso-tétra (4-
pyridyl) porphyrine (Gd (TPyP)) macromoléculaire. Son efficacité a été comparé avec deux produits 
de référence : la Mn(III)-méso-tétra(4-sulfonatophenyl)porphyrine (Mn(III)TSPP), et Fe(II)-méso-
tétra(N-methylpyridinium)porphyrine (Fe(II)TMPyP) à de deux champs magnétiques de 20 MHz et 60 
MHz.  En particulier, la relativité r1 la plus grande est obtenue pour le complexe Gd(TPyP) (24 mM
-1
s
-
1
à 60 MHz) soit une efficacité au moins 6 fois plus importante que pour les complexes de Gd 
conventionnels. Afin d’améliorer sa biocompatibilité médicale, sa solubilité de l’eau, et augmenter son 
efficacité en IRM, la Gd-porphyrine a été conjuguée avec les nanoparticules de chitosan. Ainsi, une 
valeur de 38 mM
-1
s
-1
 à 60 MHz  9 fois plus élevée que celle de Dota-Gd a été obtenue dans l’eau.  
Dans la 2
ème
 partie de la thèse, nous avons développé le concept de greffage de Mn dopé à la surface 
de nanoparticules ZnS afin d’améliorer l’accessibilité de l’eau au moment magnétique du Mn. Les 
nanoparticules ont une relaxivité r1 variant de 20.34 à 75.5 mM
-1
s
-1
 pour un taux de Mn passant de 0.1 
à 0.3, par rapport au produit commercial Mn DPDP (r1=2.8 mM
-1
.s
-1
 à 42 MHz). Par la suite, 
l’influence de la granulométrie de Mn0.3Zn0.7S sur son efficacité a été étudiée. Leur r1 a diminué de 
75.5 à 42.81 mM
-1
s
-1
 avec l'augmentation de la dimension particulaire. Pour expliquer le mécanisme, 
une simulation numérique de la dynamique moléculaire de l’eau au voisinage des nanoparticules de 
MnZnS a été développée. Les résultats de la simulation de la structure cristalline de MnZnS sont 
concordent avec les valeurs expérimentales par la cristallographie aux rayons X. Le modèle a été 
amélioré en incluant un effet de la concentration variable au Mn dans un environnement aqueux. 
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